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Thesis outline
Over the last decade, Epithelial-to-Mesenchymal Transition (EMT) has gained the
attention of cancer researchers due to its potential to promote cancer migration
and metastasis. However, the complexity of EMT intertwined regulation and the
involvement  of  multiple  signals  in  the  tumour  microenvironment  have  been
limiting  the  understanding  of  how  this  process  can  be  controlled.  Cell-cell
adhesion and focal adhesion dynamics are two critical  properties that change
during EMT, which provide a simple way to characterize distinct modes of cancer
migration. Therefore, the main focus of this thesis is to provide a framework to
predict  critical  microenvironment  and de-regulations in  cancer that  drive inter-
conversion  between  adhesion  phenotypes,  accounting  for  main
microenvironment signals and signalling pathways in EMT. Here, we address this
issue  through  a  systems  approach  using  the  logical  modelling  framework  to
generate new testable predictions for the field.  
In Chapter 1, we describe the basic features that characterize the process of
Epithelial-to-Mesenchymal Transition, including changes in cell adhesion and its
role  in  the  process  of  metastasis  of  carcinomas.  Here,  we  highlight  involved
signalling  pathways,  main  reported  microenvironment  signals  and  key
transcription factors that regulate EMT. In this chapter, we focus on E-cadherin
mediated cell-cell  adhesion and integrin mediated focal adhesion dynamics as
key  cell  adhesion  properties  that  characterize  Epithelial,  Mesenchymal,  and
partial EMT phenotypes. We review the literature for the existent mathematical
models of EMT and highlight their main focus and predictions. Finally, we provide
a  description  of  the  main  concepts  of  the  logical  modelling  framework  and
highlighted the reasons to choose this approach.     
In  Chapter  2,  we  describe  the developed  model  of  the  regulation  of  cell-cell
adhesion and the focal adhesion dynamics, taking 8 microenvironment signals as
inputs and the 2 cell adhesion properties as readouts. In this chapter, we validate
the  model  by  recapitulating  phenotypic  markers  and  observations  on  cell
adhesion changes from published experiments on Epithelial cell lines exposed to
several microenvironment signals or containing mutations on specific molecular
v
components.  In  addition,  we  also  recapitulate  activity  changes  in  model
components described in the above mentioned experiments. In this chapter, we
associate cell adhesion properties to phenotypes and analyse the conditions that
result  in  the  switching  between  phenotypes.  Strikingly,  our  model  analyses
showed  that  cell-cell  contact  signals  activating  Receptor-Protein  Tyrosine
Phosphatases  (RPTP)  are  key  microenvironment  signals  to  control  EMT,
promoting  the  Epithelial  phenotype.  On  the  other  hand,  we  predict  that  the
ectopic activation of another transmembrane protein regulated by cell-cell contact
signals (FAT4) can promote the stability of collective migration phenotypes. This
protein is observed to be overexpressed in several cancers supporting the idea
that FAT4 over-activation could play a role in cancer invasion. Moreover, with our
approach, we also provide an explanation for the observed correlation between
hypoxia  and  metastasis,  reinforcing  the  idea  that  uncontrolled  SRC  ectopic
activation  is  enough  to  promote  the  stability  of  single  cell  cancer  migration
phenotypes.
In  Chapter  3,  the  main  predictions  generated  by  our  model  and  inherent
limitations are discussed. In this chapter, we also outline possible future work and
proposed some experiments to test our predictions.
In summary, this thesis provides a new mathematical model and a workflow to
generate  predictions  that  explore  the  combinations  of  microenvironment  and
mutational effects on the switching between cell adhesion properties. Importantly,
this thesis  contributes to the field with the identification of  a not  yet  reported
mechanism of  controlling EMT and propose new hypotheses that  explain  the
stability of collective and single cell migration of carcinomas.
Resumo da Dissertação
Na última década, a transição Epiteliar para Mesenquimal (EMT) tem chamado a
atenção dos cientistas derivado ao seu potencial para promover a migração de
células cancerosas e metastases.  Contudo,  a complexidade da regulação da
EMT, envolvendo multiplos sinais do microambiente tumural e regulação cruzada
tem sido uma limitação para perceber como se pode controlar EMT em tumores.
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A adesão célula-célula e a dinâmica de adhesão focal são duas propriedades
criticas  que  alteram  durante  a  EMT e  constituem  uma  maneira  simples  the
caracterizar distintos modos de migração de células cancerosas. Sendo assim, o
principal  foco  desta  tese  é  proporcionar  um modelo  matemático  para  prever
condições criticas que levam à transição entre fénotipos com differentes tipos de
adesão  celular,  tendo  em  conta  os  principais  sinais  do  microambiente  e
desregulações frequentes em células cancerosas.  Nesta tese,  é proposto um
modelo matemático integrativo baseado no formalismo lógico para gerar novas
previsões para este campo.  
No capítulo  1,  apresentamos uma descrição das caracteristicas princípais  do
processo da EMT, incluindo as alterações nas propriedades adesivas das células
e o seu papel no processo de metastases em carcinomas. Aqui, as principais
vias de sinalização, sinais do microambiente e factores de transcição envolvidos
na EMT são sublinhados. Neste capítulo, a adesão célula-célula mediada pela E-
caderina  e  a  adesão  focal  mediada  por  integrinas  como  propriedades  que
caracterizam  as  células  Epiteliais,  Mesenquimais,  e  fénotipos  resulatntes  de
EMT  parcial são apresentados em promenor. Também é apresentado aqui, uma
revisão da literatura referente aos modelos matemáticos existentes em EMT ,
sublinhando os  seus principais  objectivos  e previsões.  Por  fim,  descrevemos
aqui os principais conceitos da modelação lógica e apresentamos as razões para
a escolha desta metodologia.  
No capitúlo 2, apresentamos o modelo lógico da rede intracellular da regulação
das propriedades adesivas desenvolvido neste trabalho, considerando 8 sinais
do microambiente como variaveis de entrada e 2 propriedades de adesão celular
como variaveis de leitura.  Neste capítulo, validamos o modelo comparando os
seus resultados com marcadores fenotipicos e observações nas propriedades
adesivas e actividade intracelular retiradas experiências publicadas em células
Epiteliares expostas a sinais  extracellulares ou contendo  mutações em seus
components  moleculares.  Os  resultados  do  modelo  aqui  apresentados  são
compativeis  com todas as observações experimentais tanto a nível  fenotipico
como em termos de actividade experimental, suportando a sua validação. Neste
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capitulo,  as  propriedades  adesivas  foram  correspondidas  com  os  fenótipos
celulares  e  analisou-se  as  condições  que  levam  à  inter-conversão  entre
fenótipos. Surpreendentemente, a nossa análise mostrou que sinais que provêm
de contactos célula-célula que activam as fosfatases de tirosinas membranares
(RPTPs) são sinais do microambiente que têm um papel chave no controlo da
EMT.  Por  outro  lado,  o  modelo  gerou  previsões  que  sugerem  os  contactos
célula-célula que resultam na activação da proteina membranar  FAT4 pode levar
a  estabilização  de  fenótipos  envolvidos  na  migração  colectiva  de  célular
cancerosas.  Esta proteina foi  observada estar  sobre-expressa em tumores,  o
que suporta a ideia qua a sobre activação de FAT4 pode ter um papel na invasão
de  tumores.  Por  fim,  a  abordagem  apresentada  nesta  tese  permitiu  uma
explicação para a correlação entre hipóxia e metastases, e permitiu reforçar a
ideia  que  o  a  activação  ectopica  de  SRC   é  suficiente  para  promover  a
estabilidade  de  fenótipos  envolvidos  na  migração  unicelular  de  células
cancerosas.   
No  capitúlo  3,  as  principais  previsões  do  modelo  e  suas  limitações  são
discutidas.   Neste  capitúlo,  também  é  referido  possível  trabalhos  futuros  de
continução  e  algumas  experiências  para  testar  as  previsões  do  modelo  são
propostas.
Em  suma,  esta  tese  contribui  com  um  novo  modelo  matemático  e  uma
metodologia  que  permite  gerar  previsões  que  exploram  sistematicamente  as
varias  combinações  de  microambientes  e  efeitos  mutacionais  que  levam  a
mudanças  nas  propriedades  adesivas  das  células.  Os  resultados  expressos
nesta tese  constituem um contributo relevante para a área com a identificação
de um novo mecanismo de controlo  da EMT e propõe novas hipóteses que
explicam a estabilidade da migração individual e colectiva de carcinomas.      
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Abstract
The objective of this thesis is to provide an integrative (holistic) computational
approach to better understand how Epithelial-to-Mesenchymal transition (EMT) is
controlled  by  the  microenvironment  in  the  context  of  cancer  and  metastasis.
Since  EMT regulation  is  complex,  we  focus  on  cell-cell  adhesion  and  focal
adhesion dynamics as proxies for the main phenotypes involved in the process of
metastasis  (Epithelial,  Mesenchymal  and  Hybrid  phenotypes).  Therefore,  we
developed  a  literature-based  logical  network  model,  accounting  for  8  key
microenvironment  signals  as  model  inputs,  9  key  signalling  pathways  or
regulatory mechanisms, and two cell adhesion properties as model readouts that
describe phenotypes. The model was able to recapitulate the observed activity
degrees  of  9  Epithelial/Mesenchymal  markers,  reported  activity  patterns  of
pathways,  and 169 observations  from 13 experiments on Epithelial  cell  lines.
Next, we aimed to interrogate the model to generate novel predictions for the
control  of  the  switching  between  phenotypes.  Strikingly,  the  model-based
analysis  showed  that  RPTP  activation  by  cell-cell  contacts  (model  input)
prevented the switching from Epithelial to Mesenchymal/Hybrid  phenotype in the
presence of signals that promote EMT. The model-based analysis also showed
that  RPTP  activation  triggered  the  switching  from  Mesenchymal/Hybrid  to
Epithelial phenotype. These results suggest that RPTP could play a role as a
control mechanism of EMT. In addition, the model-based analysis showed that
the combination of ROS with an EMT promoting signal inhibited the RPTP control
mechanism.  This  explained  the observed correlation  between  metastasis  and
the  combination  of  hypoxia  with  chronic  inflammation  signals.  Perturbation
analysis  on model  components  (e.g  KO or  Ectopic  activation)  resulted in  the
identification of 23 single and 24 double perturbations that either stabilized the
Hybrid  phenotype  or  destabilized  the  Epithelial/Mesenchymal  phenotypes,
suggesting possible critical intra-cellular alterations. Among these, SRC ectopic
activation  destabilized  the  Epithelial  phenotype  and  FAT4  ectopic  activation
stabilized the Hybrid phenotype. These perturbations were correlated with high
overexpression  in  carcinomas  supporting  their  role  in  carcinoma  invasion.
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Further,  the model-based analysis showed that a perturbation that mimics the
SRC  overexpression  prevents  the  RPTP  control,  explaining  the  correlation
between this alteration and cancer invasion. Moreover, the model-based analysis
showed that cell-cell contacts that activate FAT4 in the case of a perturbation that
mimics  FAT4  overexpression  modulate  the  transitions  between  Hybrid  and
Mesenchymal  phenotype.  In  conclusion  from  this  thesis,  RPTP  and  FAT4
activation by cell-cell contacts are key microenvironment signals that are capable
of  controlling  the  transitions  between  Epithelial,  Mesenchymal  and  Hybrid
phenotype. 
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ROS Reactive Oxygen Species 
RPTP Receptor-type Protein Tyrosine Phosphatase 
RPTPL Receptor-type Protein Tyrosine Phosphatase Ligand
RTK Receptor Tyrosine Kinases
SHH Sonic hedgehog
SMAD Mothers against decapentaplegic homologue protein
Snail Human homologue Zinc finger protein 
SRC Proto-oncogene tyrosine-protein kinase Src 
STAT Signal transducer and activator of transcription
STG State Transition Graph
TAZ WW domain-containing transcription regulator protein 1
TCF T-cell-specific transcription factor
TGF-β Transforming Growth Factor beta
TGF-βR Transforming Growth Factor beta receptor 
Twist Twist-related protein
YAP Yes-associated protein 1
Zeb Zinc finger E-box-binding homeobox protein 
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CHAPTER 1
Introduction
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1. Thesis Scope 
The main goal of this thesis is to provide an integrative (holistic) approach to
better  understand  how  carcinoma  cells  gain  the  capacity  to  migrate  and  to
colonize  other  organs  through  Epithelial-to-Mesenchymal  transition  (EMT).  In
particular, to predict critical conditions that drive the inter-change between non-
migrating and distinct forms of cell migration. This has been a hard challenge in
cancer research due to the complexity of EMT regulation and by the involvement
of multiple signals in the tumour microenvironment. To achieve our goal, we first
aim to develop and analyse a logical network model for  the regulation of cell
adhesion properties involved in EMT and cancer invasion, accounting for multiple
microenvironment  signals  and  de-regulations  that  may  occur  during  cancer
progression. This provides a simple way to characterize distinct modes of cancer
migration  based  on their  adhesion properties.  With  this  approach,  we aim to
generate  new  predictions  that  allow  the  identification  of  the  conditions  that
promote  the  transitions  between  non-invasive  Epithelial  cell  adhesion  and
invasive  Mesenchymal/Hybrid  cell  adhesion.  In  particular,  the  tumour
microenvironment  conditions  that  are  critical  for  the  switching  between  non-
invasive  and  invasive  phenotypes,  accounting  for  the  not  yet  explored
neighbouring  cell  contact  signals  in  combination  with  signals  from  the  ECM.
Secondly,  we  aimed to  understand  how mutations  during  cancer  progression
could  affect  the  dynamics  of  the  transitions  between  phenotypes  towards
favouring cancer invasion. In our opinion, the resulting predictions from this study
are important clues for the identification of new drug targets and the development
of new therapeutical strategies to control metastasis.          
In this chapter, we provide the background on the process EMT focusing on the
E-cadherin  and  integrin  mediated  cell  adhesion  changes  and  its  role  in  the
process of metastasis of carcinomas (section 2). We also included a literature
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review on the existent mathematical models of EMT and provide a description of
the main concepts of the logical modelling framework (section 3).    
 
2. Epithelial-to-Mesenchymal Transition (EMT)
Before defining EMT, we need to define what is an Epithelial cell, the Epithelium
and the Mesenchymal cell. An Epithelial cell is a type of cell that is the “building
blocks” of the membrane layer that surrounds most organs and glands [1,2]. In
these tissues, Epithelial cells form sheets of cells attached by strong cohesive
adhesion  forces,  in  which  the  population  of  these  cells  is  designated  by
Epithelium [1,3]. The main features that define Epithelial cells are the presence of
distinct cellular structures called adherens junctions, tight junctions, desmosomes
and gap junctions (Figure 1) [3]. These structures participate in the acquisition of
the strong cell-cell adhesion between the cell and its adjacent cells. In addition,
the spacial organization of the adhesion molecules on cell junctions together with
the actin  cytoskeleton determine the characteristic  apico-basal  cell  polarity  of
Epithelial cells (Figure 1)  [3]. Morphologically, Epithelial cells can adopt several
shapes which can provide distinct tissue structure and functionalities, where the
most common are the squamous, cuboidal and columnar [1].  On the other hand,
Mesenchymal cells are a multi-potent type of stromal cells that  can be found
between  endoderm  and  ectoderm  during  embryogenesis  [4,5].  Mesenchymal
cells do not show the presence cell adhesion structures mentioned above, and
express  characteristic  proteins  such  as  N-Cadherin,  Vimentin  and  Fibronecin
[3,4,6]. Mesenchymal cells are characterized by having elongated spindle shape
morphology with  end-to-end  cell  polarity,  and  the  capacity  of  migrating  along
large distances either individually or in chains through N-Cadherin mediated cell
adhesion (Figure 1) [2–4]. Moreover, this type of cells have also the capacity of
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degrading  and  remodelling  the  extracellular  matrix  by  secreting  matrix
metalloproteinases (MMP), collagen and fibronectin [4,7]. 
By definition, EMT is a process in which an Epithelial  cell  undergoes multiple
biochemical changes leading to the loss of the apico-basal cell polarity and cell-
cell  adhesion,  followed  by  a  “transformation”  into  a  Mesenchymal  cell  with
migratory capacity (Figure 1) [4,5,8,9]. Interestingly, EMT can be reverted through
a process called Mesenchymal-to-Epithelial transition (MET) [4,8,10]. Both EMT
and MET are classified as transdifferentiation processes based on their ability to
occur between fully mature differentiated Epithelial and Mesenchymal cell types
[10,11].  EMT is the result  of  a complex genetic program that depends on the
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Figure  1.Typical  Epithelial  and  Mesenchymal  features  involved  in  Epithelial-to-
Mesenchymal Transition (EMT). Figure (adapted) and legend reproduced from [3].     
tissue  context,  involving  multiple  genes  transcribed  in  Epithelial  and
Mesenchymal cells [4,5,8]. Multiple markers for EMT have been proposed during
the last two decades [4,12]. However, EMT cellular program can be incomplete
with  strong  Epithelial  plasticity  keeping  both  Epithelial  and  Mesenchymal
features  [5,8,13].  Due  to  such  plasticity  and  complexity  of  EMT  program,
researchers have proposed the notion of  EMT-like and define EMT based on
functional criteria of phenotype changes [8,13]. 
2.1. Physiological function
In the last two decades, EMT has been studied by researchers and observed as
a process that plays a role in several physiological and pathological conditions,
including  embryogenesis,  wound  healing,  organ  fibrosis  and  cancer  [3–5].
Historically, EMT was first observed in gastrulation and neural crest cell migration
during early embryo development [6,9,14]. Since then, EMT has been observed
in other developmental processes such as placental implantation and during the
morphogenesis  of  many  tissues  in  early  embryogenesis.  In  general,  EMT
together with its reverse (MET), are two key steps that mediate the formation of
the endoderm and mesoderm layers during organ development  [4,9,14]. These
steps are essential  for  the establishment of  the epithelial  barrier  that  delimits
organs  [4,9,14].  For  example,  through  the  occurrence  of  EMT,  the  primitive 
epithelium  gives  rise  to  the  primary  mesenchyme  layer  [4,9,14].  Then,  the
Mesenchymal cells migrate and through MET originates the secondary epithelial
layer [4,9,14]. Several in vivo developmental studies in Drosophila, Xenopus and
mouse  models  have  documented  the  functional  role  of  EMT  during
embryogenesis  [6]. The outcomes from these studies have placed EMT as an
evolutionarily conserved mechanism, essential for all multicellular organisms that
develop organs [9].  
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After  embryogenesis,  EMT  is  also  a  necessary  process  to  ensure  the
maintenance of epithelial tissue integrity of multicellular organisms during acute
infections and injuries [2,3]. Mouse and Xenopus studies have provided insights
on the role of EMT in epithelial tissue regeneration during wound healing and
inflammatory  damage  [2–4].  Upon  injuries,  massive  cell  death  occurs  in  the
epithelium  followed  by  a  re-epithelialization  of  the  tissue  [3].  In  response  to
damage,  fibroblasts  and  inflammatory  cells  are  recruited  and  secrete  growth
factors,  cytokines  and  collagen  type  I  [2–4].  Under  these  conditions,  EMT
program  in  functional  Epithelial  cells  is  naturally  reactivated  [3].  Then,  the
transformed Mesenchymal cells migrate to the damaged region and promote the
decomposition of the basal membrane, causing apoptosis of damaged Epithelial
cells [3]. Once the inflammatory signal is gone, the Mesenchymal cells undergo
MET and re-epithelize the damaged epithelium  [2,3]. Therefore, EMT in wound
healing and acute inflammation is characterized by a transient and self-limiting
process  [3].  This  transient  behaviour  is  considered  as  normal,  whereas  the
permanent stimulation of EMT due to chronic inflammation is pathological  [3].
Consequently,  chronic inflammation further results in tissue fibrosis,  excessive
cell death due to the accumulation of Mesenchymal cells, which eventually leads
to organ failure or cancer development [3]. 
In  the  cancer  context,  EMT and  its  reverse  (MET)  captured  the  attention  of
researchers due to its potential to constitute a way for cancer cells to invade from
the  organ  where  they  developed,  migrate  and  metastasize  [4,5,15].  This
motivated researchers to study EMT in several types of cancer to find key players
which could be used as drug targets to prevent metastasis [4,5,7]. However, the
role of  EMT in promoting metastasis  is still  a debatable question since some
evidences  points  towards  not  being  necessary,  together  with  supporting
evidences  for  its  role  only  based  on  correlation  [11,15].  Meanwhile,  these
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evidences are both weak and can be case/tissue specific due to the diversity of
cancer genetic alterations together with the complexity and Epithelial plasticity of
the EMT cellular program.
2.2. EMT functional steps
Because EMT is a complex cellular program, researchers have used functional
criteria to define EMT [8,13]. Based on developmental studies and according to
Savagner  [6],  EMT can  be  defined  and  broken  down  into  the  following  four
independent functional steps (Figure 2).
Step  1:   Loss  of  apico-basal  cell  polarity  with  cell-matrix  adhesion  and
cytoskeleton remodelling [6]. This is considered as the initial step of EMT and
characterized by the dissolution of  tight  junctions and desmosome structures,
leading  to  a  homogeneous  distribution  of  apical  and  basolateral  membrane
components  [5,6,8].  On this step, multiple membrane proteins and complexes
that compose tight junctions are  down-regulated, including the EMT marker ZO-1
[5,10]. Here, specific integrins that participate in cell polarity are down-regulated,
including the ones that mediate cell to cell junctions and the ones that mediate
cell to basement membrane connections [5,6]. During this step, the cytoskeleton
is remodelled, where cytokeratin is replaced by vimentin and F-actin synthesis is
increased  (an  G-actin  polymer  also  named  by  stress  fibres) [5,10].  Together
these  molecular  changes  result  in  a  change  from  Epithelial  cell  shape  (e.g.
cuboidal) to a Mesenchymal shape (spindle) [5,6,8]. 
Step 2:   The loss of cell-cell adhesion forces and cell individualization  [6]  . This
step results in a phenotype change which is characterized by the dissolution of
the adherens junction [6,16]. On the adherens junctions, catenins α, β and δ are
a  class  of  proteins  that  directly  interact  with  E-cadherin  and  subsequently
participate in ensuring cell-cell adhesion strength  [5,10,16]. E-cadherin is a key
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adhesion molecule of the adherens junction and its down-regulation is often seen
as the hallmark of EMT, leading to cell individualization [4,5,10,12]. The loss of E-
cadherin expression is  subsequently  replaced by N-cadherin,  a less adherent
molecule, which is a Mesenchymal marker [5,8,10].       
Step 3  : Acquisition of back-front polarit  y and motility [6]. During this step, cells
acquire the capacity to migrate along the extracellular matrix (ECM) [5,6,10]. This
is  characterized  by  the  formation  of  long  sheet-like  actin-rich  membrane
protrusions (lamellipodia) and spike-like extensions (filopodia) at one side of the
cell  (front)   [5,6,10].  These  membrane  protrusions  penetrate  and  temporarily
interact with the ECM through the formation of localized cell-to-matrix adhesions
(focal adhesions)  [5,6]. Movement is then achieved through a front-rear pulling
force  generated  by  a  mechanism  of  assembling  and  disassembling  of  focal
adhesions,  causing  contraction  and  generating  lamellipodia,  filopodia,  or
invadopodia  [5,6,10].  This  step  requires  the  activation  of  several  proteins
including  small  Rho  GTPases,  myosin  kinases,  and  the  expression  of  α5β1
integrins [5,10].    
Step 4  : Basement membrane invasion and invasiveness acquisition [6]. During
this final step, cells gain the capacity to decompose the basement membrane
components  by  secreting  matrix-metalloproteases  (MMPs)  [5,8,10,17].  In
addition, cells also produce and secrete ECM components such as collagen type
I  and  fibronectin  that  remodel  the  ECM  to  facilitate  migration  and  invasion
[4,5,18]. The acquisition of resistance to apoptosis and anoikis is also postulated
to be a feature acquired during this stage, but still debatable as a feature of EMT
[5,6,8]. 
According to the above mentioned authors, a typical EMT is when all these steps
are fully achieved, whereas partial EMT is when at least one step is not fully or
partially achieved. In this thesis, since we will only focus on the cell  adhesion
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changes during EMT, we consider EMT-like events that can result in phenotypes
with  adhesion  features  characteristic  of  Mesenchymal  cell  or  partial  EMT
phenotypes. 
2.3. Partial EMT phenotypes
Phenotypes that conserve cell-cell adhesion during EMT (incomplete step 2 of
EMT) are often the result of incomplete genetic program (partial EMT)  [5,8,13].
Some of these phenotypes also acquire migratory capacity as Mesenchymal cells
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Figure 2.  EMT archetype and Epithelial plasticity. During EMT, epithelial cells lose their
apico-basal polarity. Tight junctions which typically maintain apicobasal polarity dissolve allowing
the  mixing  of  apical  and  basolateral  membrane  proteins.  Adherens  and  gap  junctions  are
disassembled and cell surface proteins such as E-cadherin and epithelial-specific integrins (green)
are replaced by N-cadherin and integrins specific to extracellular  components (blue).  The actin
cytoskeleton is remodelled into stress fibres which accumulate in areas of cell  protrusions. The
epithelial intermediate filaments, cytokeratins, are replaced by vimentin. Meanwhile, the underlying
basement membrane is degraded and the cell invades and moves into the surrounding stroma,
devoid of cell-cell contacts. Figure (adapted) and legend reproduced from [5,6].
(complete step 3 of EMT, see section 2.2. for details), usually called as “Hybrid
Epithelial-Mesenchymal  phenotypes”  [19,20].  Other  “intermediate  phenotypes”
which do not acquire Mesenchymal migratory capacity can also result from partial
EMT [5]. In this case, step 2 and 3  of EMT are incomplete (section 2.2.), where
lamellipodia, filopodia, and invadopodia are absent or reduced in their capacity.
In this thesis, we adopted the names “Hybrid” and “Intermediate” phenotypes for
these  two  possible  outcomes  of  partial  EMT  [5,20,21].  Together,  Hybrid  and
Intermediate  phenotypes  can  be  part  of  a  diversity  of  collective  migratory
behaviours (Figure 3)  [19,20]. The observation of these phenotypes came from
several  in  vivo  and  in  vitro models  which  have been subject  to  EMT driving
signals,  suggesting  that  these  phenotypes  could  result  from  partial  EMT
[5,19,22]. Collective migration phenotypes such as Hybrid phenotypes have been
observed in 2D sheet movement of cells on an epithelial layer (Figure 3a). This
type  of  collective  behaviour  was  found  in  the  intestinal  epithelium  and  in
epidermal keratinocytes during wound closure, suggesting it plays a role in tissue
repair  [5,22]. These cells are characterized by having cell-cell adhesion without
tight  junctions  (incomplete  step  1  of  EMT),  together  with  the  acquisition  of
Mesenchymal-like  membrane  protrusions  with  lamellipodia  and  pseudopodia
(step 3 of EMT) [5,22]. Hybrid and Intermediate phenotypes have been observed
together in multicellular 3D clusters moving through a tissue (Figure 3b-f). These
multicellular 3D clusters are composed by cells with distinct roles that lead to the
classification into “leaders” (the cells located at the tip of the moving front) and
“followers” (the cells located at the rear of the moving front) [22,23]. “Leaders” are
characterized  by  having  fully  Mesenchymal  migratory  capacity  with  long
membrane  protrusions,  driving  the  collective  movement  (step  3  of  EMT),  the
Hybrid phenotype. “Followers”, on the other hand, are devoid of Mesenchymal
migratory  features  such  as  the  Intermediate  phenotypes  [22].  “Leaders”  and
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“followers”  have been found to be organized into strands of  cells  or  in  small
detached clusters (typically 6-8 cells) [22,24]. Collective migration of multicellular
3D clusters with both “leaders” (Hybrid phenotype) and “followers” (Intermediate
phenotype) have been found in the morphogenic duct and gland formation during
branching  morphogenesis  (Figure  3b)  and  in  vascular  sprouting  during
angiogenesis (Figure 3c) [5,22]. On these biological processes, the multicellular
3D clusters are characterized by strands of cells that maintain tight junctions and
cell polarity, forming a tubular structure with an inner lumen [5,22]. 
Another  example  of  3D  multicellular  clusters  is  the  migration  of  border  cells
observed in Drosophila melanogaster egg chamber during oogenesis (Figure 3e).
This type of migration is characterized by an isolated small group of cells that
migrate through the tissue without the typical migratory features of Mesenchymal
cells (Intermediate phenotypes). In addition, these type of cells does not have
tight  junctions  (step  1  of  EMT),  which  ensures  the  characteristic  loss  of  cell
polarity and flexibility necessary for border cells migration. Interestingly, 3D solid
strands (Figure 3d) and small clusters detached from these strands (Figure 3f)
have been found in several types of carcinomas and implicated in invasion and
metastasis formation [13,22,24]. These solid strands and small clusters move as
poorly organized masses of carcinomas cells without the typical Epithelial cells
polarity (dissolution of tight junctions, step 1 of EMT), features not observed in
normal  3D  collective  migration  such  as  vascular  sprouting  or  branching
morphogenesis  [22,24]. Both solid strands and the small detached clusters are
characterized by having cells typically differentiated into “leaders” and “followers”
that  resemble  the  Hybrid  and  Intermediate  phenotypes,  respectively.  In
carcinomas, Hybrid and Intermediate phenotypes are characterized by completed
step 1 of EMT (Intermediate and Hybrid phenotypes) and step 3 in the case of
the leaders (Hybrid phenotypes only) [6,24]. These observations lead to the idea
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that  EMT  steps  2  and  3  are  determinant  for  the  stability  of  partial  EMT
phenotypes, especially in carcinomas.    
 
19
Figure  3.  Types  and  variants  of  collective  cell  migration. (a)  Epidermal  monolayer
moving across a two-dimensional ECM substrate. Actin-rich pseudopodia and lamellipodia lead the
migration with cells connected through adherens junctions.  (b)  Terminal end bud sprouting in the
developing mammary gland during branching morphogenesis. Induced by stromal signals, the end
bud  extends  from a  duct  through the  protrusive  movement  of  tight  junction-connected  luminal
epithelial cells and loosely connected myoepithelial cells. (c) Vascular sprouting in newly forming or
regenerating vessels.  A tip cell  with filopodial  protrusions leads the migration through ECM.  (d)
Invasion of poorly differentiated multicellular masses and elongated strands in cancer.  (e)  Border
cell cluster consisting of mobile outer cells and two less mobile polar cells migrating along cell-cell
junctions of  nurse cells in the Drosophila melanogaster egg chamber.  (f)  Collective invasion of
detached cancer cells that are moving as a small cluster.  F-actin,  filamentous actin; MT1MMP,
membrane  type  1  matrix  metalloproteinase  (also  known  as  MMP14);  UPA,  urokinase-type
plasminogen activator. Reproduced figure and adapted legend from [22].
2.4. EMT in carcinomas
According to the National Cancer Institute (https://www.cancer.gov), carcinomas
are a type of cancer that originates from a mutated Epithelial cell in the epithelial
layer surrounding an organ, a gland or a body structure.  Carcinomas are the
most frequent type of cancers, affecting more than 10 million people in the world
regardless of their sex or race [11,25,26]. Statistical studies in human populations
also indicate that carcinomas such as the ones that develop in lung, breast, colon
and stomach are the most deadly types of cancers, leading to around 1-2 million
of deaths every year in Europe and US [25,26]. The poor survival prognosis of
carcinomas has been associated with the acquisition of the capacity to invade
and spread throughout other organs, designated by metastasis [11,27]. Invasion
and metastasis are further considered as a hallmark of cancer progression which
determines the malignancy of carcinomas  [28].  Cancer therapy has very poor
success  when  carcinomas  start  to  spread,  forming  metastasis.  This  has
motivated  further  cancer  research  in  order  to  understand  how  metastasis  is
achieved and to find new therapeutic strategies [15]. Cancer researchers believe
that  during  cancer  progression,  carcinomas  acquire  invasive  properties  by
hijacking the EMT genetic program  [5,7,13,15].  Although this is still  debatable
based on lacking clinical proof, several  in vitro studies from mouse models and
cell cultures have supported the role of EMT in invasion [13,15,29]. Researchers,
further argue that only through undergoing EMT-like programs, carcinomas are
able to metastasise [6,7,13]. Thus, understanding how to control EMT in the case
of carcinomas could provide the means to fight metastasis, ultimately through the
identification of new drug targets [15].
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2.4.1. Modes of invasion and metastasis
As  possible  outcomes  of  EMT  in  carcinomas,  Mesenchymal  and  Hybrid
phenotypes have been associated with metastasis acquisition by ensuring single
and  collective  migration  capacity  during  invasion,  respectively [24,30,31].
Amoeboid-like migration behaviour was also observed in a few breast cancers
and small lung carcinomas, where cells migrate as isolated round shaped cells,
without the formation of long membrane protrusions, often with chaotic movement
and  blebbing  morphology  (Amoeboid-like  phenotypes)  [30–32].  Metastasis  of
carcinomas is achieved through a complex and dynamical process of invasion,
migration  and  interconversion  between  Epithelial,  Hybrid,  Mesenchymal  and
Amoeboid-like  phenotypes  [7,20,21,31,33].  In  addition,  the  process  involves
multiple steps from the initial tumour site until the colonization of a secondary site
(Figure 4). EMT provides one way to promote invasion, where the transformed
cells either by Mesenchymal cells (complete EMT) or Hybrid phenotypes (partial
EMT)  degrade  the  basal  membrane  and  escape  the  primary  tumour  site
[24,30,31]. As cells migrate through the ECM, the Amoeboid-like phenotype can
also  arise  from  the  process  of  Mesenchymal-to-Amoeboid  transition  (MAT)
[31,33–35]. This process is controlled by GTPases Rac1 and RhoA, resulting in a
rapid  interconversion  between  Mesenchymal  and  Amoeboid-like  phenotypes,
ensuring  an  advantage  in  the  migration  through  soft  tissues  as  “pathfinders”
[34,35].  
To further advance in  the process of  invasion,  carcinoma cells  must  gain the
capacity to penetrate blood vessels through a process called intravasation [7,36].
Mesenchymal  and Hybrid  phenotypes are  known to  be  more effective  in  the
intravasation through the formation of actin-rich long protrusive invadopodia [37].
Then,  carcinoma  cells  may  enter  the  circulation  and  travel  through  the
bloodstream  as  small  multicellular  3D  clusters  (Hybrid)  or  as  single  cells
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(Mesenchymal) [7,36]. In vivo studies have confirmed the presence of circulating
cancer cells mainly as multicellular 3D clusters, suggesting that Hybrid phenotype
is the main form of migration of carcinomas in the bloodstream  [24,30,38]. To
invade  secondary  sites  and  initiate  the  colonization  process,  the  circulating
carcinoma  cells  must  exit  the  blood  vessels  through  a  process  called
extravasation  [7,36].  Next,  carcinoma  cells  penetrate  and  invade  the  basal
membrane of the new organ until reaching the epithelial layer [7,36]. 
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Figure  4.  Modes of  invasion of carcinomas and metastasis acquisition. Complete
EMT mediated single cell invasion (left) and incomplete EMT mediated collective invasion (right).
Normal  epithelial  cells  (orange cells).   Mesenchymal  cells  that  result  from complete  EMT of  a
primary tumour (blue cells). Collective cell migration and invasion resulting from incomplete EMT
with Hybrid and Intermediate phenotypes (green cells). Figure reproduced from [31].
Finally,  to  integrate  and  colonize  the  epithelial  layer  of  the  new  organ,  the
invading  Mesenchymal  cells  are  thought  to  undergo  MET  [7,36].  For  the
colonization of multicellular 3D clusters in the epithelial layer, it is believed that
they  undergo  the  process  of  Hybrid-to-Epithelial  transition  (HET)  [20,21,33].
Cancer  researchers  postulate  that  these  two  alternative  modes  of  migration
dynamically  cooperate  to  achieve  a  more  effective  tumour  invasion  and
colonization  [20,38]. Moreover, this dynamics is also believed to be involved in
the  resistance  to  drugs  and  recurrence  of  carcinoma  in  situ upon  removal.
Therefore, the understanding of how to control the formation of these phenotypes
and  their  interconversion  in  the  metastasis  context  it  is  still  an  important
challenge in the cancer field [6–8]. 
2.4.2. Cell adhesion role in carcinoma invasion 
Integrin mediated cell-cell adhesion and E-cadherin mediated cell-cell adhesion
are two properties that change during EMT and play a critical role in carcinomas
invasion (Figure  5)  [16,39,40].  During cancer  invasion,  integrin mediated cell-
matrix adhesion is characterized by fast cycles of assembling and disassembly of
focal  adhesions,  which  lead  to  contraction  of  the  membrane  protrusions,
generating the front-rear pulling force necessary for producing movement along
ECM  [31,40–42].  These  focal  adhesion  dynamics  have  been  considered  as
characteristic features of Mesenchymal and Hybrid phenotypes [31,39,40]. The
assembling  of  focal  adhesions  involves  clustering  of  integrins  at  a  given
membrane  location  (Figure  5),  where  more  than  800  adapter  and  signalling
proteins are recruited (adhesome) [43]. These structures ensure a strong integrin
mediated adherence to specific ECM components such as laminin, collagen I and
fibronectin, necessary for the pulling force [43–45]. On the adhesome, specifically
through Talin binding, actin is polymerized into F-actin stress fibres by small Rho
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GTPases  [39,42,45].  Then,  F-actin  causes  the  elongation  of  membrane
protrusions  with  the  necessary  rigidity  for  invading  the  basement  membrane
[39,42,45]. In migrating cells, the high rates of formation and turnover of focal
adhesions  (high  focal  adhesion  dynamics)  potentially  can  result  in  faster
movement of cells, a property often correlated with cancer invasion  [30,40,41].
The  dynamics  of  focal  adhesion  formation  and  turnover  have  been  found  to
depend on the activation of integrin signalling by ECM signals and growth factors
[18,46–48]. The activation of FAK-SRC complex and PAK downstream of integrin
signalling have been associated with both high turnovers of focal adhesions and
cancer invasion [49–53]. Moreover, this has been also associated with the over-
expression and over-activation of  α5β1 integrins on focal adhesions,  ensuring
high contractile forces during cancer migration [47,54]. 
In contrast,  typical  Epithelial  cells lack high focal adhesion dynamics and are
characterized by permanent integrins mediated attachment to the ECM (strong
cell-ECM  adhesion),  which  plays  other  functional  roles  such  as  Epithelium
fixation  and  preventing  apoptosis  (anoikis)  [5,45,55].  For  phenotypes  with
amoeboid-like  migration,  the  cell-ECM  adhesion  is  absent  or  very  reduced,
allowing them to move freely on soft tissues [31,34].
On the other hand, cell-cell adhesion through E-cadherin was found to be critical
for the maintenance of the adherence between cells during collective migration of
cancer cells  [16,39]. This places E-cadherin mediated cell-cell  adhesion at the
frontier between single and collective forms of invasion [24,31,39]. Thus, this type
of adhesion is a common feature of both Epithelial and Hybrid phenotypes, and
absent in Mesenchymal and Amoeboid-like phenotypes [16,31,39]. E-cadherin is
a transmembrane protein located at  the adherens junction  and holds cell-cell
adhesion  through  homophilic  binding  with  E-cadherin  molecules  of  the
neighbouring cells (Figure 5)  [56–59]. E-cadherin binds to catenins α, β and δ,
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forming  a  complex  that  participates  in  the  maturation  of  cell-cell  adhesion
[16,57,58]. First, E-cadherin binds with catenin δ, also called p120, which was
demonstrated in several Epithelial cell lines to stabilize E-cadherin at the surface,
increasing  the  abundance  of  E-cadherin  able  to  participate  in  the  cell-cell
adhesion  [60–62]. Secondly, the maturation of cell-cell adhesion proceeds after
the binding of E-cadherin with β-catenin [63,64]. Once the E-cadherin-β-catenin
complex is formed, the docking for α-catenin is possible,  allowing G-actin to be
polymerized  into  F-actin  by  small  Rho  GTPases,  linked  to  the  E-cadherin-β-
catenin-α-catenin  complex  [57,63,65].  Next,  the  F-actin  cables  re-enforce  the
strength of cell-cell adhesion through the concentration of adhesion molecules in
the  lateral  side  of  cell-cell  contacts,  in  particular,  E-cadherin  and  Nectins
[57,63,65,66].  For these  reasons,  the  E-cadherin-β-catenin-p120  complex  is
considered as a proxy for the cell-cell adhesion strength [16,65]. The strength of
adhesion can be compromised through phosphorylation of p120 and β-catenin by
tyrosine kinases activated during EMT such as SRC and MET, demonstrated in
vitro to be capable of dissolving the E-cadherin-catenins complex [67–69]. 
On the other hand, specific receptor-type protein tyrosine phosphatases (RPTPs)
are  capable  to  dephosphorylate  catenins  which  can  recover  the  E-cadherin
binding forms of p120 and β-catenin [70,71]. This suggests possible intermediate
degrees  of  cell-cell  adhesion  for  Intermediate  and  Hybrid  phenotypes  by
modulation of  RPTP and tyrosine kinases activity.  Indeed,  Epithelial  cells  can
exhibit stronger cell-cell adhesion in comparison to collective migrating 3D cell
clusters during invasion [24,31,39]. This is in part explained by a partial formation
of the E-cadherin-catenins complex resulting from phosphorylation of p120 or β-
catenin [16,57]. For example, in Drosophila, border cell migration occurs without
β-catenin  at  adherens  junctions  [72].  Moreover,  the  loosening  of  cell-cell
adhesion  in  collective  migration  during  cancer  invasion  is  thought  to  be  a
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necessary  trait  to  allow  intravasation  and  extravasation  [31,39].  Taken  all
together,  the combination of  E-cadherin mediated cell-cell  adhesion and focal
adhesion  dynamics  are  two  properties  able  to  distinguish  invasive  from non-
invasive cancer cells and their correspondent modes of invasion (summarized in
Table 1) [31,39]. Moreover, these adhesion types are critical properties necessary
for  cancer  invasion  and  suitable  traits  for  the  characterization  of  the
Mesenchymal, Hybrid and Epithelial phenotypes [31,39].   
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Figure 5. Critical cell adhesion changes during EMT progression. Cell-cell adhesion by
adherens  junctions  and  cell-matrix  adhesion  through  the  formation  of  focal  adhesion.
Representation contains only the critical components of the adherens junction and focal adhesion,
based on the figure in [39]. 
Table 1. Cell adhesion properties of invasive and non-invasive  phenotypes. 
Phenotypes Focal adhesion 
dynamics
Adherens 
junctions
Invasiveness Behaviour 
Epithelial Reduced Fully mature Not invasive  Collective  
Intermediate Reduced  Partial Reduced Collective
Amoeboid-like Reduced Reduced  Mild Single 
Hybrid High  Partial High Collective
Mesenchymal High Absent High Single
2.4.3. The role of the microenvironment
The microenvironment is a complex and dynamic system including signals from
diffusible  molecules,  biophysical  properties  in  the  ECM,  and cell-cell  contacts
from neighbouring cells [30,73–75]. In this thesis, we consider neighbouring cells
as the adjacent  cells to a cell  in the Epithelial  layer which is  able to provide
juxtacrine signals (cell-cell  contact  dependent)  [73–75].  In the case of  signals
from the diffusible molecules in the microenvironment, we considered that they
can  come  from  endocrine,  paracrine  or  even  autocrine  origin.  Currently,  the
tumour  microenvironment  is  postulated  to  play  a  fundamental  role  in  driving
metastasis  of  carcinomas  [24,30,75,76].  Although  mutation  during  cancer
progression  is  thought  to  contribute  to  the  acquisition  of  the  metastable
phenotype,  the  changes  in  the  tumour  microenvironment  are  believed  to  be
required to trigger the transition between phenotypes with and without migration
capacity (Mesenchymal/Hybrid and Epithelial, respectively)  [20,30,75]. Through
the  last  2  decades,  multiple  signals  from  the  microenvironment have  been
considered as hypotheses to drive the migration of carcinomas [74–76].  Among
them,  the  addition  of  growth  factors  such  as  TGF-β,  EGF  and  HGF  in  the
microenvironment (diffusible molecules) has been reported to be able to trigger
EMT on carcinoma cell lines in cell culture conditions  [77–79].  In vivo, the up-
regulation  of  these  growth  factors  in  the  tumour  microenvironment  can  be
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achieved through the secretion  by the tumour cells or by recruited fibroblasts and
macrophages during chronic inflammation  [80–83]. These 3 cell types can also
secrete  to  the  tumour  microenvironment  collagen  type  I  and  fibronectin,
remodelling  the  ECM  composition  [18,81,84].  These  changes  in  ECM
composition cause an increase in the ECM stiffness (biophysical property), which
have been also demonstrated to cause the down-regulation of E-cadherin (EMT)
in  ovarian  and  squamous  carcinoma  cell  culture  conditions [85–87].  Due  to
accelerated tumour growth, oxygen consumption can lead to the state of hypoxia
in  the  tumour  microenvironment  [76,84].  Hypoxia  has  been  found  to  further
promote  the  metastasis  outcome  in  cooperation  with  the  ECM  composition,
suggesting  that  multiple  signals  can  synergistically  lead  to  the  metastasis
outcome [84]. Chronic inflammation has been also associated with hypoxia and
tumour invasion by leading to the collagen type I induced ECM stiffness and by
the  production  of  ROS,  TGF-β,  HGF  and  cytokines  [81,84,88,89].  Among
cytokines, IL6 is hypothesised to play a role in cancer invasion based on reported
evidence  for  its  capacity  to  stimulate  EMT in  breast  cancers  cell  lines,  and
because it is frequently overexpressed in the tumour microenvironment [90]. The
endogenous production of  ROS,  not  only  drives mutation acquisition but  also
triggers HIF1 expression, which has been involved in EMT stabilization  [81,91–
93]. Recently, signals from the neighbouring cells mediated by Delta-like ligands
activation of Notch receptors have been considered as juxtacrine signals in the
tumour  microenvironment  that  contribute  to  the  invasiveness  of  carcinomas
[20,94]. Unfortunately, the microenvironment signals that drive MET and stabilize
Hybrid phenotypes (incomplete EMT) are still  unknown  [74,75]. Therefore, the
microenvironment changes that lead to the switching between these phenotypes
are yet to be characterized [20,30]. Thus, how the microenvironment controls the
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switching between Epithelial,  Hybrid  and Mesenchymal  phenotypes is  still  an
open question in the cancer field.   
Interestingly, MET was observed to be induced  in vitro with co-cultured normal
Epithelial cell lines with Mesenchymal-like carcinoma cell lines, suggesting that
cell-cell  contact  signals  by  neighbouring  cells  could  trigger  MET  [95].  A vast
number  of  cell-cell  contact  molecules  have  been  found  to  trigger  signalling
between cells, opening new possibilities in the cancer field to understand how
these signals could modulate cancer invasion dynamics [73,96]. In this thesis, we
will only focus on 3 cell-cell contact signals ligands, the Notch, Receptor Protein
Tyrosine Phosphatases (RPTP) and the membrane receptor FAT4 ligands. These
last 2 cell-cell contact signals are quite interesting because are reported to inhibit
particular EMT signalling pathways, suggesting that they potentially could prevent
EMT [70,97]. In addition, these two receptors are good candidates because are
ubiquitous expressed in most cell types and are reported to be strongly activated
only by cell-cell contacts in high cell confluence conditions, i.e. high numbers of
neighbouring cells (high cell density conditions) [98–101]. However, the effects of
these signals are quite difficult to predict since multiple signals are present in the
tumour  microenvironment  making  this  depend  on  the  regulatory  mechanisms
involved. Based on these reasons, we chose to focus on the analysis of RPTPs
and FAT4 as two possible hypotheses that could explain MET.
2.5. Transcriptional regulation of EMT
The transcription of genes during EMT has been found to be under a complex
and intertwined regulation, involving multiple transcriptional, post-transcriptional
and even alternative splicing mechanisms  [10,102]. During the last 2 decades,
more than 21 transcriptional factors have been identified to be up-regulated in
transformed cell lines and involved in the regulation of critical genes during EMT
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[8,10,102]. Among them, Snail, Zeb and Twist family of transcription factors have
been found to be the master regulators of EMT, which simplified the view of EMT
regulation  [10,102,103].  In particular,  Snail  family member Snail  1,  because it
controls  the expression of  both Zeb and Twist  families  [103–105].  These key
transcription factors have been found to directly down-regulate several genes of
key molecules associated with Epithelial features, and up-regulate several genes
of key molecules associated with Mesenchymal features [10,102] (Figure 6). One
of the most relevant targets of Snail, Zeb and Twist family is the E-cadherin gene
(CDH1), considered as the hallmark of EMT [10,102,103,106]. 
Studies in cancer cell lines have demonstrated that Snail, Zeb and Twist directly
bind to the DNA sequences of the E-box of E-cadherin gene promoter (CDH1)
repressing the gene expression [10,103,107]. The activity of Snail, Zeb and Twist
has been demonstrated to be under a complex post-translational regulation that
results  from  upstream  signalling,  involving  multiple  phosphorylations,  lysine
oxidation and ubiquitination (Figure 6)  [10,102]. The transcriptional regulation of
Snail  and  Zeb  is  also  subject  to  epigenetic  control  by  histone  modifications
through  several  deacetylases,  demethylase  and  methyltransferases,  further
increasing  the  layer  of  complexity  [10,102].  As  negative  regulators  of  EMT,
several  small  non-coding RNAs (micro RNAs)  have been identified  to  play  a
tumour suppressing role by selectively bind to mRNA of Snail,  Zeb and Twist,
targeting them to degradation  [10,102]. The miR200 family is the most studied
and important regulatory micro RNAs based on its capacity to counteract invasion
of  several  cancer  models  and  recover  of  Epithelial  phenotype  [108–111].
However,  the  expression of  Snail  and Zeb family  is  also  able  to  repress the
expression of these micro RNAs resulting in feedback which can drive different
cell  fates  and  explain  bi-stability  of  Epithelial  and  Mesenchymal  phenotypes
[10,102,112,113]. 
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2.6. Signalling pathways involved in EMT 
Multiple signalling pathways have been found to cooperate and participate in the
regulation of EMT [10]. Among them, the transforming growth factor-β (TGF-β)
signalling  has  been  considered  as  the  major  driver  of  the  initiation  and
progression of  EMT  [10,102,114,115].  Mechanistically,  TGF-β signalling drives
EMT  through  the  crosstalk  with  multiple  signalling  cascades  encompassing
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Figure  6 Roles and regulation of major EMT transcription factors. EMT is  driven  by
SNAIL, zinc-finger E-box-binding (ZEB) and basic helix–loop–helix (bHLH) transcription factors that repress
epithelial  marker genes and activate genes associated with the mesenchymal phenotype. Post-translational
modifications regulate their  activities,  subcellular  localization and stability.  (a)  Glycogen synthase kinase-3β
(GSK3β)  phosphorylates (P) SNAIL1 at two motifs;  phosphorylation of the  first  motif  facilitates the  nuclear
export of SNAIL1, and phosphorylation of the second motif enables the ubiquitin (Ub)-mediated degradation of
SNAIL1. Phosphorylation of SNAIL1 by protein kinase D1 (PKD1) also leads to its nuclear export. Conversely,
phosphorylation  of  SNAIL1  by  p21  activated  kinase  1  (PAK1)  or  large  tumour  suppressor  2  (LATS2),  or
dephosphorylation of SNAIL1 by small C-terminal domain phosphatase1 (SCP1) promotes the nuclear retention
of SNAIL1 and enhances its activity. SNAIL2 is degraded as a result of its p53-mediated recruitment to the p53–
mouse double minute 2 (MDM2) complex.  (b) TWIST is phosphorylated by the MAPK p38, JUN N-terminal
kinase (JNK) and ERK, which protects it from degradation, and thus promotes its nuclear import and functions.
(c) ZEB2 is sumoylated (Sumo) by Polycomb repressive complex 2 (PRC2) and subsequently exported from the
nucleus,  which  reduces its  activity  as a transcription  factor.  E-cadherin,  epithelial  cadherin;  ID,  inhibitor  of
differentiation; MMP, matrix metalloproteinase; N-cadherin, neural cadherin; PALS1, protein associated with Lin-
7  1;  PATJ,  PALS1-associated  tight-junction  protein;  SPARC, secreted protein  acidic  and rich  in  Cys;  ZO1,
zonula occludens 1. Figure and legend reproduced from [10].
several  transcriptional,  post-transcriptional,  translational  and  even  post-
translational mechanisms (Figure 7). TGF-β signalling is initiated by the binding
of TGF-β protein family to the TGF-β membrane receptors type I and type II,
which  in  turn  activates  the  SMAD  dependent  and  independent  signalling
cascades,  respectively  [10,115,116].  Activation of  TGF-β receptors induce the
first  step  of  EMT  through  the  activation  of  RHO-GTPases  signalling,  which
causes subsequent cytoskeleton changes, dissolution of tight junctions and finally
results in the loss of cell polarity [6,10]. Canonically, TGF-β induces the activation
of  SMAD2,  SMAD3,  and  SMAD4  into  a  complex  that  undergoes  nuclear
translocation  and  then  participates  in  the  transcriptional  activation  of  several
genes associated to the initiation of EMT such as the master EMT regulators
Snail1  and Zeb  [107,114,117].  Independently  of  SMAD signalling,  TGF-β can
activate  PI3K-AKT  signalling  resulting  in  the  post-translational  modifications
necessary to trigger the translation or repression of additional genes associated
with EMT progression [9,10,118]. For example, PI3K-AKT signalling is reported to
stabilize  Snail1  expression  and  therefore  the  Mesenchymal  phenotype
[10,119,120].  This  is  through  AKT  mediated  inhibition  of  GSK3β  by  a
phosphorylation  mechanism,  preventing  Snail1  proteolysis  via  Snail
phosphorylation  by  GSK3β  [119,120].  PI3K-AKT  signalling  pathway  also
participates  in  the  activation  of  the  anti-apoptotic  genes  necessary  to  gain
resistance to anoikis during migration and enhancing the expression of Snail1
through the activation of NFkB  [9,10,118,121]. 
Several other signalling pathways cooperate during EMT progression to complete
the EMT program (Figure 8). One of these signalling pathways is the canonical
MAPK (RAS-RAF-MEK-ERK), reported to be fundamental for both initiation and
progression of EMT in Epithelial cell lines [10,122]. Activation of MAPK signalling
was  found  to  be involved  in  EMT by the stimulation  both  Snail1  and  Snail2
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expression in several Epithelial cell lines through the activation of Egr-1 and AP-1
transcription factors [79,122,123]. Multiple receptor tyrosine kinases (RTKs) have
been  reported  to  activate  canonic  MAPK,  including  the  receptors  of  several
growth factors such as TGF-βR, EGFR and MET  [10,79,83,107].  Activation of
integrins constitutes another alternative way for the activation of MAPK signalling,
leading to EMT activation  [10,46,124].  Interestingly,  integrin and growth factor
signalling  were  found  to  crosstalk  and  enhance  the  migration  capacity  of
transformed cancer cells [46–48,125]. In addition, integrin signalling through the
activation of ILK has been found to crosstalk with PI3K-AKT signalling in several
carcinoma  cell  lines,  suggesting  this  is  an  alternative  way  to  lead  to  EMT
progression  [10,126–128].  Other MAPK members such as JNK and p38 have
been found to be activated by several integrins and growth factors receptors such
as TGF-βR, also capable of stimulating the EMT progression  [10,124,129].  
Activation  of  the  canonic  Wnt  and  Sonic  hedgehog  (SHH)  developmental
signalling pathways is another alternative way to drive EMT  [10,130,131]. Wnt
signalling mediates the nuclear translocation of β-catenin through the inhibition of
GSK3β and β-catenin destruction complex  [130,132]. Once β-catenin is in the
nucleus, it binds to TCF/LEF super-family of transcription factors and activates
the gene expression of Snail2 [107,133].  Recently, the joint activation of Wnt and
SHH in hepatocyte cell lines demonstrated a positive feedback of Wnt signalling
that  sustained  the  autocrine  activation  of  Wnt  and  TGF-β  signalling,  further
explaining the autocrine stabilization of the Mesenchymal phenotype in other cell
lines [131,134]. The activation of TCF/LEF and SMAD gene expression in EMT
progression have been also found to depend on the Hippo signalling through the
activation of nuclear translocation of YAP and TAZ upon releasing LATS inhibition
[135–137].
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Experiments with cancer cell lines have shown that the over-activation of Notch,
STAT3  and  HIF1α  signalling  can  further  stimulate  EMT leading  to  enhanced
invasion  capacity  [10,89,92–94,138].  In  addition,  synergistic  effects  have  also
been  found  between  Notch/HIF1α  and  STAT3/HIF1α  in  breast  cancer  and
prostate cell lines suggesting cooperation between these signalling pathways for
carcinoma  invasion  capacity  [89,92,93].  In  breast  cancers,  Notch  signalling
activation was found to directly activate Snail2, suggesting it can initiate EMT by
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Figure 7 Regulatory mechanisms of TGF-β induced EMT. TGF-β complex type I and II
receptors (TβRI and TβRII) activate SMAD2 and SMAD3, which then bind with SMAD4. The
SMAD complex  translocates to  the nucleus  and cooperates with  transcription  factors  in  the
inhibition or activation of target genes decreases the expression of the epithelial splicing. TGFβ
can  also  induce  non-SMAD  signalling  pathways  activating:  PI3K–AKT–mammalian  TOR
complex  1  (mTORC1)  signalling;  RHO-GTPases  through  phosphorylation  of  PAR6-SMURF1
signalling leading to tight junctions dissolution; Diaphanous (DIA1) and also RHO-associated
kinase (ROCK) to promote actin reorganization by the phosphorylation of  myosin light chain
(MLC) to activate LIM kinase (LIMK) and thus inhibit cofilin. RAC and CDC42 also participate in
cytoskeletal  changes  through  p21  activated  kinase  1  (PAK1)  and  direct  the  formation  of
lamellipodia and filopodia. 4E-BP1, eukaryotic translation initiation factor 4E-binding protein 1;
S6K1, ribosomal S6 kinase 1. Figure reproduced and legend adapted from [10].
itself [139]. However, Notch was also found to crosstalk with TGF-β, MAPK and
AKT signalling by overexpressing both NFkB and EGFR, further increasing the
complexity of the enhanced EMT stimulation in cancer  [94,140,141]. Moreover,
STAT3  and  HIF1α  signalling  are  capable  of  enhancing  EMT  through  the
activation  LIV1  and  LOX  expression  respectively,  two  alternative  ways  of
stabilizing Snail1 independently of GSK3β activity [92,93,142]. Taken all together,
multiple  and  intertwined  signalling  pathways  make  the  understanding  of  the
regulation of EMT a complex and challenging scientific problem. 
3. Addressing EMT through a Systems Approach
Systems  biology  is  a  multidisciplinary  scientific  field  originated  in  the  60s  to
address biological-based complex problems with an integrative thinking (holistic),
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Figure  8 Signalling pathways involved in EMT progression.  Integrin  induced  signalling
(orange),  SMAD independent  TGFβ signalling  (pink),  Receptor  tyrosine  kinase  induced  signalling  (purple),
Notch signalling (dark green), Wnt signalling (dark blue); Sonic Hedgehog signalling (SHH in light blue); STAT3
signalling (STAT3 in green) Hypoxia inducing factor 1 α signalling (HIF1α in light green), AKT signalling (PI3K-
AKT), MAPK signalling (RAS-RAF-MEK1/2-ERK1/2). Additional abbreviations: ECM (extracellular matrix); FZD
(frizzled); ILK (integrin-linked kinase); MKK (MAPK kinase) ; mTORC2  (mammalian TOR complex 2); Notch-IC
(intracellular  fragment  of  Notch);JNK;  (c-JUN N-terminal  kinase);  SHCA (adaptor  protein  SRC homology  2
domain-containing-transforming A); GRB2 (growth factor receptor-bound protein 2); SOS (son of sevenless);
TRAF6  (TNF  receptor-associated  factor  6);  TAK1  (TGFβ-activated  kinase  1);  GSK3β  (glycogen  synthase
kinase-3β); TCF/LEF (transcription factors lymphoid enhancer-binding factor LEF and T cell factor TCF); PTCH1
(patched  1);  SMO (smoothened);  GLI1  (glioma  1);  IL-6  (interleukin-6);  JAK (Janus kinase);  STAT3  (signal
transducer and activator of transcription 3); NF-κB (nuclear factor-κB).. Figure reproduced from  [10].
instead  of  the  traditional  reductionist  approach  [143–146].  Systems  biology
encompasses  a  wide  range  of  methodologies  and  concepts  that  came  from
computer science, mathematical modelling, enzyme kinetics, control theory, and
cybernetics  [144,145,147].  Since  the  year  2000,  the  field  has  been  more
dedicated to the analysis of large networks, motivated by the emergence of large
quantitative  and  qualitative  data  sets,  generated  from  the  always  evolving
experimental techniques in genomics and proteomics [143,145,148]. This forced
the improvement of computational and modelling methods to deal with such large
multi-scale datasets  [145,148,149]. Since then, several frameworks in systems
biology  have  been  evolving,  combining  both  theoretical  and  experimental
methods in a dynamic cycle to discard hypothesis and generate new testable
predictions  (Figure 9). Currently,  the systems approach is  considered to be a
fundamental asset for the understanding of complex and multi-variable problems
in biology such as signalling networks in cancer and other diseases  [148,149]. 
The regulation of EMT is indeed a multi-variable complex problem due to the
involvement of multiple microenvironment signals, the intertwined nature of the
involved signalling pathways, and the presence of multiple positive and negative
feedback loops  [8,10,102]. In addition, the complexity further increases in this
system  when  mutational  effects  during  cancer  progression  interfere  with  the
regulation  of  EMT  [28,150].  According  to  some  cancer  researchers,  the
integrative approach of systems biology could help to understand how EMT is
controlled in the cancer context  [8,20,151]. In particular, to identify drug targets
that can  prevent metastasis [149].
Experimental  data  concerning  regulatory  effects  on  EMT  in  normal  and
carcinoma cell lines have been accumulating in the literature during the last two
decades at a rate superior to its integration and analysis [8,102].  Computational
researchers have made efforts to store these data in publicly available databases
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such  as  the  KEGG  PATHWAYS and  the  Atlas  of  Cancer  Signalling  Network
(ACSN)  [151,152].  Computational  methods  such  as  NaviCell  and  Cytoscape
have been developed for the visualization, navigation and pathway analysis on
these databases, which have already provided useful information [148,149,153].
However,  the  complexity  and  extent  of  the  network  of  regulatory  effects  are
humanly  impossible  to  intuitively  grasp  behaviours  from  only  looking  at  the
descriptive  network  and  analysing  its  patterns.  Thus,  the  complexity  of  EMT
regulation  calls  for  mathematical  modelling  frameworks  to integrate  the
documented regulatory mechanisms and analyse their dynamic behaviours.  
Several continuous and discrete mathematical frameworks (Figure 9) have been
used in systems biology to describe the regulation of biological processes and
generate testable predictions [154,155].  The most popular are the kinetic and the
logical modelling frameworks [155].     
Briefly, the kinetic modelling framework relies on simulation or solving systems of
ordinary  differential  equations  (ODE)  to  generate  continuous  and  quantitative
changes of biological entities (variables) through time. In this framework, the rate
laws  (v)  of  each  variable  (x)  is  integrated  in  order  of  time  (t)  with  the  form
v = dx/dt, where ∫ dx dt = x(t). For more details on kinetic modelling framework
please see review in [155]. On the other hand, the logical modelling framework is
based on a qualitative and discrete approach. In this approach, the changes of
the variables (x) through time (t) are accounted through rules-based functions (F)
and an update scheme with the form x(t+1) = F(x(t)), where time has arbitrary
units. A detailed description of logical modelling framework and comparison with
kinetic  modelling  approach  in  the  context  of  systems  biology  and  cancer  is
presented in the next section and sub-sections.   
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3.1. The logical formalism
The application of the logical formalism in biology started in the 60-70s with the
work of Sugito, Kaufman and R. Thomas [156–158]. In modern systems biology,
this framework is now being used with success in the analysis of large molecular
regulatory  networks  (genes,  proteins,  microRNA’s)  to  describe  complex
behaviours and cell fate decisions [155,159,160]. Briefly, the framework consists
in the development and analysis of a logical model that describes one or more
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Figure  9.  The  systems  biology  cycle. From  questions  in  biology  that  include  multiple
hypotheses  and  large  data  sets,  the  systems  approach  gathers  all  pieces  of  information  to
construct a network model. The analysis of this network is through the association to mathematical
modelling  frameworks,  which  are  selected  to  meet  the  questions  and  available  data.  The
frameworks frequently used in systems biology are: Ordinary Differential Equations (ODE) based
kinetic models;  Logical  models (Boolean and multi-valued);  Fuzzy logic models;  And piecewise
Linear Differential Equations (LDE) models. To generate trustable predictions, models have been
trained  or  calibrated  with  experimental  data  sets  that  result  from  genomic,  transcriptomic  or
proteomic  data.  In  some  cases,  models  have  been  validated  by  comparing  its  results  with
independent  experimental  data.  To  analyse  the  models  according  to  particular  questions  and
dependent on the data itself, sometimes new analytical methods must be developed. Finally, the
analysis  of  validated/calibrated  network  models  provides  a  way  to  evaluate  hypothesis  and
generate experimentally testable predictions, which can eventually be confirmed.                    
phenomenological properties, assuming a non-linear regulation of its regulatory
components,  which  depends  only  on  the  presence  or  absence  of  regulators
[161].  A  logical  model  is  an  abstraction  of  the  regulatory  network  and  is
represented  through  a  graph  (regulatory  graph).  The  graph  edges  reflect
influence  effects  between  the  network  components  (nodes)  that  account  for
processes of activation or inhibition. In logical models, the nodes of the graph are
the variables and are often binary (Boolean, ON/OFF), describing two qualitative
states  of  biological  activity  or  concentration  for  the  respective  molecular
components. In alternative, the nodes can also be multi-valued, where multiple
discrete  and  finite  degrees  of  activity/concentration  can  be  associated  with
molecular  components.  The behaviours of  logical  models are given by logical
functions  (also  called  logical  rules)  that  define  the  evolution  of  the  variables
towards attractors,  according to an update scheme. In general,  there are two
types  of  attractors  in  logical  modelling,  the  point  attractors  and  the  cyclic
attractors. Point attractors, are also called stable states (we will use more this
term), which are fixed points where the functions are no longer updatable. This
means that all variables evolved towards a stationary value, which is equivalent
to the frequently called steady-state that result from kinetic models. In the case of
cyclic attractors in logical modelling, the values of a particular sub-set of variables
are always changing in t →∞ with a defined oscillatory behaviour, whereas the
remaining variables have fixed values (stationary). This behaviour is comparable
with  the  limit  cycle  oscillatory  behaviour  observed  in  some  kinetic  models.
Moreover,  the logical framework introduces the notion of threshold values that
define  changes  in  the  activity  of  the  model  components  according  to  logical
functions. Thus, logical modelling provides a discrete and qualitative analysis of
molecular networks, rather than the commonly used quantitative and continuous
ODE-based kinetic modelling  [159,160].
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3.1.1. Advantages and limitations
Logical  modelling  of  molecular  networks  has  advantages  and  limitations  in
comparison  with  commonly  used  continuous  and  quantitative  modelling
approaches  (see  [155] for  a  detailed  comparison).  Thus,  the  choice  for  the
framework depends on the type of information available and the type of network
to  model.  The  most  common  approach  in  network  modelling  is  through  the
development of kinetic models, which rely on detailed knowledge about the rate
laws and kinetic constants of each individual process [155]. Logical modelling has
the  advantage  of  not  requiring  precise  knowledge  about  the  kinetics  of  the
individual  processes  in  the  network  [155,159,162].  This  is  particularly
advantageous  for  most  molecular  networks  containing  signalling  processes
because  their  kinetic  rate  laws  and  kinetic  parameters  are  usually  unknown.
Although kinetic parameters can be estimated through global optimization fitting
methods to experimental data, it becomes very hard to find solutions in the case
of  large  networks  models  [155].  In  addition,  the  uncertainty  around  each
estimated parameter scales up to the number of total parameters. Thus, logical
modelling is  then a suitable alternative  for  large regulatory networks such as
signalling networks. Logical models only rely on qualitative information for the
construction and testing of the resulting predictions. This type of data has the
advantage of being easily obtained experimentally or by searching the literature.
The reason is that most of the problems in biology were tackled with qualitative or
semi-quantitative experimental  techniques to report  effects of  inhibitions, gene
knockout  and  overexpression  over  time.  Thus,  this  type  of  methods  are
commonly  available  and  a  great  number  of  reports  with  qualitative  data  are
accumulated in the literature. 
On the other hand, logical modelling has the limitation of being much less precise
in  describing  individual  biological  processes  in  comparison  with  the  kinetic
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modelling  approach  (Figure  10)  [155].  This  is  because  logical  modelling
predictions  are  not  continuous  (discrete  values)  and  therefore  neglect  the
transitory  behaviour  between  initial  and  final  state  of  a  process.  Meanwhile,
logical models can be as informative as kinetic models if we just want to know a
global change (final - initial). Therefore, logical modelling are suitable to describe
biological processes in threshold concentrations of a biological entity that result in
a maximum response in  a biological  target  such as biological  processes that
follow a sigmoid behaviour (Figure 10).  For example, this is the case of gene
expression  (gene  →  protein)  and  signalling  processes  above  threshold
concentrations of its activator/inhibitor (strong signal). 
 
Time is implicit in the logical framework through the variables update calls, which
is defined by logical rules, without accessing the rates of the processes. This is a
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Figure 10. Modelling the time-course kinetics using a kinetic model and the correspondent
logical  abstraction. Red lines  are theoretical  values by  both kinetic  and logical  models.  Dots
correspond to the experimentally observed values for an biological molecule in time. Most biological
processes  lead  to  a  saturation  of  a  product  during  its  production  or  during  a  chemical
transformation of molecule with time (sigmoid behaviour). This is when the rate of production of a
biological  chemical  species equals  the rate of  consumption.  For  example:  The production of  a
protein by its gene activation reaches its limit when its rate of production is equal to the rate of
protein turnover; The phosphorylation of a protein by kinases (activation/inhibition) in signalling is
limited by the constant protein concentration; Chemical reactions and molecular binding of proteins
when they reach equilibrium.          
good  approximation  if  the  rates  of  the  processes  are  similar  (in  the  same
timescale). However, in particular conditions where the rates of the processes are
different in orders of magnitude (different timescales), this may result in dynamics
and  regulatory  feedback  effects  which  are  not  biologically  plausible.  This
limitation can be overcome by adding delays, probabilities or rules of priorities on
logical models, given the availability of data that supports these features [155].
Finally,  combinatorial  explosion  occurs  as  the  number  of  states  grows
exponentially with the number of variables (model components). This hampers
the analysis of large models (because the state space is too large). Moreover,
model design may be hard due to the combinatorial explosion of the number of
potential logical rules for components that have large number of regulators.
3.1.2. Model definition 
A Logical model is defined by a regulatory graph and associated logical functions
(see the illustrative example in (Figure 11). According to the formal definition in
[160], a logical model is a mathematical object defined by (G, K),  where:  
• G = {g1, g2, …, gn} is the set of n network components, where each gi  (i =
{0,..,n}) is a variable that can adopt integer values from 0 to a defined
maximum value (maxi) as in the set  {0, 1, 2,..., maxi}.  Each value of gi
means a biological  feature (e.g.  concentration  or  activity  degree).  The
vector g = (g1, g2, …,  gn) contains all variables and characterizes a state
of the model in the  finite state space S given by the Cartesian product
∏
i=1
n
{ 0,...max i} . 
• K  =  {k1,  k2,  …,  kn}  is  the  transition  function  between  model  states,
composed by a set of discrete logical functions k i ,  each defining the value
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of gi., which depends on the current state g (and more precisely on the
values of its regulators), which is depending on an initial state of g. Thus,
the model behaviours are defined by the transition function k: S→S, with
each successor state of g  given by K(g)=(k1 (g), k2 (g)…, kn (g)).
The nodes of the graph correspond to the variables gi in G (network components)
and the incoming edges the regulatory effects (activations and inhibitions). For
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Figure 11 Formal logical model definition, an illustrative example. (a) The regulatory
graph that reflects the topology of the network, where the nodes are the variables of the model
(network components). The edges represent the regulatory effects of activation (green) or inhibition
(red). Gray node represents an input variable (no function attributed) and the remaining nodes are
variables  that  are  given  by  logical  functions.  (b,  c)  The  logical  functions  are  written  for  the
regulatory graph variables to define the model dynamics, where b considers all variables Boolean
and c the variable G1 as multi-valued. The mathematical symbols “ ,” “ ,” and “¬” represent the∧ ∨
logical operators AND, OR and NOT, respectively. Figure and legend adapted from [160].
nodes with no incoming edges, the variables g i  are defined as model inputs and
no logical functions are defined for these variables. In the case of nodes with no
outgoing edges, these variables are usually considered as model outputs. Logical
functions in  K are written accounting for the regulatory graph using conjunctive,
disjunctive and negation between variables gi  (AND, OR, and NOT) [160]. Thus,
for each variable gi that has incoming edges (activations or inhibitions), a logical
function is written considering the variables in G that correspond to all incoming
edges  (regulators).  Here,  the  rules  are  written  by  connecting  the  regulators
through the logical operators (see Figure 11 for examples).
For multiple activations of a node, the AND rule is chosen when these regulators
are required to be together, and the OR rule when each regulator can  activate
the  target  node  independent  of  the  status  of  the  other  regulators.  For  the
inhibition of a node by a regulator, the rule is  defined by using the NOT operator
as the prefix. Therefore, multiple functions with distinct transition dynamics can
be written for each graph, depending on the number of regulators. Thus, each
graph can be associated with a family of logical models, and each K corresponds
to  a  unique  regulatory  graph  [160].  Functions  can  be  developed  based  on
information from the literature, where the rules are chosen based on biological
knowledge. Or in alternative, rules can be inferred from observed data through
truth tables.
3.1.3. Model dynamics
A Logical model generates a discrete dynamics over S, which is  defined by the
transition function K and depends on the initial state g. To generate a dynamics, if
K(g)  ≠  g the function is call  to update at least one variable in g to match the
one(s) in K(g) [160]. Whenever  K(g) = g, there is no call for update of variables,
and this state is denominated a stable state (also called point attractor, which is a
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stationary state). If not, variable updates generate transitions towards successive
states.  The  dynamics  is  frequently  represented  by  a  State  Transition  Graph
(STG),  where  the  nodes  of  STG  are  the  model  states  and  each  state  is
connected to its successor state through the edges  [160]. The analysis of the
STG provides the identification of  the initial  conditions and paths that  lead to
stable states or cyclic attractors (see examples in Figure 12). Biologically, stable
states  indicate  a  cell  fate  and  cyclic  attractors  an  oscillatory  behaviour
[159,160,162,163]. In the STG, the stable states, are identified by the nodes of
the graph  (states)  that  do  not  possess outgoing edges.  For  cyclic  attractors,
these are identified in the STG when the dynamics falls into a set of transient
states  that  results  in  a  closed  loop  of  transitions  (without  outgoing  edges).
However, the STG of large network models can result in a huge graph that is
impossible for a human to understand. As alternative, the Hierarchical Transition
Graph (HTG) is a compact representation of an STG that hides most transitions,
only showing the outgoing transitions that lead to stable states or cyclic attractors
(for more details see  [163] ).  
The two most common forms to update variables are called the synchronous and
the asynchronous update schemes  [160]. These types of  variables  update can
generate  distinct  dynamics  (see  examples  in  Figure  12).  In  the  synchronous
update, all variables in g change simultaneously in each update call. This update
scheme originates deterministic dynamics, where one state can only generate a
unique successor.  In the asynchronous update,  when more than one variable
does not match its function (K(g) ≠ g), each node value is updated independently,
generating  non-deterministic  concurrent  states.  Thus,  asynchronous  dynamics
generates all possible concurrent transitions. Within the asynchronous updating
scheme,  probabilities  can be used to  randomly  select  the  variable  to  update
(Random asynchronous update), generating a particular dynamics and discarding
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others  [160].  This  can  be  also  applied  in  the  case  of  networks,  where  the
regulatory  processes  have  distinct  timescales  such  as  in  the  case  of
phosphorylation  of  proteins  and  transcription  of  genes  [160].  In  these cases,
defining high and lower probabilities can provide an approximation to the kinetics.
In alternative, rules of priority can also be defined in the asynchronous update,
where nodes are ranked into classes with an order of update [163,164]. Formally,
for a set of variables in G of size n, it is possible to define the priority classes C1;
C2; ...; Cp with p ≤  n [164]. Here, the variables that belong to the highest rank
will be checked first for the update, followed by next rank only if no variables in
the higher rank are call to update. This strategy is suitable to mimic molecular
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Figure 12  Model dynamics, an illustrative example.  State Transition Graphs (STG)  that
represent the dynamics of the Boolean version of the model(Figure 11), starting from any state of
the state space. On top, the dynamics with the asynchronous update and on the bottom with the
synchronous update.  Dynamics generated for each input  condition fixed (G4=0 and G4=1).  The
values of the states g are denoted in each node of the STG as a string of the values with the
following order: x1, x2, x3, and x4. Nodes in white are the transient states, yellow shows the stable
states, blue shows a cyclic attractor and pink a new terminal cycle. Figure and legend adapted from
[160].
entities that are transformed in different time scales and can be defined for the
increase and decrease in activity of variables [164]. 
3.1.4. Methods and tools
Free software tools for the construction and analysis of logical network models
have been developed by several groups [160,165]. Through the Consortium for
Logical  Modelling  and  Tools  (CoLoMoTo),  a  joint  effort  has  been  made  to
standardize and integrate most of the analytical methods in the already available
software tools (Table 2)  [165].  Extensive description and comparison of  these
methods are available in the CoLoMoTo web page (http://colomoto.org/software).
Among them, the GINsim (Gene Interaction Network simulation) is a versatile
software tool, exclusively dedicated to the analysis of regulatory networks using
the logical framework (http://ginsim.org) [166]. With this tool, the regulatory graph
can be design and the respective logical model can be formulated and analysed
in a user friendly environment. Here, both Boolean and multi-valued variables are
supported.  The  models  can  also  be  easily  reduced  in  their  number  of
components  with  a  semi-automatized  method  described  in  [167].  The  model
dynamics  can  be  generated  under  the  synchronous,  asynchronous  update
schemes, including the possibility of setting priority classes. GINsim is able to
construct the STG with a reasonable size (in the order of a few million states),
and also  the respective  HTG  [163,166].  GINsim includes  several  methods to
analyse  model  properties  and  supports  multiple  model  formats  enabling  the
usage in  other  software tools  [163,166].  With  GINsim,  we can analyse static
model  properties  such  as;  the  analytical  determination  of  all  stable  states
regardless of their reachability conditions, and the identification of conditions for
positive  and negative  functional  circuits.  To analyse the reachability  of  stable
states, GINsim also recently included methods to estimate their probabilities such
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as  Avatar,  MonteCarlo  and  FireFront.  In  GINsim,  the  user  can  define
perturbations by simply fix the variables values and explore the changes in static
and dynamic properties. For example, fixing a node to value 0 or 1 to mimic the
effect of a putative knockout or over-activation of a gene, respectively. In GINsim,
it is also possible to knockout or ectopically active the effect of specific interaction
in  a  similar  way.  This  is  particularly  interesting  to  study  the importance  of  a
regulatory interaction on the network properties.  
Table 2. Summary of logical modelling software tools. Tools that belong to the CoLoMoTo
[165]. Tools share the SBML format, which enables the integrative usage in the analysis of logical
models. 
Software tools Description 
BoolNet R package for Boolean networks. Allows construction, analysis and 
simulation with several updating schemes. 
Cell Collective Web platform for Boolean networks. Allows construction, analysis and 
simulation.     
CellNetAnalyzer Toolbox (MATLAB) to provide a graphical user interface to explore structural
and functional properties of metabolic and signalling networks. 
CellNOpt Open source application (R/BioConductor, Cytoscape, Python) for the 
training of logical network models with experimental data. Supports 
Boolean, Fuzzy logics and ODE formalisms.  
GINsim Java application for the analysis of Boolean and Multi-valued networks. 
Allows simulation of dynamics with several updating schemes.   
MaBoSS C++ developed application for the simulation of time Markov processes 
derived from Boolean logical models.  Does not support SBML.
BoolSim SQUAD Search and identify all type of attractors (stable and cyclic). Also allows the 
construction of continuous models from logical models.   
3.1.5. Modelling cancer networks
Computational  modelling  of  molecular  regulatory  networks  using  the  logical
formalism has been recently applied with success in cancer research [131,168–
172]. Some modelling work has contributed to cancer research by finding new
combinations of drug targets to fight cancer, proven to have a synergistic effect in
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vitro or in a mouse model  [170–172]. Other studies have contributed to cancer
research by explaining particular behaviours or properties such as co-occurrence
of  mutational  effects and invasive cell  fate properties  [131,168,169].  All  these
logical models have been constructed based on reports from literature,  which
supported  each  regulatory  effect  (interaction).  Some  authors  developed  their
models  for  specific  cancer  types  [131,168,170,172].  Others,  have  chosen  to
develop a generic  model  and applied it  to  a few cancer  cell  types  [169,171].
These modelling choices depend on the biological question and also limited by
the available knowledge of the biological system. Choosing a particular cancer
cell type to focus simplifies model construction and validation if enough data is
available  for  that  cancer  cell  type.  This  choice  allows  exploring  particular
characteristics of a cancer type (“zoom in” approach), which may be useful to
better  understand a  particular  type of  cancer  and  design  specific  therapeutic
strategies. On the other hand, the choice of modelling generic properties (“zoom
out”  approach)  is  advantageous  for  searching  conserved  mechanisms  of
common cancer behaviours such as migration and metastasis acquisition. This
may help to find critical targets for cancer control, which could improve the design
of therapeutical strategies. However, the “zoom out” approach is more difficult in
terms of model development and validation because of biological variation and
the lack of comparable data for all cancer types.  
To  help  the  construction  of  networks,  modellers  have  resorted  to  available
signalling  networks  in  databases  such  as  KEGG  PATHWAYS,  ACSN  and
Reactome  to  identify  relevant  interactions,  instead  of  inferring  networks  from
experimental data. Logical functions have been derived by interpreting collected
literature information instead of  using fitting methods to experimental  data.  In
alternative, multiple functions generating a family of models have been analysed
to evaluate the robustness of generated predictions [171,172]. GINsim has been
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extensively  used  for  the  construction  of  the  regulatory  network  and  for  the
generation of the model dynamics  [168,169,171,172]. Other software tools like
MaBoSS have been also resourced, in particular for the analysis of reachability
properties  [171].  Perturbations of  the network nodes (components) have been
fruitful  to  generate  predictions  and commonly  resourced  for  the  simulation  of
knockout, inhibitions and over-expression experiments used in model validation.
Logical  models  in  cancer  have  been  validated  by recapitulating
phenomenological observations from a set of experiments on cancer cell  lines
[168–172]. In addition, logical models have been challenged to recapitulate some
molecular  changes in activity or  concentration during such experiments. Used
experiments  consisted  on  the  quantification  of  changes  in  phenomenological
properties  in  a  population  of  cells  in  culture  with  and  without  a  given  set  of
perturbations (e.g. gene knockout, gene over-expression and addition of growth
factors),  reflecting  the  experimental  conditions.  Most  models  have  used
experimental  observations collected from literature articles or  expression data
from  public  databases  instead  of  producing  their  own  data.  However,  most
modellers test their predictions in vitro using cell lines, which in some cases are
in  collaboration  with  experimental  groups.  For  the  comparison  with  logical
modelling predictions, modellers often binarize the observed phenomenological
changes  to  qualitative  changes  such  as  up-regulated  (value  1)  and  down-
regulated (value 0). To do so, modellers such as Cohen et al.  resorted to specific
software tools, others simply qualitatively interpret the experimental data.
To  address  cancer-related  questions  and  generate  interesting  predictions,
phenomenological  properties  such  as  survival,  apoptosis,  proliferation,  EMT,
metastasis  and  migration  have  been  defined  as  model  readouts.  The  linking
between model readouts and the regulatory network has been set to reflect a
particular  activity  status  of  the  network  components,  which  are  reported  as
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markers for the correspondent phenomenological property. The usage of these
readouts  has  been  quite  useful  for  model  validation  and  testing  predictions.
Except for EMT and metastasis, the predicted phenomenological properties are
relatively easy to access in cell culture with commercially available assays. For
EMT and metastasis, commercially available cell adhesion and migration assays
have been used as proxies, together with the quantification of E-cadherin as a
marker of  EMT  [131].  Taken all  together,  the logical modelling framework has
been  proven  to  successfully  identify  and  understand  combinatorial  effects  of
perturbations of regulatory networks in cancer.   
3.2. Mathematical models of EMT
During the last decade, mathematical models have been developed to address
particular  questions  about  the  regulation  of  EMT in  the cancer  context.  Both
continuous (kinetic modelling) and discrete (logical modelling) frameworks have
been  used  as  modelling  approaches  for  describing  EMT  properties.  In  the
following subsections, we will  briefly describe these modelling works and their
main objectives and findings. 
3.2.1 Kinetic models of EMT
With the purpose of  analysing the behaviours of  multiple regulatory feedback
loops between MAPK and Wnt signalling during EMT, Shin et al. developed an
ODE-based continuous model that describes the expression of E-cadherin (EMT
readout) in response to EGF and Wnt [8,20,151]. In this model (Figure 13), the
inhibition  of  E-cadherin  transcription  by  Snail1  and  Snail2  was  considered
together with the mechanisms of Snail activation by  Wnt and ERK  [173]. The
authors concluded: 1) Coupling positive feedback loops containing the inhibition
of Raf kinase inhibitor protein (RKIP) by ERK with the transcriptional repression
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of RKIP by Snail are essential to generate a switch-like behaviour of E-cadherin
expression; 2) RKIP expression, inhibits EMT progression by preventing MAPK
signalling and E-cadherin suppression [173]. 
The mutual inhibitions between the EMT master transcription regulators (Zeb and
Snail) and the microRNAs (miR200 and miR34 families) have been proposed to
be  the  core  regulatory  circuit  of  EMT (Figure  14),  and  have  been  modelled
through ODE in order to explain several observed cell  fate properties of EMT
[174–177].  In  the  work  of  M.  Lu  et  al.,  the  function  of  the  miR200/Zeb  and
miR34/Snail  modules  of  the  regulatory  EMT circuit  was  analysed  [174].  The
authors found that miR34/Snail circuit  acts as a noise buffering integrator that
depends on the strength of external and internal signals, controlling EMT initiation
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Figure  13.  Network representation of  the mechanisms of EMT by EGF and Wnt
signalling, modelled in the work of Shin et al. The rates laws in the model are represented
by the letter v and the variables in the model by the letter x. Figure reproduced from [173].
[174].  On  the  other  hand, ZEB/miR200  forms  a  circuit  with  3  stable  states;
high/low,  medium/medium  and  low/high  levels,  which  were  associated  to
Epithelial, Hybrid and Mesenchymal phenotypes [174].
In another work, the core regulatory circuit of EMT (Figure 14) was analysed   to
explain  the  reversible  behaviour  of  EMT (MET)  in  response  to  TGFβ  [175].
Through deterministic and stochastic analysis, the authors showed that the EMT
circuit explains EMT and partial EMT in a two-step process (Epithelial → Hybrid
→ Mesenchymal), where the Hybrid state is an intermediate and depends on the
strength and duration of the TGFβ signal [175]. In this work, they also found that
the miR-34/Snail1 mutual inhibition was responsible for the reversible switch and
regulates  the  initiation  of  EMT,  whereas  the  ZEB/miR-200  controls  the
establishment of  an irreversible Mesenchymal state by autocrine regulation of
TGFβ, generating hysteresis behaviour [175]. Except for the autocrine regulation
of TGFβ, the predictions from the modelling work of Lu et al. and Tian et al. were
confirmed experimentally in cell cultures using MCDK cell lines  [115]. Later on,
detailed  kinetic  models  accounting  for  the  molecular  mechanisms  that  could
control  the  mutual  inhibitions  between  ZEB1/2  and  miR200b/c  have  further
demonstrated the dose-dependent autocrine TGFβ effect on the stabilization of
Mesenchymal  phenotype [177].  These  models  were  validated  by  comparing
predictions with series of time course kinetics that followed the concentrations of
miR200b,  miR200b,  Zeb1,  Zeb2  an  in  MCDK cell  lines  exposed  to  different
concentrations of TGFβ [177].  
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The transitions between Mesenchymal, Hybrid and Amoeboid-like have been also
analysed by coupling the core regulatory circuit of EMT with the mutual inhibitory
circuit  of  Rac1/RhoA that  determines the Mesenchymal-to-Amoeboid transition
[35,176].  In  this  model,  the authors predicted that  the overall  strength  of  the
miRNAs inhibition on Snail/Zeb family is critical to determine the repression of
EMT/MET, and eventually results in hybrid phenotypes [176]. This means that, at
low degree of microRNAs, the model predicts that Amoeboid-like/Mesenchymal
cell fate is favoured, dependent on the degree of activation of Gab1 and Grb2 co-
receptors by HGF receptor  [35].  On the other hand, strong microRNAs levels
were  predicted  to  stabilize  the  Hybrid  phenotype  [176].  Recently,  Jolly  et  al.
identified additional stability factors in lung cancer cell lines, that are required to
be coupled with EMT regulatory core circuit in order to explain how miR200 can
stabilize Hybrid phenotypes during carcinomas migration [19].  
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Figure 14. The proposed core regulatory circuit of EMT. The circuit is composed of
two linked mutual inhibition circuits,  the miR200/ZEB and the miR34/Snail.  Activations are
represented  by  arrows  and  inhibitions  by  a  solid  bar.  Solid  lines  denote  transcriptional
mechanisms and dashed lines denote the translational regulation mechanisms triggered by
microRNAs. Dotted lines indicate indirect regulation. The numbers along the arrows represent
the number of binding sites involved, deduced from experimental  data.  Figure reproduced
from [174].    
3.2.2. Logical models of EMT 
A Boolean logical model was recently developed by Steinway et al. to understand
how TGFβ drives EMT in hepatocarcinoma (Figure 15) [131]. So far, this model is
the most detailed literature based EMT regulatory network, accounting for several
signalling pathways and transcription factors reported to be involved in EMT of
hepatocarcinomas [131]. The analysis of the model showed a joint activation of
Wnt,  Sonic  hedgehog  and  TGFβ  signalling  as  a  conserved  axis  of  the
mesenchymal  phenotype  during  EMT  in  hepatocytes.  This  prediction  was
experimentally confirmed  in vitro using murine and hepatocarcinoma cell lines.
Moreover, the model analysis predicted a total of 8 regulatory circuits involved in
EMT and in the stabilization of the mesenchymal phenotype, including the Wnt/β-
catenin  feedback loop and the miR200/ZEB crosstalk  with both MAPK/SMAD
circuit  and the TGFβ feedback loop. The model of Steinway et al. was further
used  in  a  posterior  research work  that  explored  all  possible  combinations  of
single, double and triple KO of model components [170]. This was done with the
purpose of identifying effective drug combinations that could improve the usage
of SMAD drug inhibitors in cancer therapy. In this work, the model predicted that
SMAD inhibition in combination with NOTCH, RAS, AKT or PI3K would be more
effective  in  preventing  TGFβ  driven  EMT  in  hepatocarcinoma  [170].  These
predictions  were  tested  in  cell  cultures of  hepatocarcinoma  cell  lines  by
measuring E-cadherin expression and with comparing migration assays. In this
work, several combinations of network perturbations, including SMAD inhibition,
have  resulted  in  stable  states  that  were  compatible  with  both  Hybrid  and
Intermediate  phenotypes (partial EMT phenotypes).
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Meanwhile, another logical network model was developed for predicting the role
of individual and combinations of mutations driving the metastasis potential of
EMT in carcinomas [171]. Additionally to EMT, the model accounted for migration,
invasion, apoptosis and cell cycle arrest as phenomenological outputs [171]. The
model  was analysed considering generic ECM and DNA damage as two external
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Figure  15.  Network model  of  EMT signalling in hepatocarcinoma cell  lines. The
nodes represent molecular entities such as proteins, genes, miRNAs and other biological
molecules.  Nodes in  white  are  regulatory  components,  dark gray represent  upstream
signals, nodes in light gray the downstream signals (transcription factors), and the node in
black  with  white  text  the  output  of  the  model  (EMT).  Edges  represent  activation  or
inhibitory effects between nodes. Full names of the nodes, logical rules and references of
the model are in [131]. Figure reproduced from [131]. 
signals  from  the  microenvironment.  In  this  study,  the  model  recapitulated
experiments  of  TGFβ induced  in  lung  carcinoma  cell  lines  and  reported
mutations.  The  model   analysis  identified  combinations  of  mutational  effects
(gene knockout and overexpression) that resulted in a synergistic increase of  the
probability of reaching the metastasis fate. Interestingly, the authors identified a
synergism  for  the  combination  of  NOTCH  over-activation  with  p53  knockout
leading  to high cancer cell migration,  which was  in agreement with the results
observed in a mouse model of gut cancer [171].  
3.3. Modelling the effects of microenvironment signals on cell adhesion 
So far, how multiple microenvironment conditions affect Mesenchymal and Hybrid
cell  fates  have  not  been  analysed  accounting  for  mutational  perturbations  in
cancer. In addition, the role of cell-cell contact signals has not been yet explored
in the context  of  carcinoma invasion and metastasis.  Moreover,  mathematical
models  that  include features  (e.g.  cell-cell  adhesion and focal  adhesion)  that
characterize the distinction between invasive (e.g. Mesenchymal or Hybrid) and
none-invasive phenotypes (e.g. Epithelial) have not been yet developed. Thus,
the development of such models would provide a proxy to understand the effect
of the microenvironment on cancer migration and metastasis acquisition in an
holistic manner. This calls for new mathematical models to integrate the current
knowledge  and  provide  a  framework  that  establishes  a  relation  between
microenvironment and phenotypes.  In the next chapter of this thesis,  we will
present a novel logical model that accounts for the effects of 8 microenvironment
signals  on the regulations of cell-cell adhesion and focal adhesion. Moreover, in
the next chapter, we will also analyse the model towards addressing the following
main questions, previously highlighted during this chapter.
57
1)  How  does  the  microenvironment  control  the  switching  between  Epithelial,
Hybrid and Mesenchymal phenotypes?
2)  What  is  the  role  of  cell-cell  contact  signals  on  the  switching  between
phenotypes? 
3)  How  does  mutational  perturbations  in  cancer  interfere  with  the  switching
between phenotypes?
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CHAPTER 2
Logical Modelling of the Regulation of
Cell Adhesion properties in EMT 
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Summary
E-cadherin mediated cell-cell  adhesion and the focal adhesion are two critical
features that change during EMT, and also characterize partial EMT phenotypes
with collective migration properties (Hybrid phenotypes). The switching between
Epithelial, Mesenchymal and Hybrid phenotypes is believed to play a key role in
the process of metastasis. However, the microenvironment conditions that allow
the  control  of  the  switching  between  phenotypes  accounting  for  cancer
mutational  background  are  still  unknown.  The  regulation  of  cell  adhesion
properties during EMT is complex, involving multiple microenvironment signals
and signalling pathways. Mathematical modelling with the logical formalism has
been demonstrated to be a useful tool to understand complex systems such as
signalling in cancer. Based on an extensive literature search, we constructed a
logical network model that encompasses a total of 8 microenvironment signals
involved  in  the  regulation  of  EMT (3  signals  from  cell-cell  contacts,  4  from
diffusive molecules, and 1 biophysical property from the ECM). We developed the
model to account for the main regulatory signalling pathways represented by 42
intracellular components (nodes) and 134 regulatory interactions. In our model,
we define the cell-cell adhesion and focal adhesion dynamics as model readouts,
which were associated to the Epithelial, Mesenchymal and Hybrid phenotypes.
Our model was able to recapitulate the stability of Epithelial and Mesenchymal
phenotypes together with their reported markers. Further, the model recapitulated
the observed activity changes of cell adhesion and molecular components from
published  experiments  on  Epithelial  cell  lines  exposed  to  microenvironmental
signals  or  containing  mutations.  With  our  model,  we  generated  predictions
suggesting that cell-cell contact signals that activate RPTP and FAT4 determine
cell adhesion properties and control the switching between phenotypes. Further,
we also predicted that SRC and FAT4 overexpression in carcinomas were two
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critical  perturbations  that  promotes  the  switching  towards  Mesenchymal  and
Hybrid  phenotypes,  respectively.  Moreover,  we  also  provided  a  mechanistic
explanation for  the effects of RPTP and FAT4 on the control  of  cell  adhesion
properties.    
1. Introduction 
Epithelial-to-Mesenchymal transition (EMT) is a complex and reversible (MET)
cellular program, where an Epithelial cell loses the adhesion to its neighbour cells
(cell-cell  adhesion)  and  transforms  into  a  Mesenchymal  cell  with  migration
capacity  [1–3]. This process is known to be hijacked by carcinomas, which is
often associated with the acquisition of invasion capacity [4–6]. However, EMT in
carcinomas is  often incomplete (partial  EMT),  where the E-cadherin mediated
cell-cell  adhesion  is  maintained  [2,7].  In  particular  cases,  partial  EMT  in
carcinomas  results  in  the  gain  of  the  Mesenchymal  migration  capacity  often
called as Hybrid phenotypes [8–10]. Thus, carcinomas can migrate as single cells
(e.g. Mesenchymal phenotype) or as a group of cells through the formation of
Hybrid phenotypes [8,9,11]. Epithelial, Mesenchymal and Hybrid phenotypes can
be distinguished by their characteristic E-cadherin mediated cell-cell adhesion in
combination with the characteristic focal adhesion dynamics, two cell adhesion
properties  critical  to  ensure  the  mode  of  cancer  migration  [10,12–14].  For
example, an intermediate strength of cell-cell  adhesion is often found to be a
feature of collective migration in carcinomas, whereas Epithelial cells have high
cell-cell  adhesion  strength  [10,12,15].  On  the  other  hand,  focal  adhesion
dynamics is an integrin mediated cell-matrix adhesion property that mediates the
migration capacity along the extracellular  matrix  (ECM) of  Mesenchymal cells
[10,12,13]. Thus, we focused our work on these two cell adhesion properties as a
proxy of Epithelial, Mesenchymal and Hybrid phenotypes.
74
The dynamics of the interconversion (switching) between Epithelial, Hybrid and
Mesenchymal phenotypes are key steps that participate in the initial  and final
steps of metastasis of carcinomas [11,12,15–18]. The tumour microenvironment
is  considered  as  the  main  hypothesis  that  drives  the  switching  between
phenotypes  in  metastasis  [11,16,17,19].  However,  how  and  which
microenvironment  signals  control  the  switching  between  phenotypes  are  still
unknown  [8,11,20].  This  is  mainly  due  to  the  complexity  of  the  tumour
microenvironment, which is composed by a variety of diffusible signals from the
ECM and signals from neighbouring cells (cell-cell contact signals) in a dynamic
equilibrium [8,16,19,21]. In vitro, several microenvironment signals such as ECM
stiffness, inflammatory signals, hypoxia, growth factors and Delta-Notch cell-cell
contact signals have been already postulated to play a key role in driving EMT in
cancer  cells  [8,22–24].  On  the  other  hand,  microenvironment  signals  that
counteract  EMT  are  still  unknown  [19,25].  The  regulation  of  EMT  by  the
microenvironment  is  complex,  involving  multiple  and  intertwined  signalling
pathways with feedback loops  [25–27]. The complexity further increases when
mutations  in  cancer  progression can alter  the  regulatory  control  [8,28].  Thus,
innumerous  hypotheses  that  consist  of  the  combination  of  microenvironment
signals  with mutational  effects  can arise for  the switching conditions between
phenotypes.  Accessing  these  conditions  is  a  challenge  suitable  for  systems
biology  frameworks,  provides  a  methodology  that  facilitates  the  analysis  and
understanding of such complex systems and generate new testable predictions
(hypothesis) [29]. Some kinetic and logical models of the regulation of EMT have
been developed to address particular questions and to explain EMT properties
[30–34]. Recently, a logical network model of EMT in hepatocarcinoma predicted
inhibitory  effects  on  intracellular  signalling  components  capable  of  stabilizing
partial  EMT  phenotypes  by  only  considering  E-cadherin  (ON/OFF)  as  the
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indicator of EMT [35]. However, the relation between multiple microenvironment
signals and the acquisition of invasive adhesion properties (cell-cell adhesion and
focal  adhesion  dynamics)  on  these  phenotypes  are  yet  to  be  explored.  This
motivated us to develop a network model to predict the microenvironment and
mutational  conditions  for  the  switching  between  adhesion  features  that
characterize  Epithelial,  Mesenchymal  and  Hybrid  phenotypes.  Because  the
kinetic laws and constants are unknown for most signalling processes, the logical
modelling framework is an alternative systems biology approach since it does not
require knowledge of the kinetics [36]. This framework has been quite successful
in recapitulating experimental observations and generating robust and testable
predictions  in  cancer  research  [31,32,37–39].  Thus,  we  chose  to  develop  a
literature-based logical network model for the regulation of E-cadherin mediated
cell-cell adhesion and focal adhesion dynamics. Here, we present a model for the
regulation  of  cell  adhesion  properties  that  accounts  for  the  main
microenvironment signals and signalling pathways that drive EMT. This model
was  validated  by  recapitulating  Epithelial  and  Mesenchymal  markers,  and
observations from experiments on Epithelial cell lines that included the effects of
several microenvironment signals or mutations. In this chapter, we focus on the
analysis of the role of cell-cell contact signals on the regulation of cell adhesion
properties  during  EMT.  Here,  we  explore  the  potential  of  cell-cell  contact
activation of Receptor Protein Tyrosine Phosphatases (RPTP) and the membrane
receptor FAT4 to control EMT [40,41]. These receptors were chosen based on
their reported potential to inhibit RTK (RPTP) and Wnt signalling through Hippo
signalling  activation  (FAT4),  signalling  pathways  associated  with  EMT
progression [40,42]. Our model analysis resulted in predictions for the capacity of
RPTP and FAT4 activation by cell-cell  contacts to control cell  adhesion in the
presence of all possible combinations of EMT driving signals. In this work, we
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also identified critical alterations in the network that favoured either Mesenchymal
or  Hybrid  adhesion  phenotypes.  Among  them,  two  correlate  with  tumour
expression  degree  in  comparison  with  normal  tissues,  and  their  roles  in  the
switching of phenotypes was explored. Moreover, we provide here a mechanistic
explanation based on our model for the effects of RPTP and FAT4 signals on cell
adhesion properties during EMT.
2. Methods
2.1. Software tools
2.1.1. GINsim
GINsim is a free software tool developed in JAVA for the modelling and simulation
of  regulatory  networks  (www.ginsim.org)  [47].  This  tool  is  the  result  of  a
collaborative development coordinated by C. Chaouiya (Instituto Gulbenkian de
Ciênica, Oeiras) and D. Thieffry (Ecole Normale Supérieure, Paris). We used the
currently stable version 2.4 for the setup and analysis of the model presented in
this thesis. We also used a version under development with new analytic tools for
attractors search, implemented by Rui Henriques at INESC-ID and supervised by
Pedro Monteiro and C. Chaouiya.      
       
2.1.2. R and Rstudio
For  numerical  manipulations  and  data  plot,  we  used  R version  3.3.2,  a  free
software environment for statistical computing and graphics (www.r-project.org)
initially  created  by  Ross  Ihaka  and  Robert  Gentleman  in  1993.  R  code  was
written  and  run  under  the  Rstudio®  integrative  console  environment,  version
1.0.136. 
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2.1.3. Python 
For automatic and systematic analysis of results, we wrote several scripts using
the  python  version  2.7  (www.python.org),  an  object  oriented  high-level
programming language, originally created by Guido van Rossum in 1991. 
2.1.4. Scripts
R and python scripts used in the work presented in this chapter are available in
GitHub public repository (https://github.com/rjpais) under the project cell adhesion
network model. We include the running instructions inside each file. 
2.2. Model construction
2.2.1. Network construction 
To construct and visualize the network, we used GINsim software [47]. With this
tool, we built the interaction map (network) which contains the regulators (nodes)
connected through arcs, representing activations or inhibitions (interactions). We
based on regulators and interactions  from signalling  pathways and regulatory
processes  involved  in  cell-cell  adhesion  and  focal  adhesion  to  construct  the
network.  To find these regulators and interactions, we started from records in
KEGG PATHWAY database [48]. Initially, we explored the KEGG reference maps
of  adherens  junction,  focal  adhesion  and  several  signalling  pathways  that
participate in cell adhesion regulation (Table 3). To complement this source, we
used the Atlas of cancer signalling database (ACSN) developed at the Institute
Curie (https://acsn.curie.fr).  In particular,  we explored the ACSN map for EMT
and cell  motility  that  contains  modules for  the regulation of  cell-cell  and cell-
matrix adhesion (Focal adhesion)  [49]. We used the NaviCell  web platform to
navigate on the ACSN and find additional interactions and regulators  [50]. We
also brought-in the regulators and interactions of the EMT network developed for
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hepatocytes  by  Steinway  et  al.  [31].  Next,  we  searched  the  literature  for
experimental work, preferably on Epithelial cell lines, in order to provide support
for each interaction in the network. Additional interactions not found in databases
were obtained from references found in the literature.
Table 3 .KEGG reference maps used for network construction. Maps were taken from
KEGG  PATHWAY  database  available  at  www.genome.jp/kegg/pathway.html.  Maps
indicated with *** were used for the main basis of the regulatory network, ** additional
pathways included, * maps inspected to find additional crosstalk points.        
Process/signalling pathways  Reference maps for humans Usage Last update
Adherens junction hsa04520 *** 2013
Focal adhesion hsa04510 *** 2015
Notch signalling hsa04330 ** 2017
Hippo signalling hsa04390 ** 2017
HIF1 signalling hsa04066  * 2017
JAK-STAT signalling hsa04630 * 2015
TGF signalling hsa04350  * 2015
Wnt Signalling hsa04310 * 2017
AKT signalling hsa04151 * 2017
MAPK signalling hsa04010 * 2017
RAP1 signalling hsa04015 * 2015
ERBB signalling hsa04012 * 2015
NF-kappa B  signalling hsa04064 * 2017
RAS signalling hsa04014 * 2017
2.2.2. Network annotations 
For  each node of  the network,  we annotated the name of  the correspondent
molecular component, type of molecule, cellular localization, role in cell adhesion
and  molecular  activity.  We used the  UniProt  (www.uniprot.org)  and  the NCBI
gene database (www.ncbi.nlm.nih.gov/gene) as sources for the annotation. For
each molecular component, we check on these databases the tissue specificity,
existence in humans, and the Gene Ontology (GO) term that would best describe
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the molecular activity. When needed, specific reviews on each component were
used  to  get  further  biological  information.  For  interactions,  we  collected
information  about  the  biological  mechanisms  from  the  supporting  reference
articles. We also searched on the supporting references for information regarding
cooperative  relations  with  other  model  components.  We  defined  a  controlled
vocabulary  to  simplify  the  description  of  the  biological  mechanisms  of  the
interactions (Table 4). Because these mechanisms have distinct time scales, we
also  annotated the correspondent  time scale  of  the  interaction  based on  the
slowest  biological  mechanism identified.  We stored all  annotations  in  GINsim
annotation box, where we included the links to references using PMID, UniProt
and  NCBI  identifiers  (Figure  16)  [47].  Here,  we  also  included  additional
comments  about  the  presence  of  the  interaction  in  signalling  databases  or
published model.
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Figure 16.  Examples of annotations in GINsim annotation box. (A) Annotation for
the node MET. (B) Annotation of the interaction between  MET and RAS. 
Table 4. Controlled vocabulary used for the description of biological mechanisms
and their correspondent time scales.
Biological mechanism
(interactions)
Time scale References 
Transcription SLOW (minutes) [51,52]
Translation SLOW (minutes) [51,52]
Oxidation SLOW (minutes) [53,54]
Phosphorylation FAST (seconds) [55,56]
Dephosphorylation FAST (seconds) [55,56]
Molecular binding FAST (seconds) [51,57]
Transport FAST (seconds) [51,58]
2.2.3. Logical model construction
For the exploration of the regulatory capabilities of the constructed network, we
setup a logical model in GINsim based on the formalism initially proposed by
René  Thomas  (see  sections  3.1  and  3.3  of  chapter  1  for  formalism  details)
[47,59]. First, we associated a Boolean (0 or 1) or multi-valued (0, 1, 2) variable
to each node of the network. For the nodes with no incoming interactions, we set
them as model inputs. For each of the remaining nodes, we set a logical function
for the value 1 and, if multi-valued, we set another for value 2.  No function was
required  for  value  0  in  GINsim  because  this  value  is  used  by  default  when
function  evaluations  are  false.  Logical  functions  were encoded by connecting
regulators (R) of a target node (X) through the logical operators OR (denoted in
GINsim by |), AND (&) and NOT (!). Logical functions were chosen to abstract the
biological  mechanisms  of  activation  and  inhibition  of  model  components,
annotated in the network (see illustrated examples in Figure 17). Here, inhibitory
roles were treated as the negation of regulator role (NOT R). Finally, we checked
the logical  functions for  consistency using a tool  implemented in  GINsim that
computes the interaction functionality.    
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2.2.4. Definition of updating priority rules
To generate the model dynamics accounting for mechanisms that occur in two
timescales (seconds and minutes), we defined two priority classes for the update
of variables (FAST and SLOW)  [60]. We defined FAST as a set of nodes that
update first and SLOW the set of nodes that update last. We defined FAST and
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Figure  17.  Examples of biological  mechanisms and their correspondent logical
abstraction. Target  nodes are identified by X and regulators  by R1 and R2.  Active
regulators are depicted in green, active target in orange and inactive target in grey. The
logical abstraction of each mechanism (left) is composed by the regulatory graph and
the logical functions (right). In the first mechanism (top), a transcription factor (R1) binds
to the gene promoter and activates the translation of the protein X, which requires being
phosphorylated by a kinase (R2) to activate its function.  The second example (middle)
shows the modulation of an protein activity by the phosphorylation/dephosphorylation
degree of the active site, mediated by kinases (R2) and phosphatases (R1). The last
example  (bottom)  shows  the  activation  of  a  protein  by  the  formation  of  an  active
complex with other two molecules  (R1 and R2).    
SLOW sets for two updating situations, when a node value increases (+) and
when it decreases (-). We set the priority rules in GINsim dialog box (Tools / Run
simulation / Priority Class Selection / Configure) [47]. Here, whenever there is a
call to update variables of nodes, the model will first update the variables of the
nodes that  belong to the list  of  first  priority  (FAST) if  any.  Variables will  then
iteratively  update  asynchronously,  generating  successive  co-current  states.  In
each update call, logical functions are re-evaluated to match each of the resulting
states. Only when no variable of the first priority nodes is required to update, the
variables of the nodes of the second priority (SLOW) are updated. This iterative
update stops when logical functions are no longer are updatable, reaching one or
more stable states. We selected the nodes for FAST and SLOW sets based on
the identification of slower mechanisms (e.g. transcription) as limiting steps on
the annotated regulatory interactions (section 2.2.2.). 
2.2.5. Model documentation
To  facilitate  the  access  to  the  model  documentation  and  references,  we
generated  an  HTML  file  (Model_documentation.html)  that  contains  a  brief
description  of  the  model,  the  components  (nodes),  logical  functions  and
annotations.  In  this  file,   we add the links to the abstracts of  each reference
through the PubMed or UniProt ID numbers. To generate this file, we used the
export tool functionality implemented in GINsim (File/export/Documentation). The
file was made available in the GitHub public repository (https://github.com/rjpais)
under the project cell adhesion model. After the download of the file, run the file
to visualize in your web browser. In alternative, http://htmlpreview.github.io/  MD). 
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2.3. Model static analysis
2.3.1. Computing model stable states
Regardless of their reachability properties, we analytically determine the model
stable  states  using  an  algorithm  based  on  multi-valued  decision  diagrams,
developed and implemented in GINsim by Naldi  et  al.  [61].  We computed the
stable states using python scripts adapted from the one developed by Naldi and
provided  by  the  lab  of  C.  Chaouiya.  First,  we  adapted  the  python  script  to
compute the stable states of the unperturbed model (GetModelSS.py). Next, we
adapted the python script  (GetModelSS_SP.py)  to  systematically  compute the
stable states for each perturbation on a single model component (node), where
the value of the node (0,1, or 2 if multi-valued) was fixed to be constant (single
perturbation).  Finally,  we  systematically  computed  the  stable  states  of  all
combinations  of  single  perturbations  with  the  python  script  from  Naldi
(GetModelSS_SDP.py). The computed stable states for unperturbed, single and
double perturbations were saved in 3 separated text files to be further processed
in  the subsequent  static  analysis.  To generate a separate file  with the stable
states for each perturbation, we wrote a script that extracts the stable states of a
selected perturbation from the files that contain single or double perturbations
(SelectPerturb.py).
 
2.3.2. Identification of the stable states of adhesion phenotypes
For the analysis of the activity patterns of each adhesion phenotype, we wrote a
python  script  (InternalSS.py)  to  identify  distinct  stable  states  of  the  model
excluding the model input values (internal stable states) for each model output
combination (phenotype). To perform the identification, we run the script to parse
the previously generated files with the stable states of the unperturbed model
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(section  2.3.1.)  and  perturbations  (section  2.3.2).  The  script  was  written  to
remove the input nodes from the stable states and systematically identify distinct
stable  states  (only  with  the  internal  nodes),  discarding  repetitions.  Next,  the
stable states were ordered by output combinations and printed to an output file.
With this script, we also automatically checked if the value of each node in the
stable states was conserved (if  has the same activity level) for each adhesion
phenotype. Then, a stable state showing the nodes that had conserved activity
and the ones that had different activity degrees was computed and printed to the
output file.        
 
2.3.3. Single and double perturbation analysis
To  identify  the  effects  of  single  perturbations,  we  developed  a  python  script
(SP_analysis.py) to parse the file with the stable states of these perturbations
(section 2.3.1) and identify the perturbations that result in the gain or the loss of
an adhesion phenotype.  With this  script,  we systematically  identify  the output
combinations  (adhesion  phenotypes)  within  the  stable  states  for  each
perturbation.  Next,  the presence or  absence of  each output  combination  was
systematically  compared  with the ones computed for  the unperturbed model
(reference).  This  allowed  us  to  identify  automatically  a  gain  or  a  loss  of  an
adhesion phenotype. For the analysis of double perturbations, we adapted the
previous script to identify only the double perturbations that result in a synergistic
effect  (not  obtained in  the single  perturbations).  We used the modified  script
(SP_analysis.py) to parse the file with the single and double perturbations and
systematically compare the gains and losses of adhesion phenotypes between
double and single perturbations. We set filter conditions in this script to select the
double perturbations that had a gain/loss of phenotype not verified in the case of
the two single perturbations. To show the results, the output file was printed in the
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form of lists containing all  perturbation names that were identified to cause a
gain/loss  of  adhesion  phenotypes,  organized  by  phenotype  and  effects
(gain/loss).
2.3.4. Identification of input conditions for the adhesion phenotypes 
To  systematically  analyse  the  compatibility  of  adhesion  phenotypes  with
microenvironments, we wrote a python script  (MicPhenComb.py)  to identify the
combinations of model input values (microenvironments) for each combination of
output values (adhesion phenotype) on the model stable states. This script was
designed to parse a file with the stable states and returns a file with a list  of
combinations of input values (without repetitions) for each adhesion phenotype.
With this script, the input combinations were listed for each combination of values
of two selected model inputs under analysis (RPTPL and FAT4L in this work). We
also  compute  the  percentage  of  the  remaining  input  combinations  for  each
combination of RPTPL and FAT4L values for each adhesion phenotype. We used
the previously produced files (section 2.3.1.) containing the stable states of the
unperturbed model and selected perturbations as input files to run the script.
2.4. Analysis of model dynamics
2.4.1 Simulation of biological scenarios
For the simulation of biological scenarios, we first set the model input values in
GINsim  toolbox  (Tools  /  Run  simulation)  according  to  the  microenvironment
conditions described in experiments (model validation) or to mimic a physiological
scenario  (model  analysis).  When  needed,  we  set  perturbations  on  model
components in the dialogue box (Tools / Run simulation/ Select a perturbation /
Configure).  These  perturbations  were  set  to  mimic  reported  knockouts  or
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overexpression of genes that produce molecular components of the network. For
knockout effects, we fix the node value to 0.  For an overexpression that results
in an ectopic activation, we chose to fix the node value to 1 or 2 if multi-valued. In
the case of an overexpression that is dependent on a subsequent activation by a
regulator  and  is  subject  to  an  inhibition  by  another  regulator,  we  choose  to
knockout the inhibitory effect by fixing the value of the regulator effect to 0. This is
a more realistic perturbation for the cases where the overexpression of a protein
leads to the insensitivity to its inhibitor  (e.g.  competitive inhibition),  where the
increase in concentration reduces the effect of the inhibitor, but yet the protein
still  requires  to  be  activated  by  a  post-translation  modification  (e.g.
phosphorylation)  or  other  molecular  processes such as  molecular  binding.  To
analyse the reachability of adhesion phenotypes, we set the simulations to start
from all possible combinations of initial states (from all state space). To analyse
the dynamics of transitions between phenotypes, we set the values of the nodes
in the initial  state of simulations to correspond the stable state of a particular
phenotype  (e.g.  Epithelial,  Mesenchymal  or  Hybrid)  compatible  with  the
conditions  before  the perturbation.  Simulations  were then performed with  two
complementary  methods  described  in  the  sections  2.4.2  (transitions  between
phenotypes) and 2.4.3 (reachability of phenotypes).
2.4.2.  Simulation of the state transition graph
To  obtain  the  stable  states  that  can  be  reached  starting  from  a  particular
biological scenario (section 2.4.1), we computed the state transition graph (STG)
using the “run simulation” tool implemented in GINsim [47,62]. In these graphs,
the nodes are the vectors encompassing the activity values of model components
(states), while the arcs connect successive states, called “state transitions” (see
section 3.4 of chapter 1 for more details). In the STG, a stable state is found
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when a state with no successors is reached. This method enables the exploration
of all trajectories according to an updating scheme, represented through the STG
[62]. We have run simulations under asynchronous updating policy, according to
rules  of  priority  that  account  for  timescale  constraints  of  the  regulatory
mechanisms included in the network (section 2.2.4.) [60,62]. We believe that with
the  priority  rules,  we  explore  only  the  biologically  plausible  “state  transitions”
which results in a reduced and more realistic STG.  
2.4.3. Probability of reaching stable states
To estimate the probabilities of reaching stable states or adhesion phenotypes
starting  from a particular  biological  scenario (section 2.4.1),  we used the tool
“Analyze attractors” implemented in GINsim. We chose the MonteCarlo algorithm
to  perform  a  randomized  search  for  stable  states,  exploring  a  subset  of  all
possible “state transitions”. This algorithm was chosen over others that perform a
more exhaustive and detailed search for several types of attractors (AVATAR and
FireFront).  Since we were only interested in the reachability of stable attractors,
the  MonteCarlo  algorithm was  chosen  because  is  faster  and  as  effective  as
AVATAR or  FireFront  for  the estimation of  the probabilities of  reaching stable
states.  To  estimate  the  probabilities  of  the  reaching  the  stable  states  with
MonteCarlo algorithm, we have run simulations with a total of 10000 iterations
that explored a maximal number of 10000 “state transitions” randomly visited in
each iteration (depth of trajectories).
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2.5. Model validation data and comparisons
2.5.1. Epithelial and mesenchymal markers
To validate the model stable states of adhesion phenotypes, we used Epithelial
and Mesenchymal markers commonly used as markers of EMT, because these
cell  types  have  distinct  cell  adhesion  properties  [63–65] (Table  4).  The  used
markers consist of proteins or RNA that are found to be differentially expressed in
Epithelial and Mesenchymal cell types in specific cellular localization.
Table 4. EMT biomarkers used for model validation. 
Molecule / marker  Cellular 
Location 
Expression in 
Epithelial cells 
Expression in 
Mesenchymal cells
References
E-cadherin Membrane Present Absent [63–65]
miR200 Cytoplasm Present Absent [63,64]
E-cadherin/β-
catenin complex
Membrane Present  Absent [64,65]
E-cadherin/p120 Membrane Present Absent [64,65]
Snail 1 and snail 2 Nuclear Absent Present [63–65]
Zeb 1 and zeb 2 Nuclear Absent Present [63–65]
Β-catenin  Nuclear Absent Present [63–65]
LEF1 Nuclear Absent Present [63,64]
2.5.2. Experiments on Epithelial cell lines
To test the model, the scientific literature provides reports with experiments on
mammalian  Epithelial  cell  lines  exposed  to  microenvironment  signals  and/or
containing mutational perturbations (e.g. knockout or overexpression of genes).
We  selected  28  published  reports,  where  we  collected  a  total  of  163
observations,  26 on cell-cell  adhesion,  12 on focal  adhesion and 125 on the
molecular activity of molecular components used in the model. In these selected
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experiments,  we  did  not  include  published  work  used  as  references  for  the
network construction. We grouped these selected experiments into 13 sets (Table
5) that consider the same conditions (microenvironments and/or mutations). 
Table  5. Selected experiments on mammalian epithelial cell lines used for model
validation,  grouped  in  perturbation  type.  The  number  of  total  observations  (N)
collected for each perturbation type. 
Perturbation Experiments description N Ref.
IL6+ Exogenous  addition of IL6 to normal mammary Epithelial cell lines. 5  [74]
EGF+
Exogenous addition of epidermal growth factor to several 
human Epithelial cell lines (cancer and normal).  18 [75–78]
ECM+ Exogenous addition of collagen type I or fibronectin to several human and mouse Epithelial cell lines (cancer and normal). 10 [78,79]
EGF+ ECM+
Exogenous addition of epidermal growth factor in combination 
with collagen type I or fibronectin to human breast, skin and 
squamous Epithelial cell lines (cancer and normal).
5 [78]
HGF+ Exogenous addition of hepatocyte growth factor to Epithelial celllines from human, canine and mouse origins. 35
[33,76,80–
82]
WNT+ Exogenous addition of Wnt protein to kidney canine and colon cancer Epithelial cell lines. 8 [33,83]
TGFb+ Exogenous addition of transforming growth factor beta to several human and mouse Epithelial cell lines.  30 [84–87]
EGF+ ROS+ Exogenous additions of epidermal growth factor with ROS intracellular generation in mammary Epithelial cell lines. 10 [88]
P120 KO Knockout  of p120 using  siRNA in hamster ovary cell lines. 8 [66,67]
B-Cat_mem 
KO
Transformation of mouse embryonic and canine kidney 
Epithelial cell lines with a mutated form of E-cadherin incapable 
of binding to β-catenin.     
5 [33,68]
CK1 E1 Overexpression of CK1 on human endothelial and canine kidney cell lines. 7 [69]
CD44 E1 Overexpression of CD44 in colon tumour cancer cell lines.  5 [70]
SRC E1 Overexpression of SRC in human breast and colon cancer cell lines. 17 [71–73]
For cell adhesion properties we collected observations from cell adhesion assays
or imaging techniques on these reports. For the observed activity of molecular
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components, we used the data from quantitative assays such as qPCR, ELISA
and  western  blotting  of  the  active  forms  (e.g.  phosphorylated  protein).  We
analysed and interpreted the collected observations in a qualitative manner by
comparing the changes in activity with the experiment control (Epithelial cell lines
not  exposed  to  external  or  internal  perturbations).  Finally,  we  discretise  the
activity  of  cell  adhesion properties and molecular  components in  3 qualitative
levels:  increased (+), decreased (-), or not changed (~). 
2.5.3. Matching simulations to experimental observations
To test the compatibility of the results from the simulation of experiments (stable
states) with the experimental observations, we constructed two matrices with the
same  dimensions  (number  of  nodes  x  number  of  experiments),  one  for  the
experimental observations and another with the stable states from simulations.
Because the experimental observations contained 3 qualitative levels of activity
(+, 0, -), we manipulated the matrix of simulations to compute a matrix with the
variations in sign (+, - or 0). Here, we subtracted the values of the final state
(stable  state)  to  the  ones  of  the  initial  state  used  for  simulations.  Next,  we
compared the two matrices and computed a matrix that identified the differences
in sign.  All manipulations of the matrices were performed using R studio.  
2.5.4. Model comparison with a published EMT network model
To further compare the stable states of Epithelial  and Mesenchymal adhesion
phenotypes of our model with the reported Epithelial and Mesenchymal activity
status, we used the published EMT network model for hepatocytes developed by
Steinway et al. [31]. First, we setup the model of Steinway et al. in GINsim using
the model components, interactions and logical rules provided in [31]. Then, we
computed the Epithelial and Mesenchymal stable states for this model in GINsim
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as it  is  described in  sections 2.3.1.  and 2.3.3.  for  the unperturbed model.  To
compare the stable states of both models,  we ordered the common nodes in
GINsim and removed the nodes not common from the files in the stable states.
2.5.5. Protein expression in carcinomas. 
To identify relevant predictions made by our model, we observed the expression
data of carcinomas from breast, prostate, colorectal and lung tissues. We used
the human protein atlas database to find this data (www.proteinatlas.org). This
database  provides  frequencies  of  expression  on  a  qualitative  scale  used  to
compare  with  our  qualitative  predictions.  We  used  the  data  provided  in  this
database  which  was  experimentally  determined  by  antibody  staining  of
carcinoma tissue samples, already statistical analysed in comparison with normal
tissues [89]. Therefore, for each model component that is a protein, we searched
on this database for the relative expression levels in carcinoma tissues [90]. We
used this data to identify overexpressions and knockouts of model components in
carcinomas that correlated with our predictions generated for single and double
perturbations.    
2.5.6. Data plots 
For the visualization of the model stable states, observations of experiments on
epithelial cell lines and perturbation effects, we adapted the heatmap2() function
in  R  (see  files  Heatmap_validation.R,  Heatmap_experiments.R,  InternalSS.R,
and  perturbations_effects.R).  To  show  the  results  of  the  microenvironments
counts, we used grouped bar plots defined in R with the barplot() function (see
file  Barplot_Phenotypes.R).  For  showing  the  probabilities  of  reaching  stable
states  we used  pie  charts  defined in  R with  the pie()  function  in  R (see  file
PieChart_Phenotypes.R).    
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3. Results
3.1. Modelling workflow 
For  our  purpose,  we  developed  and  analysed  a  logical  model  following  the
workflow presented in Figure 18.  We first constructed a regulatory network (step
1) based on the collected biological information from literature and databases
(details in sections 2.2.1 and 2.2.2).  Then, we defined a logical model (step 2)
for the regulatory network with rules (logical functions) that obey the biochemical
principals of each biological process modelled in the network. For this, we used
the biological  information annotated on the nodes and interactions  (details  in
sections  2.2.3  and  2.2.4)  together  with  reports  that  supported  our  choices.
Independently from the literature data used for model construction, we collected
qualitative observations from literature to test and validate the model (step 3). For
this,  we used reported markers for  Epithelial  and Mesenchymal cells  (section
2.5.1),  and reports  containing experiments  on Epithelial  cell  lines  exposed to
exogenous signals or with mutational alterations (section 2.5.2).  The collected
observations from experiments were then treated in a qualitative manner (step 4)
such as we could compare them with the model stable states (see section 2.5.3).
Next,  we  computed  model  stable  states  and  simulated  the  experiments  on
Epithelial cell lines to compare with the experimental observations (step 5). We
considered  the  model  validated  when  all  results  were  in  agreement  with  the
experimental observations (step 6). Here, no contradictory results were allowed
in terms of qualitative changes in activity (e.g. reduction or increase). When we
found  such  contradictions,  we  returned  to  the  literature,  revised  the  model
interactions, functions and searched for missing interactions (repeat steps 1, 2, 5
and 6). Therefore, we started from a reduced network which evolved into a larger
network  model  capable  of  explaining  all  experimental  observations,  and  still
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keeping the logical rules constrained by the supporting biological data. During the
time  of  Ph.D.,  several  model  versions  were  produced  that  were  not  able  to
recapitulate all collected experimental observations. Some versions were able to
recapitulate all data but did not accounted for regulatory interactions considered
relevant for EMT and cell adhesion newly found during literature searches. Thus,
we decided to discard these versions form this thesis assuming that the most
complete and refined is more relevant to be analysed. 
After successive model refinements, we reached a final model version (presented
in section 3.2) that recapitulated all experimental observations (sections 3.3 to
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Figure  18.  Workflow for  the  logical  network  model  construction,  validation and
analysis. The numbers in parenthesis indicate distinct steps of the workflow that were followed.  
3.5). For this final version, we analysed the model dynamics in terms of its stable
states to generate testable predictions of  conditions that  control  cell  adhesion
properties during EMT (step 7).  Therefore,  we conducted a model analysis to
establish the relationship between model inputs (microenvironment) and outputs
(phenotypes),  reachability  properties  of  model  outputs,  and  the  effects  of
perturbations on model components (sections 3.6 to 3.10). 
3.2. Logical network model of cell adhesion properties
The constructed network of the regulation of cell adhesion properties is presented
in Figure 19 (Table S1 for nodes and Table S2 for interactions). For more details
on  the  nodes,  interactions,  and  respective  references,  see  the
model_documentation.xhtml file (see section 2.2.5 to get file). In our network, we
considered the following signalling pathways and regulatory modules, where we
represent them by key regulatory components:
• TGFβ signalling (TGFb-TGFbR → SMAD);
• Integrin signalling (ILK ←ITGab → FAK-SRC → RAP1 → JNK);
• Wnt signalling (Wnt-Frizzled → DVL --|  GSK3B→ Dest_Complex --|  b-
Cat_nuc → TCF/LEF); 
• AKT signalling (PI3K → AKT → NFkB);   
• MAPK signalling (RAS → RAF1 → MEK → ERK) 
• HIF1 signalling (ROS → HIF1a ← STAT3 ← IL6/SRC);       
• Notch signalling (DELTA → NOTCH → CSL); 
• Hippo signalling  (FAT4L → FAT4 → LATS --| YAP_TAZ);
• E-cadherin transcription regulators (SNAI, ZEB, miR20, CDH1); 
• Phospho-regulation of E-cadherin/β-catenin complex  (RPTP, MET, SRC,
b-Cat_mem, p120, E-cadherin_mem).
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In  the  regulatory  network  (Figure  19),  we included several  reported crosstalk
interactions  between  the  above  mention  signalling  pathways  and  regulatory
modules. Among them, we included: The Notch signalling crosstalk with the HIF1,
TGFβ, MAPK, and AKT signalling pathways [91]; The Integrin and growth factor
signalling crosstalk, including MAPK and AKT signalling  [92–94]; and the Hippo
signalling crosstalk with Wnt signalling [95,96]. For more details on the reasons to
include  the  key  regulatory  interactions  in  the  network  and  their  underlying
assumptions see the supplemental text on end of this thesis chapter (sections
5.1.1 to 5.1.3). 
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Figure 19. Regulatory network of cell-cell adhesion and focal adhesion dynamics.
Microenvironment  signals  are  depicted  in  grey,  membrane  protein/receptors  in  blue,  signalling
components  in  purple,  transcription  factors  in  orange,  genes  and  RNA in  pink,  cell  adhesion
properties in yellow; elliptic nodes denote Boolean variables and rectangular nodes denote multi-
valued variables; red arcs are inhibitions and green arcs activations. Interactions are classified into
two distinct time scales: fast (e.g. phosphorylation) and slow (e.g. transcription and translation).
Fast interactions are denoted by plain arcs and slow interactions by dashed arcs. 
As model readouts, we defined 2 output nodes, one for the E-cadherin mediated
cell-cell  adhesion  strength  (Cell-Cell_Adhesion),  and  another  for  the  integrin
mediated  focal  adhesion  dynamics  (Focal_Adhesion_Dynamics).  For  Cell-
Cell_Adhesion, we associate it to multi-valued variables taking the values 0, 1 or
2. These values mean basal (0), intermediate (1) and high (2) degrees of cell-cell
adhesion  strength  to  distinguish  cell-cell  adhesion  degrees  of  Epithelial,
Mesenchymal and partial EMT phenotypes [10]. 
For  the  Focal_Adhesion_Dynamics  node,  we  chose  to  treat  it  as  a  Boolean
variable for simplicity.  In this case, the value 1 represents a high formation of
focal  adhesions  with  subsequent  high  turnover  that  represents  the  adhesion
status of a migrating cell [13,97]. On the other hand, the value 0 means a basal
focal adhesion formation or a basal turnover, which represents a non-migrating
adhesion status. We considered a total of 8 microenvironment signals as model
inputs (IL6, ROS, ECM, EGF, HGF, DELTA, FAT4L, and RPTPL). These input
nodes were associated to  Boolean variables  defining basal  (value 0)  or  high
(value 1) degree, whereas value 0 have no effect and 1 have an effect on its
targets (activation or inhibition).  For the node that corresponds to E-cadherin in
the membrane (E-Cad_mem), we chose to associate it to a multi-valued variable
to  account  for  the  basal  (value  0),  intermediate  (1)  and  high  (2)  degrees  of
concentration  [98–100].  For  the  remaining  40  nodes,  we  associate  them  to
Boolean variables, where the value 0 and 1 means basal (no effect) and high
degrees of activity (activation or inhibitory effect), respectively.  For each node,
the  logical  functions  that  define  the  evolution  of  the  variables  of  each  node
(except inputs) are presented in the  Table S3. The rational and support for the
choices of logical rules are described in section 5.1.4 in the supplementary text of
this  chapter.  In  the  supplemental  text (section  5.1.5),  we  also  provided  a
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comparison of our model in terms of its similarity with a published EMT network
model. 
3.3. Recapitulation of model phenotypes  
To  test  the  model  capacity  to  recapitulate  phenotypes,  we  check  which
combinations of cell  adhesion properties were present in the computed model
stable states (section 2.3.1), and which of those are characteristic of naturally
observed phenotypes. In the model stable states, we obtained 3 out of 6 possible
combinations  of  adhesion  properties  that  correspond  to  distinct  phenotypes
(Figure 20). One was the combination of high cell-cell adhesion (C = 2) with basal
focal  adhesion  dynamics  (F  =  0),  which  is  characteristic  of  Epithelial  cells
[13,98,101]. Another combination was the basal cell-cell adhesion (C = 0) with
high focal adhesion dynamics, two properties characteristic of Mesenchymal cells
[10,13,101].  Both Epithelial  and Mesenchymal phenotypes are expected to be
recovered in the stable states since they are naturally observed during EMT in
several biological systems such as wound healing, development, and cell culture
[2,102,103].
We also  obtained  stable  states  with  the  combination  of  intermediate  cell-cell
adhesion  strength  (C  =  1)  and  basal  focal  adhesion  dynamics  (F  =  0).  We
considered  this  adhesion  combination  to  be  compatible  with  an  Intermediate
phenotype that results from partial EMT. These adhesion properties are observed
during collective migration of border cells during oogenesis, supporting this result
[14]. This further indicates that we included in our model the microenvironment
conditions  that  stabilize  the  Intermediate  phenotype.  Interestingly,  the  model
stable states did not  recover adhesion properties characteristic of  Hybrid and
Amoeboid-like  phenotypes.  This  result  is  compatible  with  the idea  that  these
phenotypes are not stable or transiently formed in normal cells, and their stability
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is only reached during cancer progression  [104,105]. Thus, we considered this
result  to  be  positive  for  supporting  the model  validation.  Although  our  model
contains an output combination that is compatible with the Amoeboid adhesion,
our model is not suitable for this phenotype. The reasons are based on: 1) Cell
adhesion features are not suitable to correctly describe the invasive properties of
this amoeboid-like migration  [10,11,106];   2) Their relevance for  metastasis is
associated  to  other  types  of  cancers  such  as  leukaemia  [11,15];  3) The
Mesenchymal  to  Amoeboid  transitions  is  dependent  on  the  concentration  of
Rac1/RhoA activation,  which is  a regulatory mechanism not  accounted in  our
model [105,106].
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Figure  20.  Combinations  of  the  model  outputs  (adhesion  properties)  and
compatible phenotypes. The combinations that are recapitulated in the model computed stable
states are indicated in yellow. The phenotypes that were not recapitulated (absent) in the stable
states are indicated in grey. The model stable states were obtained as is described in section 2.3.1.
The values of  the model  outputs  are indicated  below the arrows.  Phenotypes  were distributed
according to the characteristic cell adhesion properties in [10,12,13] (see also section 2.3 in chapter
1 for description).   
3.4. Recapitulated biological markers and patterns
Here, we further test the model by comparing the computed stable states of the
adhesion properties of the recovered phenotypes with the reported markers of
Epithelial  and Mesenchymal cells (section 2.5.1).  We obtained several distinct
stable states for each combination of adhesion properties, discarding the model
inputs (see section 2.3.2 for method and Figures S5-S6 for results). These were
represented in one stable state to show only the conserved and variable activity
of each intracellular network component (Figure 21). 
For Epithelial adhesion properties (Figure 21A), our results show that high activity
in Epithelial markers with basal activity of Mesenchymal markers are conserved.
For Mesenchymal adhesion properties (Figure 21C), we obtained the opposite,
where the nodes of Mesenchymal markers have high activity, and the nodes of
the Epithelial markers basal activity. Together, these results show that the model
is  consistent  with  the reported  Epithelial  and  Mesenchymal  markers.  For  the
Intermediate adhesion stable states (Figure 21B), the representative stable state
shows the absence of Mesenchymal markers and the presence of the Epithelial
markers  miR200 and  E-cadherin.  Indeed,  these  features  were  experimentally
observed during partial EMT of H1975 and MCF10A cell  lines, supporting our
results  [34,104]. In addition, the activity of the nodes p120 and b-Cat_mem in
Figure 21B indicate that the binding of catenins with E-cadherin in the membrane
is not a feature of intermediate adhesion phenotype, which is also in agreement
with the observed status of p120 and β-catenin in Drosophila border cells [100].
Regarding the activity patterns of signalling components, the model stable states
show  that  the  joint  activation  of  TGFβ  and  Wnt  signalling  is  exclusive  of
Mesenchymal  phenotypes  Figure  21.  This  is  in  agreement  with  the  pattern
already  observed  in  Mesenchymal  cell  lines  of  normal  hepatocytes  and
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hepatocarcinomas (see sections 5.3.5 in Supplemental text for full comparison
with stable states) [31]. 
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Figure 21. Representation of the model stable states of cell adhesion properties of
Epithelial (A), Mesenchymal (B), and intermediate (C) phenotypes. The stable states
were computed as described in section 2.3.2. Red indicate basal activity, green indicates high
(Boolean nodes) or intermediate activity (Multi-valued nodes), dark green indicates high activity
(Multi-valued  nodes).  Yellow  indicates  nodes  with  variable  activity  and  the  remaining  colours
conserved activity. The symbol (-) in nodes in yellow indicate that all values are identified in the
stable  states.  The letters  in  yellow indicate exceptions  for  values 0 (a),  1  (b)  and 2 (c).  The
Epithelial markers are indicated in light orange and the Mesenchymal markers in light blue (see
section 2.5.1 for references on the biological markers).  
As  expected,  the  activation  of  MAPK,  AKT  and  integrin  signalling  are  a
characteristic  of  the  Mesenchymal  phenotype  (Figure  21C)  because  they
participate  in  the  mechanisms  of  EMT initiation  and  progression  [25].  Notch
signalling and NFkB are not activated in the Mesenchymal stable states, which
are in agreement with the idea that the enhanced activity is exclusive of cancer
cells [25,91]. EMT associated activation of STAT3 and JNK is not always active in
Mesenchymal stable states, indicating that these regulators are not crucial  for
EMT (see  Figure  S6).  Interestingly,  the  model  stable  states  (Figure  21A and
Figure 21B) show that MAPK signalling, Notch signalling, STAT3, JNK and ILK
activation  by  integrins  are  compatible  with  Epithelial  and  Intermediate
phenotypes, indicating that this would depend on the microenvironment (see also
Figures S5 and S7). Specifically for the stable states of Intermediate phenotypes
(Figure  21B),  our  model  shows  that  STAT3  is  always  activated,  which  is
consistent with the observed STAT3 activation in Drosophila border cells during
migration  [107]. Moreover, our results indicate that RPTP, FAT4 and the Hippo
signalling component LATS are basal in the Mesenchymal adhesion phenotype,
which indicates incompatibility  with this phenotype (Figure 21B).  On the other
hand, the stable states represented in  Figure 21A and Figure 21C indicate that
these  molecular  components  are  compatible  with  Epithelial  and  Intermediate
phenotypes. This result further indicates that the activation degree of FAT4 and
RPTP are characteristic  features that  distinguish Mesenchymal from Epithelial
and Intermediate phenotypes. 
3.5. Recapitulated experiments on Epithelial cell lines
In this section, we present the recapitulated effects on cell adhesion properties
and molecular activity observed in experiments on Epithelial cells by our model
(for details see section 2.5.2). Except for neighbouring cell-cell contact signals
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(NOTCH, RPTPL and FAT4L), we tested the individual effects of all  remaining
microenvironment signals in the model and/or in combination with another signal
(Figure  22).  With  this  data,  we  tested the model  capacity  to  recapitulate  the
observed  changes  during  EMT of  Epithelial  cells  exposed  to  growth  factors
(EGF+, HGF+, and TGFb+) and the increase of ECM stiffness (ECM+). We also
tested observed changes during EMT due to the overexpression of active SRC
(SRC E1)  and CD44 (CD44 E1).  Moreover,  we tested the model  capacity  to
recapitulate experiments with a reported partial reduction in cell-cell adhesion in
Epithelial cells due to IL6 exposure (IL6+), CK1 overexpression (CK1 E1), p120
knockout  (120 KO),  and the mutational  effect  that  prevented the β-catenin/E-
cadherin binding (b-Cat_mem KO). In addition, we included an experiment,  in
which no changes in cell-cell adhesion was observed due to exogenous additions
of Wnt to MDCK Epithelial cell lines (Wnt+). We simulated these 13 experiments
(details in sections 2.4.1 and 2.4.2) and compared the resulting stable states with
the collected observations of cell adhesion properties and molecular activity in
these experiments (details in section 2.5.3). In these simulations, we assumed
that the initial activity of Epithelial cells is described by the model stable state
obtained with no inputs from the microenvironment and no mutations (see Table
S4 for conditions used in simulations). we also assume no other signal from the
microenvironment was present, except for the ones reported. This is reasonable
to  assume because we used controlled  experiments to test  the model.  Each
simulation resulted in a unique stable state, indicating a deterministic outcome
(Figure 22). The results in  Figure 22 show that in all  experiments, the activity
levels of the nodes resulted from simulation was compatible with the observations
from  experiments  (no  contradictory  result  was  obtained).  Thus,  our  results
indicate that  the model  was able to recapitulate all  13 experiments.  Previous
model  versions,  which  did  not  include  all  interactions  of  the  model  failed  to
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recapitulate some experiments (data not included in this thesis). For example,  a
version  where  the  inhibition  of  free  SRC  by  FAK/SRC  complex  was  not
accounted,  resulted  in  activity  levels  of  STAT3  incompatible  with  the
experimentally  observed in   the experiments with EGF+ and HGF+ (data not
shown). 
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Figure 22.  Comparison of the observations of experiments on Epithelial cell lines
(top) with simulation results (bottom). Experimental observations collected from published
experiments on epithelial cell lines  described in Table 5. Exogenous additions of microenvironment
components are indicated by the symbol +, knockouts of intracellular network components by KO
and overexpression/overactivation by the letter E. The value after the letter E indicate an ectopic
activation at that value. For the experimental observations (top), the qualitative changes in activity
are indicated  by  dark  blue (increase),  blue  (no  change)  and cyan (decrease).  For  simulations
(bottom), the value 0 means basal activity, value 1 intermediate (Multi-valued variables) or high
activity (Boolean variables),  and value 2 high activity  (Multi-valued variables).  Here,  the nodes
coloured with green indicates compatibility  with experimental  data and red incompatibility.  Grey
indicates predicted the activity of the nodes (not tested/observed experimentally). Simulations of
experiments were carried in GINsim as described in sections 2.4.1 and 2.4.2. Parameters used in
simulations are available in table  S4. 
Concerning the quality of each experiment used to test the model, the activity
observations covered between 12% to 51% of the nodes in the stable states.
Together these experiments formed a data set that was able to cover 78% of the
model intracellular components (Figure S8). Thus, we considered that this set of
experimental data is a reasonable sample to test our model. With this data, we
tested at least once, a component of all signalling pathways, except for the Notch
signalling. Some nodes were tested more frequently than others, including the
ones that belong to cell adhesion properties (model outputs), components of the
E-cadherin/catenins complex, SNAIL, FAK-SRC complex, and ERK.Moreover, in
some experiments  we obtained  more than  one  report  for  these nodes  which
further supported the confidence on the experimental observation (Figure S8).
Together, this gives us higher degree of confidence on the model predictions for
the  above  mentioned  nodes,  in  particular,  the  ones  related  to  cell  adhesion
properties (Cell-cell Adhesion and Focal Adhesion Dynamics).
3.6. Phenotypes compatibility with the microenvironment
To Identify the microenvironment conditions compatible with phenotypes (model
outputs)  and to  explore  the role  of  cell-cell  contacts,  we analysed the model
inputs combinations for each combination of RPTPL and FAT4L signals on the
model stable states (section 2.3.4). The results of the analysis are available in
Table S6 and the phenotypic effects of cell-cell contacts are highlighted in Figure
23. Our results show that the RPTPL signal substantially increases the number of
microenvironments compatible with the Epithelial adhesion phenotype (F = 0 & C
= 2) in comparison with the absence of  these cell-cell  contact signals. These
results further indicate that the RPTPL signal (RPTPL = 1) makes the Epithelial
adhesion phenotype compatible  with  all  possible  combinations  of  signals  that
stimulate EMT (ECM, EGF, HGF and DELTA). In addition, these conditions are
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only compatible with basal levels of ROS (value 0). This is expected because the
RPTP (target of RPTPL) is directly inhibited by oxidation due to ROS, which in
turn was accounted in our model by a direct regulatory interaction [108,109]. 
On the other hand, our results show that FAT4L signal (FAT4L = 1) makes the
Intermediate  adhesion  phenotype  (F  =  0  &  C  =  1)  compatible  with  all  EMT
inducing signals (ECM, EGF, HGF and DELTA). In addition, this effect is also
compatible  with  the  activation  of  RPTP  by  their  ligands.  We  also  obtained
alternative  conditions  compatible  with  the  Intermediate  adhesion  phenotype
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Figure  23.  The  number  of  microenvironments  compatible  with  adhesion
phenotypes  for  different  combinations  of  RPTP  and  FAT4  ligands. The  x-axis
corresponds  to  the  combinations  of  the model  input  values  for  RPTPL and FAT4L,  where  the
presence is indicated by  the symbol + (value 1) and the absence by the symbol - (value 0). The y-
axis corresponds to the computed number of remaining model input combinations compatible with
the model outputs  (described in section 2.2.3). The remaining  inputs are composed of the values
of the nodes IL6, ROS, ECM, EGF, HGF, and DELTA (total of 64 combinations). The model output
Focal Adhesion Dynamics is indicated by the letter F and the Cell-Cell Adhesion indicated by the
letter C. 
which depended on the IL6 in the microenvironment (IL6 = 1). For this condition,
all  EMT signals (ECM, EGF, HGF, and DELTA) were basal,  together with the
basal level of RPTPL signal. For the Mesenchymal adhesion (F = 1 & C = 0), our
results indicate that this phenotype is compatible with all combinations of model
inputs (microenvironments), except for the conditions where RPTPL signals are
high and ROS levels are basal (RPTPL = 1 and ROS = 0). These results further
indicate  that  the  Mesenchymal  adhesion  is  compatible  with  all  remaining
conditions  in  the  absence  of  cell-cell  contact  signals  that  activate  RPTP.
Moreover,  we  identified  conditions  that  resulted  in  both  Epithelial  and
Mesenchymal  adhesion  phenotypes,  indicating  possible  multistability.  For  the
Intermediate and Mesenchymal adhesion phenotypes, the results also indicate a
possible multistability for the conditions where FAT4L equals to 1. Thus, in these
cases, the reachability of the adhesion phenotypes would depend on the initial
conditions and the model dynamics.
3.7. The reachability of adhesion phenotypes
To further explore the model dynamics and the effects of cell-cell contact signals
on  cell  adhesion,  we  analysed  the  reachability  of  the  model  phenotypes  in
relevant  physiological  scenarios.  Here,  we  further  intended  to  reinforce  the
reachability of phenotypes by estimating their reachability probabilities, fixing the
microenvironment  signals  (model  inputs)  and  starting  from  all  possible  initial
intracellular activity status (all state space). We chose to analyse the model in 3
microenvironment conditions that represent physiological conditions in Epithelial
tissues and one prototypic tumour microenvironment (see Table S7 for conditions
and references). For each of these conditions, we estimated the probabilities of
reaching  the  adhesion  phenotypes  for  combinations  of  RPTPL  and  FAT4L
signals,  starting  from  all  model  state  space  (section  2.4.2).  The  reachability
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probabilities of the analysed physiological scenarios are presented in Figure 24.
The obtained probabilities demonstrated that the RPTPL signal determines the
reachability of the Epithelial adhesion stable states (F = 0 & C = 2) in normal,
tissue growth and chronic inflammation microenvironment conditions. 
On the other hand,  these results also shows that the Mesenchymal adhesion
phenotype (F = 1 & C = 0) is the only reachable phenotype when hypoxia (ROS =
1) is combined with chronic inflammation signals (IL6 = ECM = HGF = 1). This is
because ROS directly inhibits RPTP making the signals in chronic inflammation
conditions to determine the Mesenchymal phenotype outcome whatever the initial
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Figure  24.  Reachability probabilities of  cell  adhesion phenotypes in physiologic
scenarios. Probabilities were estimated by model simulation in GINsim using the MonteCarlo
algorithm (section 2.4.3). High activation (value 1) of RPTP and FAT4 by their ligands (RPTPL and
FAT4L)  are  indicated  with  a  +  symbol  and  their  basal  activity  (value  0)  by  a  –  symbol.  For
simulations, we fixed the remaining inputs (IL6, ROS, ECM, EGF, HGF) to the values according to
the Table S7 and started from all state space.       
state. This result is in agreement with an enhanced stimulation of EMT observed
in tumour microenvironments composed by hypoxia with the chronic inflammation
conditions [22,23]. 
In addition, the simulation of the hypoxia effect alone was not able to trigger EMT,
and the combination with ECM or HGF resulted in the Mesenchymal phenotype
(data not shown). This further indicates a synergistic effect of the combination of
hypoxia with EMT driving signals such as growth factors or ECM for the stability
of the Mesenchymal phenotype. For chronic inflammation conditions, our results
show that cell adhesion stability is only affected by the RPTPL signal (no effects
for FAT4L). Interestingly, when RPTPL and/or FAT4L signals are active, multiple
reachable phenotypes including Epithelial, Mesenchymal, and Intermediate were
obtained in normal and tissue growth microenvironments. This indicates that in
these physiological  conditions,  cell  adhesion  depends on the  initial  state,  i.e.
there  is  a  set  of  initial  activity  states  that  conditioned  the  reachability  of  the
adhesion  phenotypes.  We  also  analysed  the  effect  of  DELTA  signal  in
combination  with  RPTPL and  FAT4L signals,  obtaining  similar  results.  In  this
analysis, we only identified a significant effect of DELTA in normal conditions and
in basal RPTPL and basal FAT4L signals, where it resulted in the Mesenchymal
phenotype with a probability of 1 (data not shown). This effect is in agreement
with the reported effect of DELTA in driving EMT through the activation of Notch
signalling [91,110].
3.8. The effect of model perturbations on phenotypes
To  identify  critical  alterations  for  the  stability  of  Epithelial,  Mesenchymal  and
Hybrid  adhesion  phenotypes,  we  generated  perturbations  on  the  model
components and compared the presence of phenotypes in the stable states with
the ones from the unperturbed model (see section 2.3.1 and 3.3.4 for methods).
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Here,  we  systematically  analysed  the  effects  of  all  single  and  double
perturbations  on  model  components  by  fixing  their  values  to  be  constant
mimicking knockouts (KO) or ectopic activations (E1 and E2). In this analysis, we
identified 23 single and 24 double perturbations that resulted in a gain and/or a
loss of an adhesion phenotype (Figure 25). For single perturbations, we obtained
5 perturbations that prevented the Epithelial adhesion phenotype (C = 2 & F = 0)
keeping the Mesenchymal (C = 0 & F = 1) and the Intermediate phenotypes (C =
1  &  F  =  0).  Among  them,  only  the  perturbations  of  SRC  and  MET ectopic
activation  (SRC  E1  and  MET E1)  correlate  with  higher  expression  of  these
proteins in carcinomas, indicating that they could be relevant in the context of
cancer invasion (Table S8).  SRC overexpression and its activation have been
reported in a variety of human cancers including breast and colon cancer, which
supports the relevance of this perturbation  [111]. Interestingly, MET and EGFR
ectopic activation were able to stabilize the Hybrid adhesion phenotype (C=2 &
F=1),  which  indicates  that  these  RTKs  are  critical  for  the  stability  of  this
phenotype. 
On  the  other  hand,  we  found  14  single  perturbations  that  were  capable  of
collapsing  the Mesenchymal  adhesion phenotype  keeping both  Epithelial  and
Intermediate adhesion phenotypes.  These perturbations indicate that  targeting
components  of  TGFβ,  Wnt,  MAPK,  Hippo  signalling,  and  transcriptional
regulators of E-cadherin (CDH1, miR200, ZEB and SNAI) leads to a change in
phenotype stability.  Most  of  these perturbations resulted in the stability of  the
Hybrid adhesion phenotype with an intermediate cell-cell adhesion (F=1 & C=1).
Among them, the perturbations in E-cadherin regulators and the TGFβ signalling
are  in  agreement  with  the  predictions  from  published  models  [8,20,35].
Interestingly, the comparison with the expression in carcinomas further indicated
that the perturbations in the Hippo signalling components, including FAT4 ectopic
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activation, are overexpressed in several carcinomas indicating that they could be
relevant for cancer invasion (Table S8). Although most of these KO perturbations
do  not  correlate  with  the  expression  observed  in  carcinomas,  some  reflect
inhibitory effects of drugs used in cancer therapy such as the SMAD inhibitors
[35,112].
In  contrast,  the  results  indicate  that  the  inhibition  of  MAPK  signalling  by  its
components  (MEK and ERK) or  the ectopic  activation of  RPTP were able  to
prevent the Mesenchymal phenotype without stabilizing a Hybrid phenotype. We
also obtained 2 double perturbations that resulted in the stabilization of a cell
adhesion  combination  (C=2  &  F=1)  compatible  with  the  Hybrid  phenotype.
However,  they  do  not  correlate  with  the  observed  expression  in  carcinomas
(Table S9).  For the destabilization of Epithelial  adhesion, we obtained several
combinations  of  perturbations  that  resulted  in  a  synergistic  effect,  where  3
correlate with the expression in carcinomas (Table S9). Two of them were the KO
of  RPTP in  combination  with  NOTCH  or  TCF/LEF  ectopic  activation,  which
further indicates that RPTP activation is critical for cell adhesion. The other was
the combination of PI3K with TCF/LEF ectopic activation, which have both high
expression  in  carcinomas.  Finally,  we  also  identified  several  synergistic
combinations  that  prevented  the  Mesenchymal  adhesion  phenotype.  These
perturbations indicated that the inhibition of AKT or MET in combination with the
inhibition  of  particular  Wnt  signalling  components  (e.g.  CK1)  resulted  in  the
suppression  of  the  Mesenchymal  phenotype  without  resulting  in  a  Hybrid
phenotype.  These  predictions  inversely  correlate  with  the  expression  in
carcinomas (Table S9), which places them as possible combinatorial drug targets
to prevent EMT.   
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3.9. The impact of SRC and FAT4 overexpression 
To further understand the effects of cell-cell contact signals RPTPL and FAT4L in
the cancer context, we compared the switching behaviour between phenotypes
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Figure  25.  Effects  of  single  and  double  perturbations  on  the  model  adhesion
phenotypes. Single and double perturbation on model components are indicated by the nodes
with a KO, E1, or E2, indicating  that  the values of the nodes were fixed to 0, 1 or 2.  Model
phenotypes are represented by the values of  focal adhesion dynamics (F) and cell-cell adhesion
(C). The effects of perturbations are indicated by the colours that indicate a gain or a loss of an
adhesion phenotype in comparison to the unperturbed model. The perturbations that did not cause
changes  in  the  adhesion  phenotypes  are  indicated  by  the  colours  green  (present  in   both
perturbation and unperturbed model) and grey (not present in  both perturbation and unperturbed
model). 
due  to  these  signals,  accounting  for  two  critical  alterations  observed  in
carcinomas. As critical alterations, we focused on the overexpression of SRC and
FAT4  previously  demonstrated  to  affect  the  stability  of  Epithelial  and  Hybrid
phenotypes (section 3.8). To be more realistic, we mimic the overexpression by
perturbations that made SRC and FAT4 insensitive to their inhibitors instead of an
ectopic activation (section 3.4.1). The reasons are based on the dependence of
FAT4 activation by its ligand and SRC activation by EGFR signalling  [113,114].
Here,  we  compared  the  effects  of  RPTPL and  FAT4L signals  on  the  model
phenotypes  switching  behaviour  with  and  without  these  perturbations  in  two
physiological scenarios (Figure 26). The unperturbed model showed that under
normal Epithelial tissue and chronic inflammation conditions, the RPTPL signals
activate the phenotype switching from Mesenchymal to Epithelial cell adhesion
(MET), regardless of any other cell-cell contact signals. This switching was not
possible with the SRC overexpression perturbation but was still  present in the
FAT4 overexpression. This is explained by the direct inhibition of RPTP due to
free SRC activation, which is only active in the Mesenchymal stable states in the
case  of  the  SRC  overexpression  perturbation  (Figure  S11).  This  free  SRC
activation in  the stable states is due to the removal of  the inhibitory effect  of
FAK/SRC complex  (interaction  124,  Table  S2).  This  further  indicates  that  the
proportions of FAK and SRC in the cell may be critical for the regulation of RPTP
[115,116].  Under  the SRC perturbation,  the  model  predicts  that  the  Epithelial
phenotype was only stable in normal tissue conditions (no EMT signals), whereas
it switches to Mesenchymal adhesion phenotype regardless of the FAT4L and/or
RPTPL signals in chronic inflammation conditions (EMT signal).  These results
indicate  that  the  overexpression  of  SRC  leads  to  an  irreversible  switching
behaviour towards the Mesenchymal phenotype. This further supports the idea of
the potential role for SRC overexpression in cancer invasion [111].
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Figure 26. Comparison of the model phenotype switching behaviours due to cell-
cell  contact  signals  with  and  without  perturbations  that  mimic  SRC  and  FAT4
overexpression. Adhesion  phenotypes  are  represented  by  the  correspondent  Epithelial
(orange), Mesenchymal (blue)  and Hybrid (green) illustrations (see figure Figure 20 in section 3.3.
for  adhesion  combinations).  Arrows  indicate  switching  between  phenotypes  and  the  input
conditions for RPTPL and FAT4 are indicated on top of the arrows, where * indicates all values are
compatible.  SRC overexpression was simulated by the perturbation that  removed the inhibition
effect of FAK_SRC (SRC[FAK_SRC@0] in Ginsim) and FAT4 overexpression by the perturbation
that removed the inhibition effect  by ERK (FAT4[ERK@0] in Ginsim).  Simulations performed in
GINsim with methods described in sections 3.4.2 and 3.4.3. Simulations started from the Epithelial,
Mesenchymal or Hybrid stable states correspondent to the previously obtained stable state. The
initial stable stables were the ones obtained for normal tissue conditions. Simulations were run for
all possible combinations of RPTPL and FAT4L values, fixing the remaining inputs as described for
normal epithelial tissues or chronic inflammation (Table S6).  Stable states from simulations are
shown in Figures S10 to S12.                
For FAT4 overexpression perturbation, our results indicate that this perturbation
results in the stability of the Hybrid phenotype under the FAT4L signal (FAT4 = 1)
with basal RPTPL signals (RPTP = 0). The resulting stable states of the Hybrid
phenotypes  were  mostly  identical  to  the  Intermediate  phenotype  with
intermediate E-cadherin levels, except for the activation of PAK, FAK-SRC, ERK
and PI3K (Figure S7 and Figure S12). These additional activations explain the
high focal adhesion dynamics in stable states because they are directly involved
in the dynamics of focal adhesion (interactions 34, 42, and 44, Table S2). These
activations were not compatible with FAT4 activation in the unperturbed model
because FAT4 is inhibited by ERK (interaction 41, Table S2).  The model also
indicates that this perturbation leads to a reversible switching behaviour between
Mesenchymal and Hybrid phenotypes, which only depends on the FAT4L signal
strength.  This  is  in  agreement  with  the  observation  of  both  types  of  cells  in
migrating  carcinomas  [11].  For  the  switching  from  Hybrid  to  Epithelial
phenotypes, the model showed that this behaviour exclusively depends on the
RPTPL signal strength (RPTPL = 1) in both physiological scenarios. Interestingly,
the model dynamics showed that in normal Epithelial tissue conditions the Hybrid
phenotype can only be formed from an initial Mesenchymal state containing and
the FAT4 perturbation. 
On  the  other  hand,  in  chronic  inflammation  conditions,  the  switching  from
Epithelial to Hybrid is already possible in high FAT4L and basal RPTPL signals.
This  indicates that  an EMT signal  is  required for  driving  the switching to the
Hybrid phenotype in the case of FAT4 overexpression. We also found that IL6
signal in combination with any the signals that drive EMT was necessary to drive
the  switching  from  Epithelial  to  Hybrid  phenotype.  We  also  analysed  the
combinations of RPTPL and FAT4L with the DELTA signals, where no striking
differences were found between the unperturbed and perturbations in terms of
115
the switching between Epithelial, Mesenchymal and Hybrid phenotypes (data not
shown). However, in some conditions, the DELTA signals were able to stabilize
the Intermediate phenotype in the normal and FAT4 overexpression perturbation.
Some of these conditions were compatible with the Hybrid phenotype (RPTPL=0
and FAT4L =1), indicating that DELTA signals may be involved in the formation of
a cluster of cells composed of Hybrid and Intermediate phenotypes.
3.10. The mechanism of RPTP and FAT4 on cell adhesion 
To explain how RPTPL and FAT4L signals control cell adhesion properties under
an EMT signal, we analysed the impact of several perturbations that knockout
regulatory effects (model interactions) downstream from these signals. For this
purpose, we analysed the reachability of the adhesion phenotypes under chronic
inflammation conditions  for individual and combination of perturbations (similar to
the analysis in section 3.7). The results of the reachability of phenotypes (Tables
S10 and S11) allowed us to identify the effect of regulatory interactions, discard
interactions,  and  reconstruct  the  regulatory  mechanism by which RPTPL and
FAT4L signals control cell adhesion properties (Figure 27). For the effect of the
RPTPL signal, our results demonstrated that RPTP regulatory effects on EGFR,
MET,  β-catenin  (b-Cat_mem),  and  p120  are  required  to  ensure  an  absolute
control  of  cell  adhesion properties whatever the initial state (Figure 27A). The
reachability analysis showed that the inhibition of MET together with activation of
p120 and β-catenin is critical  to ensure Epithelial  cell-cell  adhesion in chronic
inflammation conditions. This was evident in the triple perturbation knockout of
these  interactions,  which  resulted  only  in  the  Mesenchymal  cell  adhesion
phenotype (Table S10).  Here,  the RPTP activation of  the membrane forms of
p120 and β-catenin are both required to complement the effect of E-cadherin on
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cell-cell  adhesion strength leading to the conditions for high Epithelial  cell-cell
adhesion [117,118]. 
For MET inhibition, RPTP plays a key role to effectively prevent the inhibition of
E-cadherin expression (CDH1) by SNAI and ZEB via TCF/LEF activation of Wnt
and  TGFβ  signalling,  otherwise  would  completely  abolish  Epithelial  adhesion
phenotype (Figure 27A, Table S10).   
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Figure  27. Critical interactions that are involved in the control the cell adhesion
properties under chronic inflammation conditions with RPTPL (A) and FAT4L (B)
signals. Regulatory  components represented by the nodes of the model (see Table S1 for full
names).  Components  in  grey  indicate  basal  activity  and  in  black  high  or  intermediate  activity.
Arrows  in  green  indicate  activations  and  red  inhibitions.  Continuous  arrows  indicate  a  direct
interaction between two nodes in the model.  Dashed arrows indicate that the interaction effect may
be through multiple paths.       
On the other hand, the join inhibition of MET and EGFR is required to ensure an
absolute control over the inhibition of the Mesenchymal focal adhesion dynamics
via the inhibition of FAK/SRC complex. This was evident in the stabilization of
high focal adhesion dynamics in the ectopic activation of FAK/SRC complex by
MET or EGFR (Table S10). In addition, our results also indicate that ineffective
control of RPTP over EGFR or MET leads to the stabilization of Hybrid adhesion
phenotypes,  and  the  ineffective  control  of  RPTP over  catenins  (p120  and  β-
catenin)  resulted  in  loss  of  focal  adhesion  dynamics  that  could  result  in  an
amoeboid-like phenotype (Table S10). 
For the control of cell adhesion properties by FAT4L signals, our analysis showed
that the activation of Hippo signalling component LATS and subsequent inhibition
of the nuclear translocation of YAP and TAZ (YAP_TAZ ) is critical for the stability
of the Hybrid adhesion phenotype (Figure 27B, Table S11). This is demonstrated
by the reachability of the adhesion phenotypes with perturbations that removed
the effect of these interactions, which resulted in the Mesenchymal phenotype
instead of the Hybrid (Table S11). The high focal adhesion dynamics on these
phenotypes is always maintained under chronic inflammation conditions because
this  property  is  controlled  by  regulators  that  do  not  interact  with  the  Hippo
signalling  components.  On the  other  hand,  the  Hippo signalling  perturbations
affected only cell-cell adhesion, in particular through the YAP/TAZ participation in
the activation of nuclear β-catenin (b-Cat_nuc) and TGFβ signalling component
SMAD. These two interactions are both required for the stabilization of the cell-
cell adhesion correspondent of the Hybrid adhesion phenotype, where the effect
of the YAP/TAZ interaction with DVL was neglectable. This was demonstrated by
the  reachability  of  both  Mesenchymal  and  Hybrid  adhesion  phenotypes  with
perturbations on these two interactions (Table S11). Moreover, the inhibition of
SMAD  and  nuclear  β-catenin  further  explains  the  stability  of  the  Hybrid
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intermediate  cell-cell  adhesion  by  having  a  downstream effect,  repressing  E-
cadherin expression through ZEB and SNAI activation (Figure 27B).
4. Discussion
In this study, we proposed a logical model that focused on the regulation of cell
adhesion properties during EMT. This model was developed to provide an insight
on  the  conditions  that  control  the  switching  behaviour  between  Epithelial,
Mesenchymal  and  Hybrid  phenotypes.  Here,  we  have  accounted  for  the
regulation  of  E-cadherin  mediated  cell-cell  adhesion  and  the  focal  adhesion
dynamics to provide a simple way to define Epithelial, Mesenchymal and Hybrid
phenotypes.  This  allowed  us  to  better  understand  the  role  of  the
microenvironment,  in  particular,  the role of  neighbouring cells  signals  towards
invasion and metastasis  of  carcinomas. Our  systems approach allowed us to
account  for  the  complex  regulation  of  EMT,  recapitulate  several  reported
observations (model validation) and predict the conditions that drive the switching
between Epithelial, Mesenchymal and Hybrid phenotypes. In this work, we have
further focused on two cell-cell contact signals that activate the RPTP and FAT4
receptors as neighbouring cells  signals.  Moreover,  we explored the impact  of
some reported mutations in carcinomas on the switching behaviours.
Our model was able to recapitulate the Epithelial and Mesenchymal phenotypes
on  the  stable  states,  together  with  their  reported  markers  and  most  of  the
expected changes in the activity of signalling pathways during EMT (Figure 21).
From the analysis of the Epithelial and Mesenchymal stable states patterns, we
have  learned  that  characteristic  signalling  activation  of  EMT depend  on  the
microenvironment,  where some reported signalling  activation  in  EMT may be
activated without resulting in a phenotype change (Figure 21). In addition, the
model was also able to recapitulate the cell  adhesion properties and reported
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molecular features of the border cells migration during developmental process of
oogenesis  by  the  Intermediate  adhesion  phenotype  (Figure  21)  [14,34,100].
Accounting for the microenvironment signals analysed here, our model predicted
that  the  Hybrid  and  Amoeboid-like  phenotypes  were  not  stable  under  any
combination of microenvironment signals (Figure 20). Although this was part of
the model validation, it suggests that the stability of these phenotypes depends
on  mutation  acquisition  during  cancer  progression  that  causes  regulatory
alterations such as KOs or overexpression of critical genes [28,119]. To reinforce
the confidence in our model predictions, we have tested the model capacity to
recapitulate the effects of microenvironment signals and mutations on Epithelial
cell  lines  (Table  5,  Figure  22).  Here,  the  model  was  able  to  recapitulate  the
observed  adhesion  changes  and  molecular  activity  during  EMT triggered  by
growth factors, ECM stiffness and mutational effects such as SRC overactivation
(Figure 22). The model also recapitulated partial adhesion changes caused by
mutations or  IL6 in  epithelial  cells  (Figure 22).  Most  of  the experiments used
came from different  cell  lines which some were cancerous (Table 5),  bringing
noise and uncertainty around the specificity of the results. Logical models have
been validated using either expression data or specific measurements of activity
in particular cell lines  [31,32,38,39]. Since most of our model components are
signalling  components,  the  expression  data  is  not  suitable  to  test  our  model
because it  does not directly reflect the activity degree  [120,121]. On the other
hand, controlled experiments that tested model components in the same cell line
and within  the same experimental  method are  not  abundant  in  the  literature.
Nevertheless, we have covered a substantial amount of model components by
aggregating observations from several cell lines and studies (Table 5), where the
adhesion properties and its direct regulators were constantly challenged (Figure
22 and  Figure  S8).  Thus,  we  considered  the  model  to  be  able  to  generate
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trustable predictions for generic Epithelial, Mesenchymal and Hybrid cell types, in
particular, for their relationship with the microenvironment.  
The model  analysis  revealed that  cell-cell  contact  signals  that  activate  RPTP
were determinant for the control cell adhesion properties during EMT (sections
3.6, 3.7, and 3.9). Our model showed that RPTP activation was able to make the
stable states that belong to the Epithelial adhesion phenotype compatible with
the presence of signals in the microenvironment that are reported to trigger EMT
(e.g growth factors,  ECM stiffness and Delta-notch activation)  (Figure 23 and
Table  S6).  Interestingly,  the  reachability  analysis  further  showed  that  RPTP
activation  by cell-cell  contact  signals  resulted into the Epithelial  phenotype in
normal, tissue growth and chronic inflammation conditions (Figure 24). Together,
these results suggest that cell-cell  contact signals from neighbouring cells are
capable of strongly activate RPTP could prevent EMT and trigger Mesenchymal-
to-Epithelial Transition (MET). This constitutes a model prediction that explains
the observed MET in cancer cell  lines due to signals from co-cultured normal
Epithelial cell lines (cell-cell contact stimulation) [65]. Our prediction also explains
EMT in tissues that suffered massive cell death (loss of cell-cell contacts) under
tissue  repair  signals,  followed  by  MET during  the  process  re-epithelialization
(regain of cell-cell contacts by repopulation of cells)  [102]. These RPTP effects
are not described in the literature and suggest that they might be relevant in the
cancer context. This role is supported by the observation of cell-cell dependent
RPTPs such as RPTP-κ and DEP-1 are often mutated and down-regulated in
carcinomas  [40,122].  Our  analysis  further  showed  that  the  control  of  cell
adhesion by RPTP depend on the combined activation of the membrane forms of
p120 and β-catenin, together with the inhibition of the EGFR and MET (Figure 27,
Table S10). β-catenin and EGFR are specifically targeted by RPTP-κ, whereas
p120  and  MET are  strongly  dephosphorylated  by  DEP-1  [40,123–125].  This
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further suggests that  both RPTPs are critical  for  the control  of  EMT, possibly
through a combined effect with more RPTPs to ensure a stronger effect. 
Importantly,  our  results  also  showed  that  high  ROS  levels  in  the
microenvironment (e.g. generated under hypoxia) favours EMT by preventing the
RPTP control  mechanism  (Table  S6 and  Figure  24).  However,  this  required
additional signals such as growth factors or ECM stiffness to trigger the switching
towards Mesenchymal phenotype (Table S6).  This  suggests that  the oxidative
inhibition of RPTPs by ROS as it was observed for RPTP-k in keratinocytes may
promote carcinomas invasion through the accumulation of  Mesenchymal cells
[108]. This effect was strikingly evident in the simulations of hypoxia with chronic
inflammation  conditions,  suggesting  that  these  signals  in  the  tumour
microenvironment may be enough to promote invasion of carcinomas, regardless
of  mutational  acquisition  (Figure  24).  This  explains  the  direct  link  between
metastasis and the observed synergistic effect of combining hypoxia with high
ECM stiffness  in  the tumour  microenvironment  [23].  Similar  effects  were also
identified for the model perturbation that mimics the overexpression of SRC in
carcinomas (sections 3.9 and 3.10).  In this case, the perturbation allowed the
activation of the free SRC form as well as the complexed with FAK to mimic the
higher concentrations of SRC in cells (Figure S10 and S11). Consequently, the
free SRC activation in the Mesenchymal stable states results in the inhibition of
RPTP  transcription  in  our  model  (interaction  108)  [126].  This  caused  an
irreversible  switching  behaviour  that  would  favour  the  accumulation  of
Mesenchymal cells in comparison to the absence of a SRC overexpression under
chronic inflammation conditions (Figure 26).  This suggests that mutations that
result in an increase of SRC concentration in carcinomas would favour invasion
through  gaining  the  capacity  to  overcome EMT control  mechanism by RPTP
[111,115]. This supports the potential role of SRC overexpression and activation
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in  cancer  invasion,  together  with  the observed down-regulation  of  RPTP-k  in
similar experimental conditions [111,126,127]. This finding is further supported by
the observation of normal RPTP-k expression during EMT in keratinocytes and
breast  cell  lines,  under  experimental  conditions  were  SRC  was  not
overexpressed  [128,129].  Perturbation  analysis  of  model  components (section
3.8)  further  highlighted the  relevance of  RPTP in  cancer  by  showing  several
perturbations  that  would  favour  the  Mesenchymal  phenotype  only  if  RPTP is
knockout (Figure 25). For example, Notch or TCF/LEF overactivation were two
cases that we found to correlate with the expression levels in carcinomas (Table
S9).  Together,  these  results  reinforce  the  idea  that  RPTP  activation  by
neighbouring cells  may be critical  to  prevent  cancer  invasion and metastasis
through an uncontrollable EMT.
On the other hand, our model analysis showed that cell-cell contact signals that
activate  FAT4  receptor  could  stabilize  Intermediate  and  Hybrid  cell  adhesion
phenotypes in the presence of microenvironment signals that trigger EMT (Figure
23, Table S6, and Figure 26). This suggests that neighbouring cells signals such
as Dcsh1 ligands involved in ureteric bud branching and skeletal morphogenesis
could play a role for the stability of partial EMT phenotypes  [43,113]. However,
this  is  predicted  by  our  model  to  be  incompatible  with  RPTP  activation  by
neighbouring  cells  signals,  suggesting  that  deregulations  of  RPTP in  cancer
would favour the stability of partial EMT phenotypes (Table S6 and  Figure 26).
Thus, mutations in RPTP ligands, hypoxia or SRC overexpression are possible
deregulations that could also play a role in stabilizing partial EMT phenotypes.
Interestingly,  our  model  predicted  that  the  stabilization  of  a  Hybrid  adhesion
phenotype was possible through a perturbation that reflects the overexpression
of  FAT4, i.e.,  a mutational  alteration that  removed the reported transcriptional
control of FAT4 by ERK activation (Figure 26) [130]. This perturbation resulted in
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the Hybrid adhesion with an intermediate cell-cell adhesion as the Intermediate
phenotype, which is in agreement with the expected adhesion properties of the
small clusters observed during cancer migration [14,15]. Despite the known role
in border cells migration, the Intermediate adhesion phenotype could also play a
role  in  the  collective  migration  in  cooperation  with  the  Hybrid  phenotype  as
follower  cells  (Hybrid  +  Intermediate  cells)  [14,100].  Therefore,  our  results
suggest  that  overexpression  of  FAT4  could  promote  invasion  of  carcinomas
through  favouring  collective  cell  migration.  Indeed,  the  FAT4  expression  is
increased in most carcinomas, supporting that this alteration could be relevant for
cancer invasion (Table S6). Strikingly, this prediction is in contradiction with the
reported  tumour  suppressor  role  of  FAT4   via  activation  of  Hippo  signalling,
making this a new hypothetical role of FAT4 in cancer [41]. 
The stability of the Hybrid phenotype by FAT4 activation was explained with our
model by a join inhibition of SMAD and TCF/LEF due to YAP/TAZ inhibition by
Hippo signalling activation (Figure 27, Table S11). In turn, this combined inhibition
was  required  for  successfully  prevent  the  down-regulation  of  E-cadherin
expression by their main transcriptional repressors (ZEB and SNAI family) under
any EMT signal  [27,131,132]. However, it requires additional EMT signals such
as the ones from chronic  inflammation to maintain integrin signalling  towards
activating high focal adhesion dynamics.  The explored dynamics of phenotype
switching under FAT4 overexpression perturbation further showed that  signals
from  neighbouring  cells  conditioned  the  inter-conversion  between  Hybrid,
Mesenchymal and Epithelial (Figure 26). Here, we have illustrated a tendency for
invasion  under  chronic  inflammation  conditions  with  inactivation  of  RPTP
(deregulation).  Here,  we  also  captured  a  tendency  for  colonization  by  the
irreversible switching to the Epithelial phenotype in normal tissue conditions with
RPTP  reactivation  by  neighbouring  cells  (Figure  26).  This  recapitulates  the
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metastasis process and places neighbouring cells signals as playing a central
role together  with changes in  the microenvironment  between the primary and
secondary  sites  of  tumours  [4,9,18].  Under  these  conditions,  Intermediate
phenotypes are also predicted to be possible further supporting the possibility of
the formation of  an invasive cluster  of  tumour  cells  (Figure  26,  Table S6).  In
addition, we also identified that Delta-notch signalling could play a role in the
interchange  between  Hybrid  and  Intermediate  phenotypes  in  these  invasive
clusters (section 3.9). Comparing with the dynamics of inter-conversion of SRC
overexpression,  our  results  support  the idea that  metastasis  would be further
stimulated  in  a  heterogeneous  tumour  containing  cells  with  these  individual
mutations, stimulating both single (Mesenchymal) and collective tumour invasion
(Hybrid + Intermediate) (Figure 26) [111].
Although we have not explored in deph all mutational effects, some mutational
alterations were pinpointed to be relevant for the invasion of carcinomas (section
3.9). One was the cMET overactivation that allowed the stabilization of the Hybrid
phenotype  with  high  cell-cell  adhesion  (Figure  25).  This  cell  adhesion  is
characteristic  of  a  multicellular  stand  invasion,  suggesting  that  cMET
overactivation might play a role in this form of invasion  [14,15]. Thus, keeping
cMET activation controlled by RPTPs or drugs (inhibitors)  is predicted to prevent
this phenotype.  In this analysis, we also identified that the combination of PI3K
with TCF/LEF activation was critical for overcoming RPTP control and collapsing
the  Epithelial  phenotype  (Figure  25).  Indeed,  PI3K  is  found  to  be  frequently
overactive  in  carcinomas  and  correlated  with  aggressiveness,  supporting  its
relevance for cancer invasion  [28]. However, TCF/LEF is a transcription factor
that depends on the activation of Wnt signalling pathways [133,134]. Interestingly,
we  also  found  that  some  KO  perturbations  in  TGFβ  and  Wnt  signalling
components  stabilized  the  Hybrid  adhesion  phenotype  compatible  with  the
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collective migration of small groups of cells. Among them, SMAD has been used
as a drug target  in  cancer  therapy,  proven to be ineffective  and predicted to
stimulate  partial  EMT  [35,112].  On  the  other  hand,  our  model  predicted  that
targeting ERK/MEK or the combination of AKT/MET with CK1 could be sufficient
to  prevent  Mesenchymal  phenotypes.  These  results  support  the  usage  of
effective MAPK inhibitors as drugs to fight cancer  [87,88]. Or in alternative, the
idea of targeting AKT and MET in combination with other drugs to increase the
efficiency  [137,138].  Together,  these  results  suggest  that  depending  on  the
microenvironment, the usage of drugs in cancer therapy could result in alternative
modes of invasion (Hybrid or Mesenchymal phenotypes). 
Taken  all  together,  our  results  showed that  neighbouring  cells  signals  in  the
tumour microenvironment play a role in metastasis by driving the interconversion
between Epithelial,  Mesenchymal and Hybrid phenotypes.  RPTP activation by
neighbouring cells  is  predicted to function  as a natural  mechanism to control
EMT.  Here,  we  showed  that  overcoming  this  control  mechanism  is  possible
through deregulations in the tumour microenvironment (e.g. hypoxia combined
with  chronic  inflammation)  or  mutational  deregulations  (SRC overexpression),
explaining  invasion  of  carcinomas  through  EMT.  Moreover,  overexpression  of
FAT4 receptors is pinpointed by our model as a critical mutational deregulation
that could promote collective cell migration of carcinomas by allowing the stability
of Hybrid phenotypes.
5. Supplemental Information
5.1. Supplemental text
For  most  nodes,  we  only  consider  the  post-translational  regulation  for  the
activation or inhibition of a component (see  Tables S1 and S2). The reason is
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because these nodes reflect proteins of signalling cascades, and we did not find
evidence  for  transcriptional  regulation.  To  make  our  analysis  computationally
feasible, we reduced the size of the network by collapsing mediators of regulatory
processes such as adapter proteins, genes and RNA (assumed to be part of an
interaction).  In these cases, we added a direct arc between the regulator and
target which bypassed mediators. Protein complexes that act as a scaffold or
families of proteins/genes with redundant effects were condensed into a single
node. We present some of these simplifications in the KEGG signalling pathways
in Figures S1-S4. 
5.1.1. Interactions for the regulation of cell-cell adhesion
The status of the E-cadherin/β-catenin complex on the adherens junctions was
adopted  as  a  proxy  of  cell-cell  adhesion  strength,  neglecting  other  adhesion
proteins  [117,118,139]. The complex is represented by the nodes E-cad_mem
and b-Cat_mem. We included two effects on cell-cell adhesion from these nodes,
the adhesion caused by E-cadherin homophilic binding (interaction 16) and the
strengthening  of  adhesion by  β-catenin  binding to  E-cadherin  (interaction  17)
[117,140]. We neglected the effect of α-catenin on cell-cell adhesion because it
depends on β-catenin binding to E-cadherin  [117,118]. For the regulation of E-
cadherin/β-catenin complex, we included the effect of δ-catenin (p120) on the
stability of E-cadherin in the membrane (interaction 26) and the effect of RAP1 on
the  transport  of  E-cadherin  to  the  membrane  (interaction  25)  [141,142].  To
account  for  the  mechanism of  E-cadherin/β-catenin  complex  disassembly,  we
included the Inhibitory effects on (δ/β)-catenin binding to E-cadherin by tyrosine
kinases SRC, MET and CK1  (interactions 6-9 and 80-83, see also Figure S1 in
section 6)  [143]. We also included the effect of RPTP kappa and DEP1 on the
activity  of  Receptor  Tyrosine  Kinases  (interactions  33  and  71)  and  catenins
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(interactions 4 and 80)  [40,42]. Based on the redundancy of RPTP activity, we
represented RPTP kappa and DEP1 by a single node (RPTP). Based on reports
that  showed  RPTP  kappa  and  DEP1  activation  is  enhanced  in  high  cell
confluency, we consider a cell  contact activation of RPTP by a generic ligand
(RPTPL)  [44,45,144].  In  this  network  model,  the  effects  of  intracellular
phosphatases (e.g. PTPs and PTEN) were neglected assuming that the strength
of  tyrosine kinase activation  is  enough to become dominant  over  intracellular
phosphatases  [145,146]. This is reasonable to assume in the case of a strong
signal to activate tyrosine kinases. We included the transcriptional repression of
E-cadherin  gene  (CDH1)  by  ZEB  and  SNAI  family  of  transcription  factors
(interactions 14 and 15, see also Figure S1 in section 6) [132,147,148]. This was
coupled with  the core  EMT regulatory  circuit  composed by  mutual  inhibitions
between ZEB/SNAI and miR200 family (interactions 72, 73 and 134)  [34,104].
Canonic MAPK and TGF-β signalling were included here because they mediate
the activation of SNAI and ZEB, respectively (interactions 110, 116 and 133, see
also Figure S1 in section 6) [25,34,80]. We accounted for the main growth factors
in the microenvironment of Epithelial  tissues able to drive EMT, the EGF and
HGF [25,149,150]. Canonic Wnt signalling was considered because is involved in
the autocrine regulation of TGF-β signalling (interaction 130) and participates in
the  dissolution  of  E-cadherin/β-catenin  complex  through  CK1  (interaction  81)
[31,69,151].  In  this  pathway,  we  also  included  a  self-activation  on  TCF_LEF
(interaction 129) to account for an enhanced activation of Wnt signalling due to
AKT and MET effects reported in carcinoma cell lines  [152,153]. 
5.1.2. Interactions for the regulation of focal adhesion dynamics
For the focal adhesion dynamics we considered as direct regulators the integrin
alpha5beta1 (ITGab), PAK1, and a complex composed by FAK and SRC (FAK-
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SRC).  Integrin  alpha5beta1  was  considered  because  ensures  enhanced
contractile forces necessary for tumour invasion (interaction 44)  [97,154]. FAK-
SRC and PAK were chosen because they both drive a dynamical formation and
turnover of  long F-actin  stress fibres,  necessary for  high invasive cell  motility
(interaction  43  and  45)  [13,155–158].  FAK isolated  effect  was  not  accounted
because  it  is  not  correlated  with  invasive  phenotype  [140,159].  Because  we
chose FAK-SRC and PAK as direct regulators of focal adhesion dynamics, we
neglected all downstream regulators such as the small GTPases Rac1 and RhoA
(Figure S2 in section 6). For upstream regulation of focal adhesion dynamics, we
accounted for several integrin and growth factor induced mechanisms (Figure S2
in  section  6).  We  included  the  direct  integrin  activation  by  ECM  stiffness
(interaction  57)  and  growth  factor  induced  activation  by  TGF-βR  and  CD44
(interactions  54  and  55).  The  effects  of  ZEB  and  RAP1  on  integrin
overexpression and transport to the membrane were also accounted (interactions
53 and 56)  [141,160]. PAK activation was found to be controlled by PI3K and
FAK-SRC,  thus  we  included  these  effects  (interactions  85  and  86).  For  the
mechanism of FAK-SRC complex formation and activation, we accounted for the
regulatory effects of integrins, EGFR, cMET, free cytoplasmic form SRC and ERK
(interactions  35-39)  [94,140,155,161].  We  assumed  that  free  SRC  in  the
cytoplasm is transient during focal adhesion formation. This was based on the
observed re-localization of SRC from the cytoplasm to a FAK-SRC complex on
focal adhesions in MDCK cells (normal cells)  [115]. It is reasonable to consider
that FAK-SRC binding would be enough to prevent the activation of SRC targets
in the cytoplasm/nuclear locations (e.g. STAT3, interaction 124). To account for
this,  we  included a  self-activation  on  FAK-SRC node (interaction  40)  and an
inhibitory interaction from FAK-SRC to SRC (interaction 122). These interactions
were necessary to account for a transient STAT3 activation due to SRC observed
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in normal cells and constitutive activation when SRC is over-expressed [127]. We
included several reported downstream effects from integrins and growth factor
induced signalling. One was through the addition of ILK to account for integrin
mediated  activation  of  SMAD  and  AKT  (interactions  3  and  109)  [162,163].
Several FAK-SRC effects were included: The inhibition of membrane β-catenin
(interaction 9); RAS mediated MAPK and JNK signalling activation (interactions
59  and  102);  and  PI3K  mediated  AKT  signalling  activation  (interaction  89).
Finally,  we  also  included  a  putative  inhibitory  interaction  from SRC to  RPTP
based on an observed negative correlation between RPTP kappa transcription
and SRC activation in  a SRC transformed MCF10A cell  line (interaction 106)
[126]. Since the mechanism of RPTP kappa inhibition is unknown and is only
observed in conditions where SRC is overexpressed, we assumed that this effect
is due to free SRC [126,128,129].
5.1.3. Interactions for the regulation of EMT and cancer invasion
Notch,  hypoxia  and  inflammatory  IL6 signalling  were  included  in  the  network
based on reports that correlated these signals with EMT stimulation and tumour
invasion  [22,23,91].  In  cancer  cell  lines,  Notch  signalling  activates  SNAI2
(interactions 20 and  111), stimulates EGFR overexpression (interactions 20 and
28),  crosstalk  with  TGF-β  signalling  and  enhances  invasion  through  NFkB
activation (interactions 20 and 74). Inhibition of Notch by DVL (Wnt signalling)
was found in MCDK cells,  thus we included this effect (interaction 79).  In the
network, Notch activation was only considered through cell-cell contact signals by
Delta-like  ligands,  represented  by  the  node  DELTA (interaction  78).  We also
considered ROS as a microenvironment signal because it can be generated by
both inflammation and hypoxia in the tumour microenvironment  [22,164].  This
signal is important  for triggering the expression of HIF1a (interaction 50), which
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is involved in the stability of SNAI1 (interaction 115) and potentiates the effect of
Notch in breast cancer migration [165,166]. STAT3 and NFkB also participate in
HIF1a expression by preventing its turnover (included in interactions 49 and 51).
In addition, we also included the effect of ROS in NFkB activation and RPTP
kappa inhibition (interactions 76 and 105). For STAT3 activation, we include two
interactions (123 and 124), to account for the IL6 and SRC induced constitutive
activation of STAT3, which participates in stabilizing SNAI1 expression [127]. In
IL6 signalling, we suppressed JAK (IL6 receptor) and add a direct link to JNK to
simplify the STAT3 signalling based on evidence that showed JNK activation was
required for a fully activated STAT3 transcriptional response  [167,168]. On the
other hand, JNK also promotes the disassembly of E-cadherin/β-catenin complex
(interaction 6) and participates in SNAI activation (interaction 114) [169–171]. IL6
was considered as microenvironment signal neglecting its autocrine production
because it  is  accumulated in tumours,  and is thought to play a role in breast
cancer invasion [22,172].  Hippo signalling was included in the network because
hypothetically can counteract EMT based on its capacity to inhibit Wnt and TGF-β
signalling through LATS activation  [95,173]. This causes cytoplasm retention of
YAP  and  TAZ  (interaction  132)  which  no  longer  participates  in  nuclear
translocation  of  β-catenin  and SMAD (interactions  10 and 107).  Experimental
evidence  showed  that  LATS  can  be  activated  by  either  E-cadherin/β-catenin
complex  or  by  the  oncogene  FAT4  in  Epithelial  cells  (interactions  62-64).
Recently,  Dsch1  was  found  to  be  a  FAT4 ligand  between  mesenchymal  cell
contacts  [43,113].  Since   the  ligands  are  unknown  for  Epithelial  cells,  we
assumed in this  network the activation  of  FAT4 by a  generic  cell-cell  contact
ligand.  We  also  included  the  reported  transcriptional  inhibition  of  FAT4  gene
expression by ERK in MCF-10A cell line (interaction 42) [130]. 
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5.1.4. Logical functions
For the high degree of cell-cell adhesion (value 2), we define the logical rule with
an  “AND”  rule  between  E-cadherin_mem  and  b-Cat_mem  at  their  maximum
levels.  This was based on the fact that mature and strong adhesion has high E-
cadherin  concentration  in  the  membrane,  bound  to  β-catenin  (E-cadherin/β-
catenin  complex)  [98,99,118,174].  For  the  intermediate  cell-cell  adhesion
strength (value 1), we assume that the intermediate level of E-cadherin in the
membrane (value 1)  is  enough to  ensure  this  level  based on the homophilic
binding capacity of  E-cadherin  [101,175].  This is also supported by reports in
Drosophila and MDCK cell lines [98–100]. Thus, we set logical rules to allow all
remaining combinations of  E-Cad_mem and b-Cat_mem states except for  the
ones with E-cad_mem value of 0 (no homophilic binding). For E-cadherin_mem,
the logical functions  were defined accounting for the role of p120 and RAP1 as
modulators  of  E-cadherin  concentration  at  the  membrane  [101,141,176,177].
Here,  we account  for  the transcriptional activation of E-cadherin (CDH1) as a
requisite for both high and intermediate levels  [178].  Since p120 stabilizes E-
cadherin in the membrane and Rap1 mediates the transport of E-cadherin to the
membrane, we assume that high concentration of E-cadherin (value 2) is given
by the combination of all activators using “AND” rules to link the regulators [176–
178]. The function for the intermediate level of E-cadherin (value 1) was set to
describe a particular scenario where E-cadherin gene expression is active and
RAP1 is the only mediator of the transport to the membrane [99,100,141]. For the
Focal_Adhesion_Dynamics, we chose to link all regulatory nodes through  “AND”
rule because all these regulators participate in the biochemical mechanisms  that
ensures an high formation and turnover of the focal adhesions [154–158]. Most of
the  logical  functions  were  based  on  reported  experimental  evidence  that
suggests  direct  effects  (activation  or  inhibition)  not  dependent  on  other
regulators. In these cases, we link the regulators through “OR” if its an activation
and “AND NOT” if its an inhibitor (see Table S3). We assume that inhibitions are
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always dominant over the activations except if there is evidence otherwise. For
example, in the functions for b-Cat_mem and p120 we considered that RPTP
activation is dominant over all inhibitors because the activity of RPTPs is about 3
orders of  magnitude higher then the activity of  RTK  [42].  In some cases,  the
“AND”  rule  was  used  between  2  or  more  activators  that  conjugate  the
transcription of a protein and its activation by post-translational mechanisms. The
activation of the nodes AKT, NfkB and HIF1a are 3 examples of regulators that
contain these types of regulatory mechanisms (see Table S3). For some nodes,
we  found  that  they  were  regulated  by  co-activation/inhibition  biochemical
mechanisms. Thus, we used “AND” rules to link activators and “OR NOT” rules
for inhibitions for these nodes. ITGab, CDH1, DVL, NfkB, PI3K, RAP1, MEK, JNK
and  SMAD  are  examples  of  nodes  that  are  controlled  by  co-regulatory
mechanisms (see Table S3).  The nodes FAK_SRC, SNAI and TCF_LEF were
also under co-regulatory mechanisms but with an higher degree of complexity.
For FAK/SRC complex, the logical function was set to describe the biochemical
mechanisms of activation of FAK/SRC such as is able to result in high formation
and  turnover  of  focal  adhesions.  These  mechanisms  include  sequential
phosphorylation  and  dephosphorylation  on  specific  tyrosine  residues  of  FAK
[140,179]. The initial step for the activation is through integrin signalling activation
in  combination  with  the receptor  tyrosine kinases (MET or  EGFR),  which are
necessary  to  remove  FAK  auto-inhibition  (Y397  and  Y194)  and  promote  the
binding affinity to SRC [140,161,180], where we write it as: ITGab “AND” (MET
“OR” EGFR). Next, SRC activation is necessary to catalyse the phosphorylation
of FAK on tyrosine residues Y576, Y577, and Y925, activating the kinase activity
of the complex [140,155]. In addition, we only found evidence for SRC activation
(phosphorylation at Y418) by either EGFR or MET suggesting that a free SRC
activation is required as initial step [94,181]. We assume that SRC effect on the
activation of FAK/SRC can be either through the activation by its free form or the
complex. Thus, we write a new condition for the activation (SRC “OR” FAK_SRC)
linked by an “AND” with the first condition. Finally, we add another “AND” rule to
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ERK  based  on  the  reports  that  showed  ERK activation  promotes  high  focal
adhesion dynamics through the dephosphorylation of FAK [94,179]. 
SNAI  logical  function  was  set  accounting  for  two  alternative  mechanisms  of
expressing snail  proteins enough to cause EMT (connected by an “OR” rule).
One is  the combination of  a transient  activation of  SNAI1 followed by SNAI2
expression  [182,183].  In  this  case,  ERK is  required for  the activation of  both
SNAI1 and SNAI2 through AP-1 induction  [80,184].  Experiments showed that
SMAD is a co-activator of SNAI1 expression indicating that it cannot cause an
effect alone [184,185]. On the other hand, notch signalling and TCF/LEF induced
transcription factors are found to directly bind to SNAI2 promoter and stimulate
gene expression  [110,186]. Taken all  these information together,  we wrote the
rules for this mechanism as: ERK “AND” SMAD “AND” (CSL “OR” TCF_LEF).
The  other  mechanism  of  activation  is  by  a  the  SMAD  induced  sustained
expression of  SNAI1  [184].  This  mechanism requires  both JNK and NFkB to
remove  the  negative  feedback  caused  by  SNAIL1  protein  [170,184].  This,
together with the co-activation by SMAD, supports the choice of linking  JNK,
SMAD  and   NfkB  through  “AND”  rule.  Finally,  STAT3,  PAK  and  HIF1a  are
regulators which are reported to play a role in preventing the repression of SNAI1
by GSK3b phosphorylation [166,187,188]. Thus the term  (STAT3 | HIF1a | PAK
| !GSK3B) was included in the logical function connected by and “AND” operator
to the rules for the 2 mechanisms. 
TCF_LEF function was also set to consider two types of activation mechanisms
(connected through “OR”). One mechanism is the translocation of catenins to the
nucleus  caused  by  their  detachment  from  the  membrane  and  cytoplasm
concentration  [189].  This  does  not  require  specific  phosphorylation  on  beta-
catenin residues.  For this mechanism we connect the negation of membrane
form  of  p120  (“NOT”  p120)  to  b-Cat_nuc  through  “AND”  rule.  The  other
mechanism reflects  the  constitutive  activation  of  TCF/LEF  transcription  factor
caused  by  an  enhanced  accumulation  and  retention  of  phosphorylated  beta-
catenin in the nucleus. This process is promoted by specific phosphorylation of
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beta-catenin  residues  by  both  MET and  AKT  [152,153,190].  To  describe  this
mechanism,  we  assume  a  self-activation  by  TCF/LEF  and  consider  that  it
depends  simultaneously  on  the  active  MET and  AKT by  connecting  through
“AND” rule.     
5.1.5. Comparison with a published EMT network model
Here,  we  compare  our  model  with  the  published  logical  network  model  of
hepatocarcinoma developed by Steinway et al. [31]. This model shares a total of
30 nodes with our model and contains others that we did not included (Table S5).
These nodes are the components of the Hedgehog signalling pathway, 3 different
growth  factor  receptors,  and  additional  transcription  factors  that  regulate  E-
cadherin expression. However, their effects were taken into account in our model
by aggregating into one node or considering a direct interaction in order to keep
our model smaller (details in Table S5). On the other hand, we included in our
model additional nodes and interactions not accounted in the Steinway’s model,
which  are:  The  Hippo  signalling  (FAT4,  LATS  and  YAP/TAZ);  The  integrin
signalling (ITGab, FAK/SRC, JNK, RAP1); The receptor tyrosine phosphatases
(RPTP); and regulators of the E-cadherin mediated cell-cell adhesion p120 and
CK1. In terms of microenvironment signals, we accounted for the ones in the
Steinway  model  and  included  additional  microenvironments,  the  two
neighbouring cell-cell contact signals (RPTPL and FAT4L), the IL6 and the ECM
stiffness (ECM). To further compare the models, we computed the stable states
of the Steinway’s model (section 2.5.4) and compared the representative stable
states  with  the  ones  for  Epithelial  and  Mesenchymal  adhesion  of  our  model
(Figure S9). The comparison of Epithelial stable state (Figure S9A and B) indicate
that  both models are in agreement,  where there is two stable states that  are
equivalent (see Figure S5). However, the activation of STAT3, Notch and MAPK
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signalling depending on the microenvironment conditions is not obtained in the
Steinway  model,  making  this  a  new prediction.  For  the  Mesenchymal  stable
states, the activity in both models is also in agreement (Figure S9C and D) ,
except  for  the Notch signalling and KFkB  activation.  In this  discrepancy,  our
model  predicts  basal  activity  for  these  two  components  and  in  the  Steinway
model  predicts  the  opposite.  The  reason  for  this  difference  is  because  we
included in our model the reported inhibition of Notch by DVL, a Wnt signalling
component  that  is  activated  in  all  Mesenchymal  stable  states  [191].  For  the
differences in NFkB activation, this is because we considered the reported NFkB
sustained activation due to Notch signalling, whereas Steinway model considered
just an initial activation by AKT  [192]. We also obtain differences in the activity of
SRC in  the  Mesenchymal  stable  states  because  we  have  considered  in  our
model two different forms of SRC, the free and the complexed with FAK. Thus
SRC in Steinway model reflected any form of SRC which is compatible with both
SRC or FAK-SRC. Among the regulators not included in the Steinway model, the
RPTP and  the  Hippo  signalling  components  FAT4,  LATS  and  YAP/TAZ,  are
predicted to have distinct  activity status between Epithelial  and Mesenchymal
adhesion phenotypes. This indicates the need to further analyze these regulators
because they could play a role in cell adhesion regulation during EMT.       
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5.2. Supplemental figures
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Figure  S1.  Adherens  junctions  regulatory  map of  KEGG PATHWAYS database
(map  hsa04520). Simplifications  on  the  regulatory  network  presented  in  section  3.2  are
depicted in colours. Nodes names of the network in 3.2 that condensed regulatory components
are identified next to the cluster in yellow. Neglected regulatory components are depicted in light
red and regulatory mechanisms that were condensed in one interaction in green.      
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Figure S2. Focal adhesion regulatory map of KEGG PATHWAYS database (map
hsa04510). Simplifications on the regulatory network presented in section 3.2 are depicted in
colours.  Nodes  names  of  the  network  in  3.2  that  condensed  regulatory  components  are
identified next to the cluster in yellow. Neglected regulatory components are depicted in light
red and regulatory mechanisms that were condensed in one interaction in green. 
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Figure S3 Hippo signalling map of KEGG PATHWAYS database (map  hsa04590).
Simplifications on the regulatory network presented in section 3.2 are depicted in colours. Nodes
names of the network in 3.2 that condensed regulatory components are identified next to the cluster
in yellow. Neglected regulatory components are depicted in light red and regulatory mechanisms
that were condensed in one interaction in green. 
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Figure S4  NOTCH signalling map of KEGG PATHWAYS database (map hsa04530).
Simplifications on the regulatory network presented in section 3.2 are depicted in colours. Nodes
names of the network in 3.2 that condensed regulatory components are identified next to the cluster
in yellow. Neglected regulatory components are depicted in light red and regulatory mechanisms
that were condensed in one interaction in green. 
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Figure S5. High cell-cell adhesion and basal focal adhesion dynamics (C=2 & F=
0)  stable  states. The  stable  states  were  computed  as  described  in  section  2.3.2.  A
representative stable state that  indicates the conserved and variable activity  of  the nodes is
shown below dashed line. Red indicates basal activity, green indicate high (Boolean nodes) or
intermediate activity (Multi-valued nodes), dark green indicate high activity (Multi-valued nodes).
In representative stable state, red and green indicates nodes with conserved activity, and the
yellow indicates nodes with variable activity. The symbol (-) in nodes in yellow indicate that all
values are identified in the stable states. The letters in yellow indicate exceptions for values 0 (a),
1 (b) and 2 (c). 
Figure S6. Basal cell-cell adhesion and high focal adhesion dynamics (C=2 & F= 0)
stable states. The stable states were computed as described in section 2.3.2. A representative
stable state that indicates the conserved and variable activity of the nodes is shown below dashed
line.  Red indicates basal  activity,  green indicate high (Boolean nodes) or intermediate activity
(Multi-valued nodes),  dark green indicate high activity (Multi-valued nodes).   In  representative
stable state, red and green indicates nodes with conserved activity, and the yellow indicates nodes
with variable activity. The symbol (-) in nodes in yellow indicate that all values are identified in the
stable states. The letters in yellow indicate exceptions for values 0 (a), 1 (b) and 2 (c). 
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Figure S8. Number of observations in the experiments on epithelial cell lines used
for model validation.  The values correspond to the experiments in  Table 5. Yellow indicate 1
collected  observation,  light  green  2  and  green  3  independent  observations  from  different
references. The purple bars indicate the total observations for each node.   
Figure  S7.  Intermediate cell-cell  adhesion  and  basal  focal  adhesion  dynamics
(C=1 & F= 0) stable states. The stable states were computed as described in section 2.3.2. A
representative  stable  state that  indicates  the conserved and variable  activity  of  the  nodes  is
shown below dashed line. Red indicates basal activity, green indicate high (Boolean nodes) or
intermediate activity (Multi-valued nodes), dark green indicate high activity (Multi-valued nodes).
In representative stable state, red and green indicates nodes with conserved activity,  and the
yellow indicates nodes with variable activity. The symbol (-) in nodes in yellow indicate that all
values are identified in the stable states. The letters in yellow indicate exceptions for values 0 (a),
1 (b) and 2 (c). 
143
 
Figure S9.  Comparison of model stable states for Epithelial and Mesenchymal
phenotypes with the ones of a published EMT model.  Epithelial and Mesenchymal
stable states of our model indicated in A and C, respectively. Epithelial and Mesenchymal stable
states of the model of Steinway [31] indicated in B and D, respectively. The representative stable
states were computed as described in section 2.3.2. Red indicate basal activity, green indicate
high (Boolean nodes)  or intermediate activity  (Multi-valued nodes),  dark green indicate high
activity (Multi-valued nodes). Yellow indicates nodes with variable activity, grey any value (*), and
the remaining colours conserved activity.  The symbol  (-)  in nodes in  yellow indicate that  all
values are identified in the stable states. The letters in yellow indicate exceptions for values 0
(a), 1 (b) and 2 (c). The symbol ? In white indicates nodes that are only included in our model.     
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Figure  S10.  Simulations  of  the  unperturbed model  for  normal  A-B and  chronic
inflammation conditions C-D. Initial and final states of simulations are indicated by the
arrows. 
Figure S11. Simulations of the model with SRC perturbation (SRC[FAK_SRC@0])
for normal A-B and chronic inflammation conditions C-D. Initial and final states of
simulations are indicated by the arrows. 
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Figure S12. Simulations of the model with FAT4 perturbation (FAT4[ERK@0]) for
normal  A-C and  chronic  inflammation  conditions  D-F. Initial  and  final  states  of
simulations are indicated by the arrows. 
5.3. Supplemental tables
Table S1. Network model components.   
Node Full name Regulatory  Module UniprotNCBI*
AKT RAC-alpha serine/threonine-protein kinase 1/2 AKT signaling
P31749 
P31751
b-Cat_mem Unphosphorylated form of β-catenin in the membrane Adherens junction P35222
b-Cat_nuc β-catenin in the nucleus Wnt signalling P35222
CD44 CD44 antigen ligand Focal adhesion P16070
CDH1 E-cadherin gene  Adherens junction 999*
CK1 Casein kinase 1 Wnt signalling P48729
CSL C protein binding factor 1/Suppressor of Hairless/Lag-1 complex. Notch signalling [91]
DELTA Delta-like protein ligand Notch signalling P78504 O00548
Dest_Complex β-catenin destruction complex Wnt Signalling [193]
DVL Human homologue of segment polarity protein dishevelled 1 Wnt signalling O14640
E-Cad_mem E-cadherin in the membrane Adherens junction P12830
ECM Collagen/fibronectin induced extracellular matrix stiffness Focal adhesion [194]
EGF Epidermal growth factor Adherens junction [149]
EGFR Human epidermal growth factor receptor family members 1 and 2 Adherens junction
P00533 
P04626
ERK Mitogen-activated kinase MAPK signalling P28482
FAK_SRC
Focal adhesion kinase (FAK) and tyrosine-
protein kinase Src (SRC) complex activity 
dynamics
Focal adhesion [140]
FAT4 Human homologue of Drosophila FAT4 protein receptor Hippo signalling Q6V0I7
FAT4L Generic Dsch1-like FAT4 ligand proteins Hippo signalling [41,43]
GSK3B Glycogen synthase kinase 3 beta Wnt Signalling P49841
HGF Hepatocyte growth factor Adherens junction P14210
HIF1a Hypoxia-inducible factor 1-alpha HIF1 signalling Q16665
IL6 Interleukin-6 JAK-STAT signalling P05231
ILK Integrin-linked protein kinase Focal adhesion Q13418
ITGab Transmembrane integrins alpha5beta1 Focal adhesion [154,195]
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JNK c-jun N-terminal kinase Focal adhesion {Formatting Citation}
LATS Large tumour suppressor complex LATS1/2 Hippo signalling O95835Q9NRM7
MEK Dual specificity mitogen-activated kinase kinase MAPK signalling Q02750
MET Hepatocyte growth factor receptor Adherens junction P08581
miR200 Micro RNA 200 family Adherens junction [196]
NFkB Nuclear factor NF-kappa-B complex AKT signaling
Q04206 
P19838 
Q00653
NOTCH Neurogenic locus notch homolog protein Notch signalling P46531
p120 Unphosphorylated form of δ-catenin in the membrane Adherens junction O60716
PAK Serine/threonine-protein kinase PAK1 Focal adhesion Q13153
PI3K Phosphatidylinositol 4,5-bisphosphate 3-kinase AKT signaling P42336
RAF1 Proto-oncogene serine/threonine-protein kinase Raf 1 MAPK signalling P04049
RAP1 Ras-related protein Rap-1 Focal adhesion P62834
RAS Ras GTPase family of proteins MAPK signalling P01116P01112
ROS Reactive Oxygen chemical Species HIF1 signalling [22,164]
RPTP Receptor-type Protein-Tyrosine Phosphatase family members Adherens junction
Q12913 
Q15262 
P28827
RPTPL Generic Receptor Protein-Tyrosine Phosphatase  Ligand Adherens junction [44]
SMAD SMAD 2, 3 and 4 signal transducer complex TGF-β signalling
P84022
Q13485
Q15796
SNAI Human homolog Zinc finger protein snail 1 and 2 Adherens junction
O95863
O43623
SRC Free form of proto-oncogene tyrosine-protein kinase Src Adherens junction P12931
STAT3 Signal transducer and activator of transcription 3 JAK-STAT signalling
P40763
TCF_LEF Transcription factor TCF/LEF family Wnt signalling
IPR024940
Q9NQB0
Q9UJU2
TGFb-TGFbR Transforming growth factor beta 1 ligand/receptor complex TGF-β signalling
P01137
P36897
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Wnt-Frizzled Human homolog Wnt and Frizzled ligand/receptor complex Wnt signalling
Q9UP38
P04628
YAP_TAZ Transcriptional co-activator YAP/TAZ Hippo signalling P46937Q9GZV5
ZEB Zinc finger E-box-binding homeobox protein1/2 Adherens junction
P37275
O60315
  
Table  S2.  Interactions of  the  network  and  their  effects.  N denotes  the  reference
number for each interaction in the model (section 3.2).  Interactions that are present in
KEGG PATHWAYS are indicated with  the letter  K,  the ones identified in  the Atlas of
Cancer Signalling Network (ACSN) with the letter A, and the ones included in the EMT
network model of Steinway [31] with the letter S.  References on each interaction are in
model_ documentation.xhtml file avaiable in gitub (see section 2.2.5 to get file).  
N Target Regulator Effect Slowest 
Mechanism
Main 
source
1 AKT PI3K Activation Phosphorylation K, S
2 AKT SNAI Activation Transcription A
3 AKT ILK Activation Phosphorylation K, S
4 b-Cat_mem RPTP Activation Dephosphorylation K
5 b-Cat_mem CDH1 Activation Molecular binding K, S
6 b-Cat_mem JNK Inhibition Phosphorylation L
7 b-Cat_mem MET Inhibition Phosphorylation K
8 b-Cat_mem SRC Inhibition Phosphorylation K
9 b-Cat_mem FAK_SRC Inhibition Phosphorylation K
10 b-Cat_nuc YAP_TAZ Activation Transport K
11 b-Cat_nuc Dest_Complex Inhibition Transport K, S
12 b-Cat_nuc b-Cat_mem Inhibition Transport K, S 
13 CD44 TCF_LEF Activation Transcription S
14 CDH1 SNAI Inhibition Transcription A, S
15 CDH1 ZEB Inhibition Transcription A, S
16 Cell-Cell  Adhesion E-Cad_mem Activation Molecular binding K 
17 Cell-Cell Adhesion b-Cat_mem Activation Molecular binding K
18 CK1 Wnt-Frizzled Activation Molecular binding K
19 CK1 Dest_Complex Inhibition Molecular binding K
20 CSL NOTCH Activation Transcription K, S 
21 Dest_Complex b-Cat_mem Activation Molecular binding K, S
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22 Dest_Complex GSK3B Activation Phosphorylation K, S
23 DVL YAP_TAZ Activation Molecular binding K
24 DVL Wnt-Frizzled Activation Phosphorylation K, S
25 E-Cad_mem RAP1 Activation Transport A
26 E-Cad_mem p120 Activation Molecular binding K
27 E-Cad_mem CDH1 Activation Transport S
28 EGFR CSL Activation Transcription L
29 EGFR ITGab Activation Molecular binding L
30 EGFR EGF Activation Molecular binding K, S
31 EGFR TGFb-TGFbR Activation Phosphorylation L
32 EGFR SRC Activation Phosphorylation S
33 EGFR RPTP Inhibition Dephosphorylation L
34 ERK MEK Activation Phosphorylation K, S
35 FAK_SRC ERK Activation Dephosphorylation L
36 FAK_SRC ITGab Activation Molecular binding K
37 FAK_SRC EGFR Activation Phosphorylation L
38 FAK_SRC MET Activation Phosphorylation K
39 FAK_SRC SRC Activation Phosphorylation K
40 FAK_SRC FAK_SRC Activation Phosphorylation K
41 FAT4 FAT4L Activation Molecular binding L
42 FAT4 ERK Inhibition Transcription A
43 Focal Adhesion  
Dynamics
PAK Activation Phosphorylation K
44 Focal Adhesion 
Dynamics
ITGab Activation Molecular binding K
45 Focal Adhesion 
Dynamics
FAK_SRC Activation Phosphorylation K
46 GSK3B DVL Inhibition Phosphorylation K, S
47 GSK3B ERK Inhibition Phosphorylation A, S
48 GSK3B AKT Inhibition Phosphorylation K, S
49 HIF1a STAT3 Activation Transcription K 
50 HIF1a ROS Activation Oxidation K
51 HIF1a NFkB Activation Transcription K
52 ILK ITGab Activation Molecular binding K
53 ITGab RAP1 Activation Transport A
54 ITGab CD44 Activation Molecular binding S
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55 ITGab TGFb-TGFbR Activation Molecular binding L
56 ITGab ZEB Activation Transcription A
57 ITGab ECM Activation Molecular binding K
58 JNK TGFb-TGFbR Activation Phosphorylation L
59 JNK RAS Activation Phosphorylation K
60 JNK IL6 Activation Phosphorylation K
61 JNK ERK Inhibition Phosphorylation L
62 LATS FAT4 Activation Molecular binding K
63 LATS E-Cad_mem Activation Molecular binding K
64 LATS b-Cat_mem Activation Molecular binding K
65 LATS PI3K Inhibition Phosphorylation K
66 MEK PAK Activates Phosphorylation K, S
67 MEK RAP1 Activation Phosphorylation K
68 MET CD44 Activation Phosphorylation S
69 MET ITGab Activation Phosphorylation L
70 MET HGF Activation Molecular binding K, S
71 MET RPTP Inhibition Dephosphorylation L
72 miR200 SNAI Inhibition Transcription A, S
73 miR200 ZEB Inhibition Transcription A, S
74 NFkB CSL Activation Transcription A
75 NFkB AKT Activation Phosphorylation K, S
76 NFkB ROS Activation Oxidation K
77 NFkB SMAD Activation Transcription A
78 NOTCH DELTA Activation Molecular binding K, S 
79 NOTCH DVL Inhibition Molecular binding K 
80 p120 RPTP Activation Dephosphorylation K
81 p120 CK1 Inhibition Phosphorylation L
82 p120 MET Inhibition Phosphorylation K
83 p120 SRC Inhibition Phosphorylation K
84 PAK MEK Activation Phosphorylation K
85 PAK PI3K Activation Phosphorylation K
86 PAK FAK_SRC Activation Phosphorylation K
87 PI3K RAS Activation Phosphorylation K , S
88 PI3K IL6 Activation Phosphorylation K
89 PI3K FAK_SRC Activation Phosphorylation K
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90 PI3K E-Cad_mem Inhibition Molecular binding L
91 PI3K b-Cat_mem Inhibition Molecular binding L
92 RAF1 RAS Activation Phosphorylation K, S
93 RAF1 MEK Activation Phosphorylation K, S
94 RAF1 ERK Inhibition Phosphorylation A, S
95 RAP1 CDH1 Activation Transport L
96 RAP1 FAK_SRC Activation Phosphorylation K
97 RAS EGFR Activation Phosphorylation K, S
98 RAS TGFb-TGFbR Activation Phosphorylation K, S
99 RAS MET Activation Phosphorylation K, S
100 RAS SRC Activation Phosphorylation K, S
101 RAS IL6 Activation Phosphorylation K, S
102 RAS FAK_SRC Activation Phosphorylation K  
103 RAS GSK3B Inhibition Phosphorylation K, S
104 RPTP RPTPL Activation Molecular binding L
105 RPTP ROS Inhibition Oxidation L
106 RPTP SRC Inhibition Transcription L
107 SMAD YAP_TAZ Activation Molecular binding K
108 SMAD TGFb-TGFbR Activation Phosphorylation K, S 
109 SMAD ILK Activation Phosphorylation A
110 SNAI ERK Activation Transcription A, S
111 SNAI CSL Activation Transcription A, S
112 SNAI JNK Activation Phosphorylation A, S
113 SNAI PAK Activation Transcription A, S
114 SNAI STAT3 Activation Transcription A, S
115 SNAI HIF1a Activation Transcription A, S
116 SNAI SMAD Activation Transcription A, S
117 SNAI TCF_LEF Activation Transcription A, S
118 SNAI NFkB Activation Transcription A, S
119 SNAI GSK3B Inhibition Phosphorylation A, S
120 SRC EGFR Activation Phosphorylation A, S
121 SRC MET Activation Phosphorylation K
122 SRC FAK_SRC Inhibition Molecular binding L
123 STAT3 JNK Activation Phosphorylation A
124 STAT3 SRC Activation Phosphorylation K, S
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125 TCF_LEF b-Cat_nuc Activation Molecular binding K, S 
126 TCF_LEF AKT Activation Phosphorylation L
127 TCF_LEF MET Activation Phosphorylation L
128 TCF_LEF p120 Inhibition Transcription L
129 TCF_LEF TCF_LEF Activation Molecular binding L
130 TGFb-TGFbR TCF_LEF Activation Transcription K, S 
131 Wnt-Frizzled TCF_LEF Activation Transcription K, S
132 YAP_TAZ LATS Inhibition Phosphorylation K
133 ZEB SMAD Activation Transcription A, S
134 ZEB miR200 Inhibition Transcription A, S
     
Table  S3.  Model  logical  functions  and  the  correspondent  type  of  regulatory
mechanisms (R.M.). The Logical operators are represented by the symbols & (AND), |
(OR) and ! (NOT).Post-translational mechanisms are indicated with PT and transcriptional
mechanisms with T.    
Node Logical function R.M.
NOTCH = 1 DELTA & ! DVL PT
CSL =1 NOTCH T + PT
TGFb-TGFbR =1 TCF_LEF T
SMAD = 1 TGFb-TGFbR & ILK & YAP_TAZ PT
MET = 1 (CD44 | HGF | ITGab) & !RPTP PT
EGFR = 1 (EGF | CSL | TGFb-TGFbR | SRC | ITGab) & !RPTP PT
RAS = 1 (TGFb-TGFbR | MET | FAK_SRC | IL6 | SRC | EGFR) & !GSK3B PT
RAF1 = 1 RAS & !ERK PT
MEK = 1 (RAF1 & RAP1) | PAK PT
ERK = 1 MEK PT
STAT3 = 1 JNK | SRC PT
JNK = 1  (RAS & TGFb-TGFbR & !ERK) | IL6 PT
AKT = 1 (PI3K | ILK) & SNAI T + PT
PI3K = 1 (RAS | FAK) & !b-Cat_mem & !E-Cad_mem PT
NfkB = 1 (AKT | ROS) & CSL & SMAD T+ PT
HIF1a = 1 ROS & (STAT3 | NFkB) T+ PT
Wnt-Frizzled = 1 TCF_LEF T+ PT
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DVL = 1 Wnt-Frizzled & YAP_TAZ PT
CK1 = 1 Wnt-Frizzled & !Dest_Complex PT
b-Cat_nuc = 1 !Dest_Complex & YAP_TAZ & !b-Cat_mem PT
TCF_LEF = 1 (!p120 & b-Cat_nuc) | (TCF_LEF & MET & AKT) T+ PT
CD44 = 1 TCF_LEF T
SNAI = 1 (ERK & SMAD & (TCF_LEF | CSL) & !GSK3B) | (JNK & SMAD &NFkB & (STAT3 | PAK | HIF1a)) T+ PT
ZEB = 1 !miR200 & SMAD T+ PT
ITGab = 1 ECM | ((TGFb-TGFbR | CD44 | ZEB) & RAP1) PT
ILK = 1 ITGab PT
PAK = 1 FAK_SRC | PI3K PT
FAK_SRC ITGab & EGFR & MET & ERK & (SRC | FAK_SRC) PT
RAP1 = 1 FAK_SRC | CDH1 PT
RPTP = 1 RPTPL & !ROS & !SRC T+ PT
SRC = 1 (MET | EGFR) & !FAK_SRC PT
FAT4 = 1 FAT4L & !ERK T+ PT
LATS = 1 (b-Cat_mem:1 & E-Cad_mem & !PI3K) | FAT4 PT
YAP_TAZ = 1 !LATS PT
GSK3B = 1 !DVL & !ERK & !AKT PT
Dest_Complex = 1 GSK3B & b-Cat_mem PT
miR200 = 1 !ZEB & !SNAI T
CDH1 = 1 !ZEB | !SNAI T
p120 = 1 (!MET & !SRC & !CK1) | RPTP PT
b-Cat_mem = 1 (!MET & !SRC & !FAK & !JNK & CDH1) | (RPTP & CDH1) PT
E-Cad_mem = 2
E-Cad_mem = 1
CDH1 & p120 & RAP1
CDH1 & RAP1 & !p120
T+ PT
Focal Adhesion 
Dynamics = 1 ITGab & PAK & FAK_SRC PT
Cell-cell
Adhesion:2
Cell-cell
Adhesion:1
b-Cat_mem & E-Cad_mem:2
E-Cad_mem:1 | (E-Cad_mem:2 & !b-Cat_mem)
PT
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Table  S4.  Parameters  used  in  the  simulations of  experiments  on epithelial  cell
lines. Only  the  nodes with  values  of  high/intermediate  activation  are  presented.  The
remaining nodes are set to value 0. 
Experiments Model 
inputs  (≠ 0)
Fixed               
perturbations  
Initial condition
 (≠ 0) 
IL6+ IL6 = 1 None 
Cell-Cell_Adhesion=2
E-Cad = 2
CDH1=1
b-Cat_mem=1
p120=1
miR200=1
GSK3b=1
LATS=1
EGF+ EGF = 1 None 
ECM+ ECM = 1 None 
EGF+ECM+ ECM = 1, EGF = 1 None 
HGF+ HGF = 1 None 
WNT+ None Wnt-Frizzled = 1
TGFb+ None TGFb-TGFbR = 1
EGF+ROS+ ROS = 1 , EGF = 1 None
P120 KO None p120 = 0
B-Cat_mem KO None b-Cat_mem = 0
CK1 E1 None CK1 = 1
CD44 E1 None CD44 = 1
SRC E1 None SRC  = 1
 
Table S5. Nodes of the Steinway EMT logical network model not included in the
logical network model of the regulation of cell adhesion properties.
Nodes Role in the regulation of EMT Cell adhesion regulatory network 
model.
SHH
PTCH
SMO
FUS
SUFU
GLI
Hedgehog signalling pathway.
Demonstrated in Steinway's work to 
directly joint Wnt signalling with TGF-beta
signalling through TCF/LEF activation.   
Considered effect and simplified by a 
direct arc between TCF/LEF and TGF-
beta (TCF_LEF → TGFb).
PDGFR
IGFR
FGFR
Activation of MAPK signalling cascade 
and none receptor tyrosine kinases by 
growth factors.
Not included in the model. These 
growth factors share similar signalling 
cascade activation. The regulatory 
effect is represented by EGF induced 
EGFR activation (the most abundant 
growth factor in epithelial cells). 
EGR1
c-fos 
Transcription factors that mediate  SNAI1 
activation via ERK.
Considered effect and simplified by a 
direct arc between  ERK and SNAI. 
Csn
Ikka
βTrCP
Signalling components that mediate  
NFkB activation by AKT and  SNAI1 
activation by NfkB. 
Simplified by removing mediators and 
linking AKT to NfkB and NfkB to SNAI  
with arcs (AKT→ NFkB → SNAI).
SNAI2 Transcription factors that participate in the Simplified by only considering the two 
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ZEB2 
TWIST1
FOXC2
transcription repression of E-cadherin 
together with SNAI1 and ZEB1.
main transcription regulators ZEB and 
SNAI family (two nodes).  
NOTCHic
HEY1
Participates in the down-regulation of E-
cadherin expression through the pathway 
NOTCH → NOTCHic → CSL→ HEY. 
The effect is considered via activation 
of SNAI.  
Simplified by considering a minimal 
path (NOTCH→ CSL → SNAI).  
LIV1 Participates in the activation of SNAI1 via STAT activation. 
Considered effect and simplified by a 
direct arc between STAT3 and SNAI. 
LOXL23 Participates in the activation of SNAI1 via HIF1a activation. 
Considered effect and simplified by a 
direct arc between HIF1a and SNAI. 
Frizzled
TGFbR
Membrane receptors of Wnt and TGF 
ligands.  
Simplified by considering one node for 
both  ligand and receptor (active 
receptor/ligand complex). 
Jagged Alternative NOTCH activating  ligand. Simplified by considering one node thatrepresents all DELTA-like ligands.   
Goosecoid 
Transcription factor involved in cell 
differentiation. 
Putative auto-regulation mechanism. 
Involved in EMT by inducing SNAI, ZEB 
and other TFs.   
Not considered in the model because it 
is not expressed in epithelial cells. 
Known to be expressed only during 
development.
CHD1L DNA damage response signal protein thattriggers EMT.  
DNA damage response was not 
considered in the cell adhesion model.
CDC42 Small GTPase that mediates PAK1 activity. 
Considered effect and simplified by a 
direct arc between FAK and PAK.
SOS
Grb2
Adapter proteins involved in MAPK 
signaling propagation.
Considered effect and simplified by a 
direct arc between growth factor 
receptor  and RAS. 
Axin2
Part of the deconstruction complex and 
considered to be auto-regulated
Simplified by assuming that is 
expressed and a part of the destruction 
complex. 
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Table S6. Model input conditions (microenvironment conditions) compatible with
the model adhesion phenotypes for each combination of cell-cell contact signals
(RPTP and FAT4 ligands). Focal adhesion dynamics is represented by the letter F and cell-cell
adhesion  by  the  letter  C.  The  percentage  of  the  remaining  microenvironments  for  a  given
combination of cell-cell contact signals is indicated in the last column.
Adhesion 
Phenotypes
Cell-cell contact 
signals 
(RPTPL, FAT4L)
Remaining microenvironment conditions
(IL6, ROS, ECM, EGF, HGF, DELTA)    %
C=2 &  F=0
RPTPL=0 & FAT4L=0
RPTPL=0 & FAT4L=1
RPTPL=1 & FAT4L=0
RPTPL=1 & FAT4L=1
IL6=ECM=EGF=HGF=DELTA=0
IL6=ECM=EGF=HGF=DELTA=0
ROS=0 |  IL6=ECM=EGF=HGF=DELTA=0
ROS=0 |  IL6=ECM=EGF=HGF=DELTA=0
3,1
3,1
51,6
51,6
C=1 & F=0
RPTPL=0 & FAT4L=0
RPTPL=0 & FAT4L=1
RPTPL=1 & FAT4L=0
RPTPL=1 & FAT4L=1
IL6=1 & ECM=EGF=HGF=DELTA=0 
IL6=1 & ECM=EGF=HGF=DELTA=0 |  IL6=0 
Not stable
IL6=ROS=1 & ECM=EGF=HGF=DELTA=0  |IL6=0
  
3,1
53,1
…… 
51,6
C=0 & F=1
RPTPL=0 & FAT4L=0
RPTPL=0 & FAT4L=1
RPTPL=1 & FAT4L=0
RPTPL=1 & FAT4L=1
All combinations 
All combinations
ROS=1
ROS=1  
100,0
100,0
50,0
50,0
Table S7.Model input configurations compatible with physiological scenarios used
in simulations.    
Physiological scenarios Input configuration  
Normal tissue
Basal level of growth factors, cytokines, ROS and ECM 
stiffness (low level of collagen type I and fibronectin) 
[22,23,197].
IL6=ROS=ECM=EGF=HGF=0
Tissue growth
High secretion of growth factors by Fibroblasts and 
adjacent Epithelial cells [149,150,197]  Stimulates cell 
proliferation to balance cell death. Occurs during tissue 
repair and tissue size homeostasis.
HGF=EGF=1 & IL6=ROS=ECM=0
Chronic Inflammation
Accumulation of collagen I, IL6 cytokine and HGF secreted 
by recruited Fibroblasts and Macrophages to inflammatory 
site [22,150].
IL6=ECM=HGF=1 & EGF=ROS=0
Hypoxia + chronic inflammation
Low levels of oxygen result in high levels of ROS [164]. 
These conditions together with chronic inflammation are 
frequently observed in invasive tumours [16,22,23].
IL6=ROS=ECM=HGF=1 & EGF=0
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Table S8. Comparison of the effects of single perturbations on model components
with the expression of these proteins in human carcinomas. The gains of a phenotype
in comparison to the unperturbed model phenotypes is  identified by the letter G and the loss of a
phenotype by the letter  L. Effects that favours or counteract tumour invasion are indicated in red
or green, respectively. Perturbations that maintain phenotypes are indicated by the letter M and the
ones that are not able to cause a gain are indicated by the letter N.  Focal adhesion dynamics is
abbreviated  by  F and  cell-cell  adhesion  by  C.  Protein  expression  levels  of  carcinomas  in
comparison to normal  issues were observed in the Human Protein  Atlas Database  [89,90] for:
Breast carcinoma (BC); Prostate carcinoma (PC); Colorectal carcinoma (CC) and Lung carcinoma
(LC).  Protein  expression  levels are  indicated  by  +  (high/medium),  -  (low  or  not  detected),   *
(variable), ? (not analysed). Correlations between perturbations and expression data indicated in
yellow.  
Model adhesion
phenotypes  
Protein Expression of
Carcinomas
Single 
Perturbations
F=0
C=2
F=1
C=0
F=1
C=2
F=1
C=1
BC PC LC CC
MET E1
EGFR E1
RAP1 KO
SRC E1
CDH1 KO 
TGFb-TGFbR KO
SMAD KO
MEK KO
ERK KO
TCF_LEF KO
SNAI KO
ZEB KO
ILK KO
RPTP E1
FAT4 E1
LATS E1
YAP_TAZ KO
miR200 E1
CDH1 E1
MET KO
Dest_Complex E1
p120 E1
b-cat_nuc KO
L
L
L
L
L
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
L
L
L
L
L
L
L
L
L
L
L
L
L
L
M
M
M
M
G
G
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
G
G
N
N
G
G
G
G
N
G
G
G
G
G
G
G
G
G
+
-
?
-
*
*
*
+
+
+
+
-
-
-
+
+
-
?
*
+
?
*
*
+
-
?
+
*
*
*
+
+
+
+
-
-
-
+
+
-
?
+
+
?
*
*
+
-
?
-
+
*
*
-
+
+
+
-
-
-
+
-
-
?
*
+
?
*
*
+
*
?
+
+
*
*
-
+
+
+
-
-
+
+
+
-
?
+
+
?
*
*
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Table S9. Comparison of the effects of double perturbations on model components
with the expression of these proteins in human carcinomas. The gains of a phenotype
in comparison to the unperturbed model phenotypes is  identified by the letter G and the loss of a
phenotype by the letter  L. Effects that favours or counteract tumour invasion are indicated in red
or green, respectively. Perturbations that maintain phenotypes are indicated by the letter M and the
ones that are not able to cause a gain are indicated by the letter N.  Focal adhesion dynamics is
abbreviated  by  F and  cell-cell  adhesion  by  C.  Protein  expression  levels  of  carcinomas  in
comparison to  normal  issues were observed in  the Human Protein  Atlas Database  [89,90] for:
Breast carcinoma (BC); Prostate carcinoma (PC); Colorectal carcinoma (CC) and Lung carcinoma
(LC).  Protein  expression  levels are  indicated  by  +  (high/medium),  -  (low  or  not  detected),   *
(variable), ? (not analysed). Correlations between perturbations and expression data indicated in
yellow.   
Model adhesion
phenotypes  
Protein (Pi) 
Expression
Protein (Pj) 
Expression
Double Perturbations
(Pi, Pj)
F=0
C=2
F=1
C=0
F=1
C=2
F=1
C=1
BC PC LC CC BC PC LC CC
NOTCH E1, RPTP KO
CSL E1, RPTP KO
TGFb-TGFbR E1, RPTP KO
JNK E1, RPTP KO
CK1 E1, RPTP KO
TCF_LEF E1, RPTP KO
CD44 E1, RPTP KO
ZEB E1, RPTP KO
SMAD E1, SNAI E1
PI3K E1, TCF_LEF E1
TCF_LEF E1, LATS KO
TCF_LEF E1, YAP_TAZ E1
SNAI E1, ZEB E1
MET KO, EGFR KO
MET KO, Wnt-Frizzled KO
MET KO, CK1 KO
MET KO, b-Cat_nuc KO
MET KO, Dest_Complex E1
MET KO, p120 E1
AKT KO, b-Cat_nuc KO
AKT KO, Dest_Complex E1
AKT KO, p120 E1
MET E1, p120 KO
EGFR E1, p120 KO
L
L
L
L
L
L
L
L
L
L
L
L
L
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
L
L
L
L
L
L
L
L
L
M
M
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
G
G
+
?
*
*
-
+
*
-
*
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
+
?
*
*
-
+
*
-
*
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
+
?
*
*
-
+
*
-
*
+
+
+
+
+
+
+
+
+
+
*
*
*
+
-
+
?
*
*
+
+
*
-
*
+
+
+
+
+
+
+
+
+
+
+
+
+
++
*
-
-
-
-
-
-
-
-
+
+
+
-
-
-
?
-
*
?
*
*
?
*
*
*
-
-
-
-
-
-
-
-
+
+
+
-
-
-
?
-
*
?
*
*
?
*
*
*
-
-
-
-
-
-
-
-
+
+
-
-
-
-
?
-
*
?
*
*
?
*
*
*
+
+
+
+
+
+
+
+
+
+
+
-
-
*
?
*
*
?
*
*
?
*
*
*
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Table  S10.  Impact  of  perturbations  on  model  interactions  in  terms  of  the
reachability  of  adhesion  phenotypes  under  chronic  inflammation  and  RPTPL
signals. The  probabilities  of  reaching  adhesion  phenotypes  were  estimated  by  simulation  in
GINsim using the method described in section 2.4.3. The letters C and F means cell-cell adhesion
and Focal adhesion, respectively.  The correspondent phenotypes are abbreviated by the letters E
(Epithelial), H (Hybrid), A (amoeboid-like), and M (Mesenchymal). All simulations started from all
state  space  and  with  the  inputs  that  describe  the  chronic  inflammation  conditions
(IL6=ECM=HGF=1 & ROS=EGF=0) with high RPTPL signals (RPTP=1 & DELTA=FAT4L=0).  
Perturbations on model interactions Reachable Adhesion Phenotypes
Unperturbed F = 0 & C = 2 (E, p = 1)
Ectopic activation of SRC –| RPTP F = 1 & C = 0 (M, p = 1)
KO of RPTP → p120 F = 0 & C = 2 (E, p = 0.9) F = 0 & C = 0 (A, p = 0.1)
KO of RPTP → b-Cat_mem F = 0 & C = 1 (I, p = 1) 
KO of RPTP –| EGFR F = 1 & C = 2 (H, p = 1) 
KO of RPTP –| MET F = 1 & C = 2 (H, p = 0.8) F = 1 & C = 0 (M, p = 0.2)
KO of RPTP –| MET 
KO of RPTP –| EGFR 
F = 1 & C = 2 (H, p = 0.9) 
F = 1 & C = 0 (M, p = 0.1)
KO of RPTP –| MET 
KO of RPTP → b-Cat_mem  
F = 1 & C = 1 (H, p = 0.8) 
F = 1 & C = 0 (M, p = 0.2)
KO of RPTP  →  p120 
KO of RPTP → b-Cat_mem  
F = 0 & C = 0 (A, p = 1)
KO of RPTP –| MET 
KO of RPTP → b-Cat_mem
KO of RPTP  →  p120  
F = 1 & C = 0 (M, p = 1)
KO of RPTP –| EGFR
KO of RPTP → b-Cat_mem
KO of RPTP  →  p120  
F = 0 & C = 0 (A, p = 1)
Ectopic activation of MET → FAK_SRC F = 1 & C = 2 (H, p = 0.8)F = 0 & C = 2 (E, p = 0.2)
Ectopic activation of  EGFR → FAK_SRC F = 1 & C = 2 (H, p = 0.8)F = 0 & C = 2 (E, p = 0.2)
Ectopic activation of MET → FAK_SRC
Ectopic activation of EGFR → FAK_SRC
F = 1 & C = 2 (H, p = 0.8)
F = 0 & C = 2 (E, p = 0.2)
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Table  S11.  Impact  of  perturbations  on  model  interactions  (Hippo  signalling)  in
terms of the reachability of adhesion phenotypes under chronic inflammation and
ectopic FAT4 signals. The probabilities of reaching adhesion phenotypes were estimated by
simulation in GINsim using the method described in section 2.4.3. The letters C and F means cell-
cell adhesion and Focal adhesion, respectively.  The correspondent phenotypes are abbreviated by
the  letters  E  (Epithelial),  H  (Hybrid),  A (amoeboid-like),  and  M (Mesenchymal).  All  simulations
started from all state space and with the inputs that describe the chronic inflammation conditions
(IL6=ECM=HGF=1 & ROS=EGF=0) with high RPTPL signals (RPTP=1 & DELTA=FAT4L=0).  
Perturbations on model interactions Reachable Adhesion Phenotypes
FAT4 ectopic activation (FAT4 E1) F = 1 & C = 1 (H, p = 1)
FAT4 E1
KO of FAT4 → LATS F = 1 & C = 0 (M, p = 1)
FAT4 E1
KO of LATS –| YAP_TAZ F = 1 & C = 0 (M, p = 1)
FAT4 E1
Ectopic activation of  YAP_TAZ → b-Cat_nuc F = 1 & C = 1 (H, p = 1)
FAT4 E1
Ectopic activation of  YAP_TAZ → SMAD
F = 1 & C = 1 (H, p = 0.9)
F = 1 & C = 0 (M, p = 0.1) 
FAT4 E1
Ectopic activation of  YAP_TAZ → DVL F = 1 & C = 1 (H, p = 1)
FAT4 E1
Ectopic activation of  YAP_TAZ → SMAD
Ectopic activation of  YAP_TAZ → DVL
F = 1 & C = 1 (H, p = 0.9)
F = 1 & C = 0 (M, p = 0.1) 
FAT4 E1
Ectopic activation of  YAP_TAZ → SMAD
Ectopic activation of  YAP_TAZ → b-Cat_nuc
F = 1 & C = 0 (M, p = 1) 
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1. Discussion 
Advances in the study of EMT in cancer context have been limited by its complex
regulation  involving  multiple  signals  from  the  tumour  microenvironment  and
multiple  intertwined  signalling  pathways  [1,2].  This  has  been  a  challenge  for
systems biology approaches to evaluate multiple hypotheses and generate new
testable predictions  [3,4]. Hopefully, to elucidate the mechanisms of metastasis
and identify new drug targets that could help the design of therapeutic strategies
to fight cancer [4].
In this thesis, we developed the first computational model for the regulation of cell
adhesion properties involved in EMT and cancer invasion, accounting for multiple
microenvironment  signals.  The  model  also  accounted  for  main  signalling
pathways   involved  in  EMT  and  allows  to  distinguish  single  (Mesenchymal
phenotype)  from  collective  (Hybrid  phenotype)  forms  of  cancer  invasion.  We
analysed  the  conditions  that  result  in  the  switching  between  Epithelial,
Mesenchymal  and  Hybrid  phenotypes  and  accessed  the  hypothetical  role  of
neighbouring cells signals through the cell-cell contact activation of RPTPs and
FAT4. The model analysis revealed that these signals play a role in the control
EMT and pinpointed mutational and microenvironment deregulations that favour
invasion of carcinomas.  In this chapter, we discussed the main advances from
this work and their limitations highlighted.
1.1.  A computational model of cell adhesion
Within this thesis, we proposed a new computational model for the regulation of
cell adhesion properties involved in EMT and carcinomas invasion, based on the
logical framework initially proposed by Rene Thomas [5]. Our modelling approach
contributed to access multiple combinatorial effects of signals from the tumour
microenvironment  (28 combinations  of  signals)  making  this  the  largest  set  of
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signals analysed so far. In addition, we applied the model to evaluate the impact
of single and double mutations in cancer. With this framework, we overcome the
lack of kinetic characterization of most processes involved in EMT and provide a
simple alternative way that consists on a qualitative view of EMT regulation. In
this model, we abstracted the main biochemical regulatory mechanisms involved
in  EMT into  influence effects  which constitutes  a  simplified  view of  biological
processes.  Time  and  dose-dependent  effects  (e.g.  concentration  of  active
molecules) are highly abstracted in this approach, which came with the cost of
losing predictive resolution, resulting in a superficial view of the EMT regulation
(binary effects). The size of the model variables (51 nodes) also brings noise to
predictions, which requires a carefully interpretation of the outcomes. Thus, the
results from the model should be interpreted as extreme cases in biology, where
the  activation  of  signalling  cascades  are  saturated  by  the  microenvironment
signals (strong signal) or basal (having no effect). Since we do not know from the
model the exact concentrations or activity thresholds, the predictions from the
model may not be verified if the degree of signalling activity in the experimental
conditions are between strong and basal.        
To  make  biologically  relevant  predictions  for  generic  Epithelial  cell  types,  we
developed the model  based on literature  knowledge for  the  regulation  of  cell
adhesion coming from the curated KEGG PATHWAYS, Atlas of Cancer Signalling
Network, together with hundreds of reports of individual effects in Epithelial cell
lines  [6,7].  Despite  of  accounting  for  a  considerable  amount  of  reported
regulatory effects, in cancer research the literature is too extensive to cover all,
with new publications every month. For the microenvironment, we just accounted
for a few relevant signals (8 signals) in comparison to the ones a cancer cell can
be exposed, particularly in the case of cell-cell contact signalling [8–10]. Thus our
model describes only a part of the  microenvironment and its predictions should
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be taken with reserve, assuming no other signals interfere. Nevertheless, this is
the most detailed model in terms of microenvironment signals and accounts for
the regulatory processes within the most detailed published EMT network model
[11]. Importantly, we have included additional details not yet analysed in the EMT
context,  such  as  the  integrin  signalling,  phospho-regulation  of  the  E-
cadherin/catenins complex and the Hippo signalling [11,12]. These features have
been considered to be quite relevant for the regulation of cell adhesion and EMT
signalling  pathways  to  be  neglected  [13–17].  With  these  features,  we
complemented  the  existent  models,  challenged  our  model  predictions,  and
provided new original predictions for the study of EMT in carcinomas.  Despite all
limitations,  the  model  was  successful  in  recapitulating  several  biological
observations  in  terms  of  phenotypes,  molecular  activity  and  reported
microenvironmental  and  mutational  effects  (sections  3.3-3.5  in  chapter  2).  In
principle, the computational model can be applied to any type of Epithelial cells
since  it  was  developed  without  any  cell  type  specificity.  Moreover,  we
recapitulated  features  from other  cellular  processes  such  as  the border  cells
migration  and  experiments  on  different  Epithelial  cell  types  with  and/without
cancer. Thus, we developed a model that can also be used in biological problems
in other cellular contexts such as development and wound healing. 
1.2. The role of cell-cell dependent RPTPs
In this thesis, we found that the activation of RPTPs in our network model by an
external signal from neighbouring cells (cell-cell contacts) was capable of keeping
the  Epithelial  adhesion  in  the  presence  of  growth  factors  and  ECM stiffness
(sections 3.6, 3.7, and 3.9 of chapter 2). Importantly,  the model predicted that
RPTP activation was also capable of switching the phenotypes (Mesenchymal or
Hybrid) in favour of Epithelial phenotype (section 3.9 of chapter 2). Although this
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is not proven, our prediction already makes an important contribution to the field
with  the  identification  of  a  novel  mechanism  for  the  control  of  EMT  [1,2,4].
Moreover, the predicted effect of RPTP activation provides the first mechanistic
explanation  for  the  microenvironment  induced  MET  in  normal  and  cancer
contexts  [18,19]. In this thesis, we propose that a strong activation of RPTP by
neighbouring  cells  would  be  able  to  control  of  EMT.  This  implies  that  RPTP
activation keeps RTK inhibited even in the presence of RTK activating signals
(growth  factors).  Indeed  this  is  possible  based  on  the  1000-fold  higher  rate
constants of activity of RPTPs in comparison with the ones reported for RTKs
[20]. It is expected that this strong activation of RPTPs is stimulated in particular
high cell confluence conditions that guarantee enough cell-cell contacts to ensure
high  stability  of  RPTP  in  the  membrane,  where  their  targets  are  localised
(catenins  and RTKs)  [21].  In  theory,  this  implies that  EMT is  favoured in  low
numbers of neighbouring cells and MET in high numbers of neighbouring cells,
assuming  they  express  RPTPs  and  their  ligands  in  all  cell  types  (Epithelial,
Hybrid and Mesenchymal cells). This would effectively control EMT based on the
demand and explain its transient behaviour in wound healing [18]. In cancer, EMT
is considered to promote invasion,  thus it  is  expected that cancer cells would
overcome this control mechanism by either mutations or inhibitory mechanisms.
Several RPTPs have been found to be expressed in most Epithelial tissues and a
few have been found to be down-regulated in cancer [21,22]. Thus, our prediction
can be applied to an entire class of proteins that requires a join activation, or in
alternative a particular type of RPTPs. Only a very small set of RPTPs have been
proven to be controlled by cell confluency through cell-cell contacts by homophilic
(RPTP-k) or other type of ligands (DEP-1) [21]. Thus our predictions place RPTP-
k and DEP1 as been hypothetically involved in the control of EMT that potentially
can prevent tumour cells from invading the primary site. This may help in the
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future the design of new therapeutic strategies that explore the RPTPs effects, or
a particular RPTP activation to prevent tumour cells to invasion primary site via
EMT (formation of Mesenchymal tumour cells). 
1.3. Critical deregulations promoting EMT in carcinomas
From  multiple  hypotheses,  with  our  approach  we  identify  few  critical
deregulations that potentially in abnormal EMT in carcinomas (sections 3.6, 3.7,
and  3.8  of  chapter  2).  The  tumour  microenvironment  composed  of  hypoxia
together  with  signals  from  chronic  inflammation  was  shown  to  result  in  an
irreversible EMT behaviour (section 3.8 in chapter 2). SRC overexpression was
also shown to be result in a irreversible EMT behaviour (section 3.10 of chapter
2). Such irreversible behaviour would lead to the accumulation of Mesenchymal
cells in the tumour, placing these perturbations to potentially favour invasion of
carcinomas. Both deregulations are found in carcinomas and correlated with the
metastable phenotype [23,24]. Further, these behaviours were associated to the
capacity of these deregulations to inhibit RPTPs activity by either an oxidation
mechanism  (hypoxia)  or  an  transcriptional  mechanism  (SRC).  Once  these
perturbations  inhibit  RPTPs,  EMT no  longer  is  able  to  be  controlled  by  our
proposed mechanism. This places Hypoxia and SRC overexpression in chronic
inflammation microenvironment as deregulations in  cancer that  are enough to
promote invasion through Mesenchymal cells. Thus, our modelling work provides
a  new  mechanistic  explanation  for  the  acquisition  of  invasion  properties  in
carcinomas through EMT. These predictions are consistent with the idea of both
mutational or microenvironment origin of metastasis,  and supports the idea of
SRC  inhibitors  and  antioxidants  usage  as  therapeutic  strategies  to  prevent
metastasis.  However,  our  predictions  are  conditioned  by  the  supporting  data
associated to RPTP-k, which could not be true for other RPTP such as DEP-1.
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This means that other RPTPs could be insensitive to ROS or not subject to SRC
mediated  transcriptional  regulation.  Nevertheless,  because  RPTP-k  is  always
expressed in Epithelial cells it is expected at least the observation of some mild
effects experimentally [21]. 
1.4. The stability of Hybrid phenotypes
Our modelling work explored both microenvironment and mutational causes of
the stability of Hybrid phenotypes, which are implicated in ensuring collective cell
migration of carcinomas (sections 3.7 of chapter 2). Our workflow provided the
identification of some putative perturbations that could promote the stability of
hybrid phenotypes. Some are clinically relevant such as the cases of SMAD and
TGF-β inhibitions, which provides an warning for the usage of drugs to inhibit this
targets  in  cancer  therapy.  Strikingly,  we  also  found  that  the  uncontrolled
expression (overexpression) of FAT4 in cancer have the potential to stabilize the
Hybrid adhesion phenotype. Our finding provided a putative novel role for the
human FAT4 genes, frequently overexpressed in carcinomas. These genes are
usually considered as tumour suppressors by their capacity to result in tumour
growth inhibition, making this finding unexpected [25]. Our modelling work, further
predicts  that  the  stability  of  the  Hybrid  phenotype  requires  the  presence  of
microenvironment signals that are considered as drivers of EMT (HGF, EGF and
ECM stiffness). This makes sense since Hybrid phenotypes result  from partial
EMT and also explains how SMAD and TGF-β inhibitions can lead to Hybrid
phenotype.  Interestingly,  Hybrid  stability  is  predicted  to  depend  on  cell-cell
contact signals from neighbouring cells for the activation of FAT4 by its ligands
without activating RPTP. In principle, this could be achieved either by hypoxia,
SRC  overexpression  or  by  mutations  in  RPTP ligands.  Hypoxia  is  the  most
plausible,  which  could  explain  the  switching  behaviour  when  tumour  cells
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colonize  normal  tissues.  Although  Hybrid  stability  is  crucial  for  collective  cell
migration, the formation of the clusters is expected to be more complex. Further
work in a multicellular context is required to understand how these clusters are
formed  and  how  invasion  and  colonization  operate.  Taken  all  together,  we
propose  the  FAT4  overexpression  as  a  critical  alteration  that  is  a  promising
candidate to promote collective cell migration in carcinomas.  
2. Conclusions
Based on the results from the computational model presented in this thesis, the
following conclusions can be outlined:
• A novel computational model was developed for generating  predictions of
adhesion  properties  characteristic  of  distinct  modes  of  migration
accounting for multiple microenvironment signals, which can be applied to
other questions and cellular contexts.      
• Cell-cell contact signals that strongly activate RPTPs could prevent EMT
and stimulate MET in the presence of growth factors and ECM stiffness,
which is novel mechanism to control EMT.       
• The tumour microenvironment (hypoxia with chronic inflammation signals)
and the reported SRC overexpression in cancer are critical deregulations
that would favour carcinomas invasion by overcoming the control of EMT
by RPTPs.   
• The  overexpression  of  FAT4  may  stabilize  collective  migration  of
carcinomas in the presence of EMT driving signals and neighbouring cells
signals (cell-cell contacts) that only activate FAT4 receptors (not activate
RPTPs), a novel function for FAT4 genes.
Taken  together,  the  predictions  generated  in  this  thesis  make  an  important
contribution to the understanding of the how EMT is controlled by signals in the
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tumour microenvironment. In this work, we raised new testable hypotheses that
explain  invasion  of  carcinomas  and  pinpointed  critical  alterations  that  favour
single and collective invasion. These predictions further highlighted the role of
neighbouring cells signals in cancer invasion and metastasis. 
3. Future work
In  this  thesis,  we  provided  predictions  that  imply  novel  mechanisms  that
hypothetically  could  be  used  to  prevent  metastasis  and  thus  they  should  be
experimentally tested in a future work. The most important to be tested is the
hypothetical role of RPTP as a control mechanism of EMT and its disruption by
SRC overexpression. At the time of the writing of this thesis, in vitro experiments
that test the effect of RPTP-k overexpression in breast cancer cell lines with and
without  SRC  overexpression/overactivation  already  started  by  the  Lab  of
Florence Janody. It would be also relevant to test the hypothesis that the RPTP-k
needs to be stabilized in the membrane by cell-cell contacts to have an effect.
Additional  modelling  work  that  explores  the  kinetic  properties  of  RPTP-k
mechanisms  in  combination  with  these  experiments  would  also  help  to
understand in deph how to control EMT in the cancer context. 
The predicted role of FAT4 overexpression in driving collective cell migration in
our  modelling  work  would  also  be  relevant  to  test  experimentally  in  vitro for
carcinoma cell lines. Importantly, studies that better characterize the RPTP and
FAT4  ligands  in  Epithelial,  Mesenchymal  and  Hybrid  cell  types  in  terms  of
expression  and  regulation  would  provide  additional  insights  on  the  role  of
neighbouring cells in cancer. Extending our model to a multicellular context using
cellular  automata  tools  (e.g.  Epilog)  would  provide  further  insights  on  the
dynamics of how collective invasion and metastasis of tumours is formed under
the influence of neighbouring cells signals. 
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In cancer therapy, the RPTP EMT control mechanism and FAT4 effect on the
stability  of  hybrid  phenotype  highlighted  in  this  modelling  work  can  also  be
explored, in particular for testing combinations of drugs that improve the control
of cancer spreading. In the case of RPTP, drugs that target its stability in the
membrane in  combination  with  antioxidants  (to  prevent  its  inactivity  by ROS)
would be potential candidates to reduce cancer invasion. In addition, additional
combination with drugs that target SRC would be a fruitful candidate in the case
of cancers that overexpress SRC. In the case of cancer that overexpress FAT4,
the development and usage of dugs that destabilize FAT4 in the membrane may
additionally help in preventing cancer invasion via the formation of collective cell
migration.  Furthermore, the predicted effects of inhibiting MAPK signalling and
the combination  of  AKT/MET with  CK1 inhibition  should  also  be  explored  as
possible drug targets to prevent cancer invasion.  Together,  these experiments
and additional modelling work would undoubtedly help clarify the fascinating and
unexpected roles of the RPTP and FAT4 by cell-cell contacts in cancer.      
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